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The rationale and scope of this review
The  first  Genetically  Modified  (GM)  Crops  have  been  put  on  the  market  in  the  mid­
nineties. Since then, uneven developments have occurred from one continent or group of 
countries to another. This working document analyses the extent and the main reasons for 
these uneven developments, with special emphasis on underlying economic issues which 
are of direct interest for the agri-food sector.
A  review  of  the  economic  literature  helped  to  find  answers  to  three  main  questions 
concerning the agri-food sector.
1.  How fast and to what extent have GM sowings developed?
Various tables and graphs on areas sown with GM seeds since 1996, broken down by 
countries and by type of crops, allow for judging on the rate of progression and the 
magnitude of GM sowings.
2.  Which reasons explain the rapid adoption of GM crops by farmers?
As  for  other  innovations,  the  rapid  uptake  of  GM  crops  is  driven  by  profitability 
expectations.  Have  these  expectations  been  met?  Is  profitability  the  only  driving 
force  behind  the  rapid  adoption  of  GM  crops?  The  review  focuses  on  studies 
analysing  the  profitability  of  the  mainly  grown  GM  crops.  Such  studies  are  mainly 
available for Northern America.
Farmers  have  been  the  first  target-group  in  the  strategies  of  biotech  and  seed 
industries,  as  the  first  generation  of  GM  crops  incorporates  agronomic  traits,  like 
herbicide  tolerance  or  insect  resistance.  The  approach  of  both  farmers  and  biotech 
firms  has  mainly  been  input-oriented.  At  the  outset,  reactions  down  the  food  chain 
have been underestimated.
3.  Which are the consequences of citizens’/consumers’ reactions and food 
suppliers’ initiatives?
Recent  developments  on  the  demand  side  have  a  cascading  effect  on  the  upstream 
sector. Based on consumer resistance to GM foods, many food suppliers have taken 
a restrictive stance to GM food. In the EU, food processors and retailers are trying 
to  avoid  or  to  restrict  GM  food.  In  the  US  and  in  Canada,  some  grain  traders  and 
processors  are  considering  segregating  GM  and  non-GM  crops  for  meeting  the 
differentiated  export,  or  even  domestic,  demand.  Segregating  implies  setting  up, 
organising and monitoring separate market channels for GM and non-GM products, 
throughout  the  food-chain.  One  step  further  is  identity  preservation,  a  production 
and marketing process which preserves the source and the nature of a specified crop. 
In the case of GM crops with quality traits (second generation), identity preservation 
is necessary for  preserving their value. Identity preservation of  GM products would 
be  a  move  away  from  the  mainstream  of  commodity-based  trading.  However, 
identity preservation is already implemented for some speciality products. Could it be 
extended to separate GM and non-GM crops, at what costs and for which benefits? 
How are the additional costs and benefits distributed along the food chain? What are 
the consequences for cropping and trading practices?
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agri-food  sector,  this  report  does  not  address  other  important  issues.  The  reasons 
explaining the uneven developments of plant biotechnology throughout the world are not 
only of an economic nature and the implications of this new technology go beyond the 
agri-food sector.
Other issues have an economic impact on the agri-food sector, in particular developments 
in  technology,  science  and  legislation.  Risk  assessment  with  regard  to  food  safety  and 
environment  and  related  regulatory  approaches  are  not  covered  in  this  report.  Some 
regulatory  elements  dealing  with  risk  management  and  consumer  choice  are  however 
taken into account, where they have a direct impact on the agri-food sector. For example, 
traceability and compulsory labelling of GM products will imply adjustments in farming 
and trading practices.
This  review  of  existing  economic  literature  on  GM  crops  intends to provide a  basis for 
further analysing the impact of plant biotechnology on the European agri-food sector.
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A review of the available literature helped to answer three main questions:
(1)  How fast and to what extent have sowings of GM crops developed? Which crops 
are concerned?
(2)  Which economic reasons explain the rapid adoption of GM crops by farmers?
(3)  Which are the consequences of citizen/consumer reactions and food suppliers' 
initiatives?
The analysis follows the path of the food chain, from the supply side up to final demand 
(see figure). This approach takes into account the chronology of developments regarding 
agri-biotechnology, but it also allows for analysing driving forces and interactions between 
the main stakeholders all along the food chain.
Figure  GMOs in the food chain, stakeholders and issues
The  supply-oriented  approach  of  both  biotech  companies  and  farmers  has  been  quickly 
confronted with reactions stemming from the downstream side of the food chain. Citizen 
and consumer concerns on biotechnology have been echoed and amplified by NGOs and 
retailers, in particular in Europe. Their reactions provoked a cascading effect back to the 
upstream  side  of  the  food  chain.  Several  initiatives  to  segregate  GM  and  non-GM  crops 
and to introduce Identity Preservation all along the food chain developed.
The  first  chapter  provides  a  global  picture  of  areas  sown  to  GM  crops  throughout  the 
world. The first significant commercial sowings of GM crops (2.6 Mio ha) took place in 
1996, almost exclusively in the US. Since 1996, the areas have rapidly expanded to reach
41.5  Mio ha in 1999. GM crops are mainly grown on the American continent: the USA 
accounts for 70% of worldwide sowings of GM crops, Argentina for 14% and Canada for 
9%.  Of  the  41.5  Mio  ha  sown  in  1999,  53%  were  soybeans,  27%  com,  9%  cotton,  8% 
rapeseed  and  0.1%  potatoes.  These  crops  have  been  genetically  modified  to  be  more 
resistant to pests or/and tolerant to herbicides.
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industries",  which  are  active  in  human,  animal  and  plant  health.  Their  experience  in 
pharmaceutical  biotechnology  and  their  crop  protection  activities  allowed  them  to 
implement and to amplify biotechnology for agricultural purposes. The life science sector 
is  undergoing  a  rapid  consolidation  process.  In  this  context,  the  development  of 
biotechnology  has  increased  concentration  on  the  upstream  side  of  agriculture.  Biotech 
companies  are  not  only  leaders  in  crop  protection,  but  most  of  them  also  hold  key 
positions  on  the  seed  market.  Farmers  adopting  biotechnology  are  confronted  with  a 
certain  number  of  constraints:  GM  seeds  are  often  sold  and  grown  under  contract,  they 
are more expensive than conventional ones, in some cases seed-saving is forbidden. As a 
result  of  increased  concentration  and  constraints,  farmers  depend  more  and  more  on  a 
limited number of input suppliers for crop production.
Farmers in Northern America and in Argentina have quickly and massively adopted GM 
crops.  Does  this  mean  that  farm-level  benefits  of  biotechnology  outweigh  the  above- 
mentioned  constraints?  Chapter  3  analyses  the  economic  reasons  for  the  rapid  and  vast 
uptake of GM crops by US farmers. They had strong profitability expectations. However, 
the studies reviewed do not provide conclusive evidence on the farm-level profitability of 
GM crops. Other factors have played a significant role. In practice, the most immediate 
and tangible ground for satisfaction appears to be the combined effect of performance and 
convenience of GM crops, in particular for herbicide tolerant varieties. These crops allow 
for  a  greater  flexibility  in  growing  practices  and  in  given  cases,  for  reduced  or  more 
flexible  labour  requirements.  This  convenience  effect  should  translate  into  increased 
labour productivity and savings in crop-specific labour costs. However, this effect is not 
always  properly  assessed  in  profitability  studies.  It  rather  translates  in  terms  of 
attractiveness of GM crops for efficiency purposes. For insect resistant crops like Bt com, 
yield losses are more limited than for conventional com, however the cost-efficiency of Bt 
com depends on a number of factors, in particular growing conditions.
Profitability of GM crops should be analysed within a long-term timeframe. First, there are 
important yearly fluctuations in yields and prices, and it is difficult to isolate the possible 
effects of biotechnology. Second, developments on the supply and on the demand side of 
the  food  chain  have  to  be  considered  together.  While  more  and  more  farmers  were 
adopting biotech crops in the US, in Argentina and in Canada, concerns about GM food 
were intensifying on the demand side, in particular in countries which are importing GM 
crops.
Chapter  4  provides  an  overview  of  differences  in  citizen  concerns  and  consumer 
preferences  between  the  EU  and  Northern  America.  These  differences  had  direct 
consequences on the strategy of retailers. European retailers have moved first to meet and 
further shape the demand for non-GM food, in contrast with the “wait-and-see” approach 
adopted by the bulk of North American retailers. The restrictive stance of EU consumers 
and  retailers has cascading effects back  to the upstream side of the food chain, both on 
domestic and on foreign markets.
In the EU, a prominent strategy of food processors is currently to avoid or to restrict GM 
food.  In  the  US  and  in  Canada,  some  grain  traders  and  processors  have  started 
segregating  GM  and  non-GM  crops  in  order  to  meet  the  differentiated  export  -or  even 
domestic-  demand.  Identity  Preservation  (IP)  and  traceability  are  concepts,  which  go 
beyond segregation and allow for keeping track of the origin and the nature of crops. The 
economic  implications  of  Identity  Preservation  and  of  GM  labelling  are  analysed  in 
Chapter 5.
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and  specialisation  will  remain  partially  unused.  Following  EU  legislation  three  different 
approaches to IP have been identified in the GMO context: voluntary IP of specific GM 
traits,  voluntary  IP  of  GMO-free  products  and  compulsory  IP  for  GM  products 
(traceability).
Identity Preservation is a move away from commodity trade and it implies additional cost 
at all stages of the food chain. According to the literature available they range between 5 
and 25 €/t, depending on the product and the IP system, which represents 6 - 17% of the 
farmgate  price  of  the  different  crops.  A  critical  factor  to  determine  the  cost  -  among 
others - will be the tolerance level for contamination. The distribution of these additional 
costs  along  the  food  chain  depends  on  a  number  of  factors,  in  particular  the  price 
responsiveness,  the  availability  of  substitutes  and  the  market  structure.  The  short-term 
development  of  prices  on  differentiated  markets  for  GM  and  non-GM  products  will 
depend on the size of supply and demand, opportunities for substitution are more limited 
for  non-GM  products  than  for  GM-products.  Currently  farmers  may  receive  a  premium 
for non-GM soybeans and corn.
Soybeans  and  com  are  widely  traded  commodities.  Countries  where  GM  varieties  are 
grown are leading exporters. Conversely, main importers of soybeans, com and associated 
products  have  adopted  a  restrictive  stance  on  GM  food.  If  a  restrictive  stance  is  also 
adopted  for  feed  uses  of  GM  soybeans  and  com,  the  market  implications  can  be 
significant.
While  being  limited  to  economic  issues  which  are  of  direct  interest  for  the  agri-food 
sector,  this  report  does  not  address  other  important  issues.  The  reasons  explaining  the 
uneven  developments  of  plant  biotechnology  throughout  the  world  are  not  only  of  an 
economic nature and the implications of this new technology go well beyond the agri-food 
sector.
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The present review is mainly based on economic articles which have been published or 
posted on the world wide web.
To  allow  for  selecting  and  channelling  the  widely  available  information  on 
biotechnology,  web  sites  which  are  of  interest  with  regard  to  the  economic  issues 
addressed  in  this  report  (fast  developments  in  sowings,  profitability  of  GM  crops, 
consumers  surveys,  segregation  GM-non  GM)  have  been  classified  in  an  intemet- 
database.
References to the articles reviewed can be found in the bibliography, which is included 
in the Appendixes. These articles have been released or published by various sources: 
governments  (e.g.  USDA),  international  institutions  (e.g.  OECD),  research  centers 
(e.g. INRA) and Universities (in particular in the USA), organisations (mainly NGOs), 
or industry (firms or their associations).
In addition, many press releases have been reviewed on a regular basis.
Meetings with biotechnology experts and researchers have also been a useful source of 
information and have provided opportunities for exchanging views.
Additional specifications about sources and data can be found in different chapters of 
the report.
The closing date for documentation was the 31st March 2000.
Abbreviations
ha
Mio ha 
t
ha
million ha 
tonnes
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TERM DEFINITION
Asri-senomics
Biotechnology
Study of the make-up of and interaction between genes in crops 
and combinatorial chemistry
According  to  the  draft  Protocol  on  Biosafety,  modem 
biotechnology means the application of:
i) in vitro nucleic acid techniques
ii)  fusion of cells beyond the taxonomic family that overcomes 
natural physiological reproductive or recombination barriers and 
that  are  not  techniques  used  in  traditional  breeding  and 
selection.
Biotechnology  is  currently  applied  in  the  health  sector 
(antibiotics,  insulin,  interferon...),  in  the  agri-food  system 
(micro-organisms,  plants  and  animals),  and  in  industrial 
processes such as waste recycling.
Biotechnology  and  genetic  engineering  are  often  used 
interchangeably (see below).
Bacillus thuringiensis Bacillus thuringiensis (Bt) is a soil bacterium that produces
(Ml
Bt crops
Bt cotton
Bt corn/maize
Canola
toxins against insects (mainly in the genera Lepidoptera, Diptera 
and Coleoptera). Bt preparations are used in organic farming as 
an insecticide.
Bt crops are genetically modified to carry genetic material from 
the  soil  bacterium  Bacillus  thuringiensis.  Crops  containing  the 
Bt  genes  are  able  to  produceBt-toxin,  thereby  providing 
protection against insects during the growth-stage of the plant..
Bt  cotton  is  genetically  modified  to  control  budworms,  and 
boll worms.
Bt  com/maize  is  genetically  modified  to  provide  protection 
against  the  European  Com  Borer.  The  words  Com  and  Maize 
are used interchangeably in this report
Canola  is  a  type  of  rapeseed  which  has  been  developed  and 
grown  in  Canada.  Canola  is  a  registered  trademark, 
corresponding to specified low contents in erucic acid in oil and 
in  glucosinolates  in  meals equivalent  to double  0  in the  EU. It 
has  initially  been  obtained  by  conventional  breeding,  but  in 
recent  years,  GM  herbicide  tolerant  varieties  have  been 
developed.
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Genetic engineering
Genetically  Modified 
food
Genetically  Modified 
Organism (GMO)
Germylasm
Herbicide-tolerant 
(HT) crops
Identity Preservation
an
Living Modified 
Organism(IJMO)- 
according to 
Biosafety Protocol
(Deoxyribo  Nucleic  Acid)  The  molecule  that  encodes  genetic 
information in the cells. It is constructed of a double helix held 
together by weak bonds between base pairs of four nucleotides 
(adenine,  guanine,  cytosine,  and  thymine)  that  are  repeated  ad 
infinitum  in  various  sequences.  These  sequences  combine 
together into genes that allow for the production of proteins.
The  manipulation  of  an  organism's  genetic  endowment  by 
introducing  or  eliminating  specific  genes  through  modem 
molecular  biology  techniques.  A  broad  definition  of  genetic 
engineering also includes selective breeding and other means of 
artificial selection.
Foods  and  food  ingredients  consisting  of  or  containing 
genetically  modified  organisms,  or  produced  from  such 
organisms.
An organism produced from genetic engineering techniques that 
allow  the  transfer  of  functional  genes  from  one  organism  to 
another, including from one species to another. Bacteria, fungi, 
viruses, plants, insects, fish, and mammals are some examples of 
organisms  the  genetic  material  of  which  has  been  artificially 
modified  in  order  to  change  some  physical  property  or 
capability.  Living  modified  organisms  (LMOs),  and  transgenic 
organisms are other terms often used in place of GMOs.
Germplasm  is  living  tissue  from  which  new  plants  can  be 
grown--seed  or  another  plant  part  such  as  a  leaf,  a  piece  of 
stem, pollen or even just a few cells that can be cultured into a 
whole plant. Germplasm contains the genetic information for the 
plant's heredity makeup.
The  insertion  of  a  herbicide  tolerant  gene  enables  farmers  to 
spray  wide-spectrum  herbicides  on  their  fields  killing  all  the 
plants  but  the  HT  crop.  .  The  most  common  herbicide-tolerant 
crops  (cotton,  com,  soybeans,  and  canola)  are  tolerant  to 
glyphosateand  to  glufosinate-ammonium,  which  are  the  active 
ingredients of common wide spectrum herbicides. There are also 
HT rapeseed and cotton which are tolerant to bromoxynil.
System  of  crop  or  raw  material  management  which  preserves 
the identity of the source or nature of the materials.
Any living organism that possesses a novel combination  of
genetic material obtained through modem biotechnology.  A
living organism is biological entity capable of transferring  or 
replicating genetic material.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 8Novel Food GM food and other foods and food ingredients consisting of or 
isolated  from  micro-organisms,  fungi,  algae,  plants  or  animals, 
or which have been obtained through new processes.
Plant breeding
Segregation
Traceability
Plant breeding is use of techniques involving crossing plants to 
produce  varieties  with  particular  characteristics  (traits)  which 
are  carried  in  the  genes  of  the  plants  and  passed  on  to  future 
generations.  Conventional/traditional  plant  breeding  refers  to 
techniques  others  than  modern  biotechnology,  in  particular 
cross-breeding, back-crossing.
Segregating  implies  setting  up  and  monitoring  of  separate 
production  and  marketing  channels  for  GM  and  non-GM 
products.
Traceability  measures covering feed, food and their ingredients 
"include  the  obligation  for  feed  and  food  businesses  to  ensure 
that adequate procedures are in place to withdraw feed and food 
from  the market where a risk to the health of the consumer is 
posed.  Operators  should  keep  adequate  records  of  suppliers  of 
raw materials and ingredients so that the source of the problem 
can be identified.
Transgenic plants Transgenic plants result from the insertion of genetic material
from  another  organism  so  that  the  plant  will  exhibit  a  desired 
trait.
Based on various sources
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About the data
The data used in this chapter are derived from a GMO dataset established by 
DG AGRI in co-operation with external experts. They originate from various 
sources:  agricultural  and  economic  administrations  and  related  research 
institutes  (of  which  USD  A,  ERS),  biotech  companies,  seed  associations  or 
seed companies, scientific reviews, news agencies and private consultants (of 
which ISAAA1 and SPARKS)
The  main  objective  was  to  obtain  a  dataset  which  was  as  coherent  as 
possible,  offering  a  good  comparability  of  data.  ISAAA  seemed  to  be 
recognised  by  most  of  the  GMO  specialists  as  a  consistent  and 
comprehensive source of data. However, ISAAA data have been confronted 
and complemented with other sources.
Despite  all  efforts  to  create  a  coherent,  reliable  and  up  to  date  dataset,  all 
figures presented in this report should be interpreted with care, certainly for 
Chinese  figures  and  for  the  2000  projections.  Indeed,  most  of  the  data  are 
based on sales of seeds and not on area surveys which can lead to a bias.
1.1.  Development of GM crops: a global picture
Analysis  was  restricted  to  studying  the  sowings  of  five  transgenic  crops 
which are covered bv a EU Common Market Organisation (CMO). soybeans, 
corn,  rapeseed,  cotton  and  tobacco  respectively.  Figures  concerning  areas 
planted  with  GM  potatoes  are  also  provided.  Research  on  genetically 
modified  crops2  started  in  the  eighties  but  sales  of  first  commodity  seeds 
began only in the midnineties. The first significant sowings of GM crops (2.6 
Mio ha) took place in 1996 and almost exclusively in the US3. Since 1996, 
the  areas  have  increased  dramatically  to  reach  41.5  Million  hectares  -  Mio 
ha - in 1999. Adoption rates for transgenic crops are in some countries the 
highest for new technologies by agricultural industry standards, much faster 
than has been the case for hybrids. Of the 41.5 Mio ha sown in 1999, 53% 
were  soybeans,  27%  com,  9%  cotton,  8%  rapeseed,  2%  tobacco  and  0.1% 
potatoes.  Figures  1  and  2  show  respectively  the  development  of  the  GM 
crops between 1996 and 1999 and their share in the 1999 GM area.
1  ISAAA  international  Service  for  the  Acquisition  of  Agri-Biotech  Applications  is  a  not-for-profit 
international organisation co-sponsored by public and private institutions that facilitate the transfer of 
agri-biotech applications from industrial to developing countries for their benefit. ISAAA produces 
each year a global review of commercialised transgenic crops, which contains reliable data on GM 
area.
2  We do not consider here GM "products" for medical purpose.
3  Since end of the eighties, China has a considerable area of GM tobacco of about 1 Mio ha. This 
technology is "home made" and is not linked with Western biotech companies.
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Mio ha 1996 1997 1998 1999 2000(e) 1999 in %
SOYA 0.45 5.04 13.59 21.78 22.49 52.5%
CORN 0.30 2.61 9.11 11.28 10.53 27.2%
RAPESEED 0.11 1.42 2.43 3.46 3.12 8.4%
POTATOES 0.01 0.01 0.03 0.04 0.04 0.1%
COTTON 0.73 1.43 2.46 3.92 4.90 9.4%
TOBACCO 1.00 1.00 1.00 1.00 1.00 2.4%
TOTAL 2.60 11.51 28.62 41.48 42.08 100.0%
Figure 1.1  Figure 1.2
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As shown in table 1.2 and in figures 1.3 and 1.4, most of the GM crops are 
sown  on  the  American  continent,  96%  of  the  total  in  1999.  Australasia 
follows with 3.8% whereas Europe and Africa represent together around
0.1%.
Table 1.2  Development of GM area by country
Mio ha 1996 1997 1998 1999 1999 m%
USA 1.45 7.16 20.83 28.64 69.1%
ARGENTINA 0.05 1.47 3.53 5.81 14.0%
CANADA 0.11 1.68 2.75 4.01 9.7%
CHINA 1.00 1.00 1.10 1.30 3.1%
BRAZIL 0.00 0.00 0.00 1.18 2.8%
AUSTRALIA 0.00 0.20 0.30 0.30 0.7%
SOUTH AFR 0.000 0.000 0.06 0.18 0.4%
MEXICO 0.000 0.000 0.05 0.05 0.12%
EUROPE 0.000 0.000 0.002 0.01 0.03%
SPAIN 0.000 0.000 0.000 0.01 0.02%
FRANCE 0.000 0.000 0.002 0.000 0.0%
PORTUGAL 0.000 0.000 0.000 0.001 0.0%
ROMANIA 0.000 0.000 0.000 0.002 0.0%
UKRAINE 0.000 0.000 0.000 0.001 0.0%
TOTAL 2.601 11.510 28.623 41.480 100.0%
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around  70%  of  the  total,  followed  by  Argentina  (5.8  Mio  ha  or  14%)  and 
Canada  (4  Mio  ha  or  >9%).  In  China  (3%),  the  GM  tobacco  area  ranks 
between  1  and  1.3  Mio  ha,  depending  on  the  sources,  whereas  they  started 
limited  sowings  of  GM  cotton  in  1998.  In  Europe,  Spain  ranks  first  with 
around  10000  ha  followed  by  Romania  with  2000  ha  and  France,  Portugal 
and Ukraine at just 1000 ha.
About Argentina and Brazil
Following a Court ruling, sowings of GM crops are not allowed in Brazil 
and  public  authorities  are  committed  to  control  it.  However,  certain 
sources  mentioned  that  at  least  10%  of  their  soybean  area  in  1999  was 
GM.  The  GM  area  would  be  located  south  and  the  seeds  would  be 
fraudulently  imported  from  Argentina.  ISAAA  does  not  give  figures  for 
Brazil and that is the reason why their total GM area in Argentina is higher 
than the one reported here, which is based on figures from the Argentinean 
"Dirección  de  Economia  Agraria"  and  from  the  Argentinean  seed 
association.
For  that  reason,  '1999  seeds  were  reallocated to  Brazil to  cover 1.2  Mio 
ha. The total of Argentinean and Brazilian soybean area of this report (7 
Mio ha) is close to ISAAA figure for Argentina (6.4 Mio ha).
Figure 1.3  Figure 1.4
Development of GM area by country  1999 Share of GM by country in%
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Of the 41.5 Mio ha sown with transgenic crops in 1999, the distribution of 
traits is as follows.
-  Ranked first is the herbicide tolerant (HT) GM crop with 69% of total,
-  followed by insect resistant (IR) GM with 21%,
-  GM crops containing both genes (HT+IR) represented 7%,
-  and virus resistant (VR) GM crop (almost exclusively Chinese tobacco) 
nearly 3%.
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containing  both  genes,  the  herbicide  tolerant  and  insect  resistant.  However, 
this  is  an  important  shift  compared  with  1996  where  virus  resistant  GM 
represented  40%  of  total,  insect  resistant  37%  and  herbicide  tolerant  only 
23%. This is mainly due to the dramatic increase in HT soybeans.
Figure 1.5 Share of GM traits in 1996 and 1999
TRAITS of Present GM crops
The  present  "wave"  of  GM  crops'  primary  objective  is  to  improve  pest  resistance;In  turn,  this  should 
reduce/change the use of crop protection products and/or increase yields.
1. Herbicide tolerance
The  insertion  of  a  herbicide  tolerant  gene4  into  a  plant  enables  farmers  to  spray  wide  spectrum  herbicides 
on  their  fields  killing  all  plants  but  GM's.  For  that  reason,  the  new  GM  seeds opened new markets for both 
products.  In  fact,  these  crops  contain  a  slightly  modified  growth-regulating  enzyme  that  is  immune  to  the 
effects  of  the  active  ingredient  and  allow  it  to  be  applied  directly  on  the  crops  and  kill  all  the  plants  not 
possessing this gene.
2. Insect resistance
By  inserting  genetic  material  from  the  Bacillus  thuringiensis  (Bt)  into  seeds,  scientists  have  modified  crops 
to  allow  them  to  produce  their  own  insecticides.  Bt  gene  responsible  for  producing  the  toxin  is  directly 
inserted  into  the  plant  to  produce  pest  resistant  varieties.  For  example,  Bt  cotton  combats  bollworms  and 
budworms, whereas Bt com/maize protects against the "European" com/maize borer.
3. Virus resistance
Today a virus resistant gene has been introduced in tobacco and potatoes (also tomato, but this product is not 
analysed in this report).
The  insertion  of  a  potato  leaf  roll  virus  resistance  gene  protects  the  potatoes  from  the  corresponding  virus 
which  is  usually  transmitted  through  aphids.  For  that  reason,  it  is  expected  that  there  will  be  a  significant 
decrease in the amount of insecticide used.
The introduction of a virus resistance gene in tobacco may offer similar benefits
4. Quality traits
Today  quality  traits-crops  are  only  sown  marginally  and  represent  less  than  50  000  ha  in  Canada  and  the 
USA.  It  concerns  high  oleic  soybeans,  high  oleic  canola/rapeseed  and  laurate  canola.  More  explanations  are 
given in chapter 1.3 "In the pipeline: quality/outputs traits crops"
□ HT Si IR @VR
1996
4 The gene introduced is either glyphosphate or glufosinate herbicide-tolerant 
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1999  was  a  turning  point  as  far  as  demand  is  concerned,  as  explained  in 
chapter 4. In Europe, as well as in some Asian countries, many food suppliers 
took a restrictive stance on GM food. In the US, some export- oriented food 
processors are considering segregating GM and non-GM crops. Whether, and 
to  what  extent,  these  recent  developments  on  the  demand  side  will  have  a 
feed back effect on 2000 GM sowings remains a controversial issue. In early 
2000,  first  indications  could  be  found  in  various  sources,  but  they  point  to 
divergent directions.
Given the contradictory signals by the time of closure of the report (end of 
March  2000),  an  own  approach  has  been  adopted  for  estimating  the  2000 
GM sowings indicated in tables 1.1. First, the latest USD A previsions for
2000  sowings  of  soybeans,  com  and  rapeseed  in  the  main  producing 
countries  have  been  recorded.  For  the  US,  the  USDA  prospective  plantings 
are  based  on  farmers'  surveys  carried  out  in  early  March.  This  first  step 
allows for taking into account various factors which are influencing farmers' 
planting  decisions,  in  particular  expected  commodity  prices.  Second,  an 
estimated  percentage  for  areas  under  GM  crops  is  applied  to  these  USDA 
forecasts.  This  percentage  is  based  on  "expert  judgement".  It  takes  into 
account  the  results  and  developments  outlined  in  the  present  report.  First, 
results  concerning  the  profitability  of  GM  crops  are  mixed,  depending  on 
varieties,  growing  conditions,  prices  etc.  Second,  developments  on  the 
demand  side  are  expected  to  have  a  cascading  effect  backward  in  the  food 
chain,  up  to  farmers.  However,  this  effect  still  is  of  limited  and  variable 
magnitude. The lack of non-GM seeds might be a factor limiting a potential 
move back to conventional crops.
As a result, the GM area for 2000 is forecast to plateau just above 42 Mio ha. 
Further specifications by type of crops are given below in chapter 1.2.
1.2.  GM crops grown on a commercial basis: input-oriented
A detailed picture is provided for the main GM crops which are grown on a 
commercial  basis.  These  crops  are  ranked  according  to  the  importance  of 
areas under cultivation. Soya and corn account for 80% of GM areas world­
wide.
1.2.1.  Soybeans
Commercialised  GM  soybeans  were  first  sown  in  1996  in  2  countries,  the 
USA and Argentina and represented respectively 1.6 and 0.8% of their total 
soybean area.
Table 1.3 Development of GM soybean area
Mio ha 1996 1997 1998 1999 2000 (e) GM %('99)
USA 0.40 3.64 10.12 15.00 51%
ARGENTINA 0.05 1.40 3.43 5.50 75%
CANADA 0.001 0.04 0.10 10%
BRAZIL 1.18 10%
ROMANIA 0.001 NR
TOTAL 0.45 5.04 13.59 21.78 22.5 47%
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52% of total GM sowings. With this area, GM soybean represents nearly one 
third  of  world  total  soybean  area  and  nearly  47%  of  area  of  countries 
producing GM soybeans. Of  the 22 Mio ha, 15 or two-third of total are in 
USA (51% of US soybean5), 5.5 in Argentina (75% of Argentinean soybean), 
1.2 in Brazil (10% of Brazilian soybean) and less than 0.1 Mio ha in Canada 
and  Romania.  Figure  1.6  shows  the  geographic  breakdown  of  GM  soybean 
area in 1999.
Figure 1.6 Geographic breakdown of GM soybean area in 1999
------------------------ 5:4%
BUSA □ ARGENTINA □ CANADA □ BRAZIL
Almost  all  GM  soybeans  are  herbicide  tolerant  (HT).  HT  crops  allow  for 
increased  flexibility  in  growing  practices.  This  "convenience effect"  appears 
to be a driving force for the quick adoption of HT soybeans by farmers. On 
the  demand  side,  the  main  soybeans  producing  countries  are  dependent  on 
exports, in particular on the European and the Japanese markets. Reluctance 
against GM food on these markets might have an incidence on growers' and 
handlers'  decisions.  However,  feed  uses  are  the  main  outlets  for  exported 
soybeans/meals (see chapter 4) and no firm stance has been taken up to now 
on the feed issue.
Given  these  factors  of  uncertainty,  a  conservative  assumption  has  been 
adopted for the estimated areas under GM soybeans in 2000. Depending on 
countries,  this  percentage  is  estimated  to  remain  unchanged,  or  to  decline 
slightly.  However,  as  USD  A  forecasts  a  global  increase  in  areas  sown  to 
soybeans, a merely unchanged share of GM applied on this basis means an 
increase in absolute terms. In particular, in the US, the total soybean area is 
expected to reach an unrecorded level of 30 Mio ha. Hence, the world area 
sown to GM soybeans in 2000 is forecast to increase by 3%, reaching
22.5 Mio ha.
5  In late 1999, the USDA revised upwards the total soybeans area for 1999. However, no indication was 
given  as  to  changes  for  areas  under  GM  varieties.  In  addition,  the  USDA  initial  estimation  for  the 
share  of  GM  soybeans  (57%)  covered  major  producing  States  and  included  non-GM  herbicide 
tolerant  varieties.  The  forecasted  share  for  2000  (52%)  only  covers  GM  HT  varieties.  For  these 
reasons, own estimates have been adopted for 1999 and 2000.
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First sowings of GM corn took place in 1996 exclusively in North America, 
0.3 Mio ha in USA and 0.001 Mio ha in Canada and represented respectively 
1% and 0.1% of their corn area.
Table 1.4 Development of GM corn area
Mio ha 1996 1997 1998 1999 2000 (e) GM %099)
USA 0.30 2.27 8.66 10.30 36%
ARGENTINA 0.07 0.09 0.31 11%
CANADA 0.001 0.27 0.30 0.50 44%
SOUTH AFR 0.05 0.16 5%
FRANCE 0.002 0.000 0.0%
SPAIN 0.01 0.2%
PORTUGAL 0.001 0.4%
TOTAL 0.30 2.61 9.11 11.28 10.5 28.0%
In 1999, GM com sowings accounted for more than 11 Mio ha and 27% of 
total  GM  sowings.  With  this  area,  GM  com  represents  about  8%  of  world 
total corn area and 28% of area of countries producing GM com. Most of the 
areas are located in USA (10.3 Mio ha or 36% of US corn), 0.3 Mio ha in 
Argentina (11% of Argentinean corn), 0.5 in Canada (44% of Canadian com) 
and a few thousands of ha in Spain, France and Portugal. Figure 1.7 shows 
the geographic breakdown of GM corn area in 1999.
Figure 1.7 Geographic breakdown of GM corn area in 1999
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Two  thirds  of  corn  area  or  nearly  8  Mio  ha  are  insect  resistant  (Bt-corn), 
about  2  Mio  ha  is  herbicide  tolerant  corn  and  around  another  2  Mio  ha  of 
corn contain both genes.
Herbicide  Tolerant  corn  was  introduced  onto  the  US  market  in  1998. 
However,  experts  (USDA)  do  not  expect  a  development  as  fast  as  for  HT 
soybeans.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 16There  is  evidence  about  yield  gains  for  Bt  corn,  however,  its  profitability 
depends  on  different  factors,  in  particular  the  degree  of  infestation  and 
market prices. In addition, farmers are required to set up refuges (ie non-Bt 
areas  to  prevent  resistance)  for  at  least  20%  of  their  Bt-area.  For  these 
reasons, the share of GM corn in US areas is forecast to decrease in 2000. 
Based on surveys carried out in early March, the USDA estimates that GM 
corn sowings in major producing States are down by 25% compared to 1999. 
By  contrast,  according  to  various  sources,  the  share  of  GM  Com  is 
forecasted to increase in Argentina, as well as in South Africa. All in all, the 
world area under GM com in 2000 is estimated to decline to 10.5 Mio ha.
1.2.3.  Cotton
First sowings of GM cotton (0.7 Mio ha) took place in 1996 in the USA and 
represented 12% of their total cotton area.
Table 1.5 Development of GM cotton area
Mio ha 1996 1997 1998 1999 2000 (e) GM %('99)
USA 0.73 1.23 2.00 3.25 55%
CHINA 0.10 0.30 8%
AUSTRALIA 0.20 0.30 0.30 79%
SOUTH AFR. 0.01 0.02 13%
MEXICO 0.05 0.05 25%
TOTAL 0.73 1.43 2.46 3.92 4.9 38%
In 1999, GM cotton sowings accounted for nearly 4 Mio ha or nearly 10% of 
total GM sowings. With this area, GM cotton represents about 12% of world 
total  cotton  area  and  38%  of  area  of  countries  producing  GM  cotton.  Most 
of the area is located in USA (3.2 Mio ha or 55% of US cotton), 0.3 Mio ha 
in China, 0.3 in Australia (three quarter of Australian cotton) and less than 
0.1  Mio  ha  in  Mexico  and  South  Africa.  Figure  1.8  shows  the  geographic 
breakdown of GM cotton area in 1999.
A Member of the European Parliament (MEP) has recently raised questions6 
about  GM  seeds  being  included  in  import  consignments  of  traditional 
cottonseed. No authorisation has been granted so far for placing GM cotton 
on the EU market. Hence imports or growing of GM seeds are not allowed in 
the EU. The question raised by the MEP deserves further checks and should 
be  addressed  in  the  process  of  revision  and  completion  of  the  EU  seed 
regulation.
6  Oral Question H-0345/00 and written question P-l 169/00
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More than 40% of the 4 Mio ha is herbicide tolerant, one third is BT cotton 
and the remainder (more than 20%) contains both genes.
In 2000, the GM cotton area is forecast to increase up to nearly 5 Mio ha. 
Most  of  this  expansion  is  expected  to  take  place  in  China,  where  there has 
been  a  three-fold  increase.  In  the  US,  the  USD  A  has  observed  significant 
increases  in  yields  for  Bt  cotton,  and  its  profitability  also  appears  to  be 
higher. Based on March surveys, the USD A foresees a decrease in the share 
of areas under GM cotton in major producing States, but a high rate in other 
producing  States.  In  addition,  a  5%  increase  in  total  cotton  plantings  is 
expected. These developments lead to a significant increase in the area under 
GM cotton, both in China and in the US (+25% world-wide).
1.2.4.  Rape seed
First  sowings  of  GM  rapeseed7  took  place  in  1996  exclusively  in  North 
America,  0.1  Mio  ha  in  Canada  and  less  than  0.01  Mio  ha  in  USA  and 
represented respectively 3% and 5% of their rapeseed area.
Table 1.6  Development of GM rapeseed area
Mio ha 1996 1997 1998 1999 2000 (e) 1999 in %
USA 0.01 0.02 0.03 0.06 15%
CANADA 0.10 1.40 2.40 3.40 61%
TOTAL 0.11 1.42 2.43 3.46 3.1 58%
In 1999, GM rapeseed sowings accounted for nearly 3.5 Mio ha or about 8% 
of total GM sowings. With this area, GM rapeseed represents about 13% of 
world total rapeseed area. The area is located in Canada (3.4 Mio ha or two 
third of Canadian rapeseed, ie Canola), and in the USA (0.06 Mio ha or 15% 
of US rapeseed).
All GM rapeseed is herbicide tolerant.
' The North-American rapeseed varieties are called canola.
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with  a  significant  increase  in  total  rapeseed  plantings)  and  to  remain  at  its 
1999 level in Canada. As total sowings in Canada are down, this translates 
into a decline in GM areas to 3 Mio ha.
1.2.5.  Potatoes
GM potatoes represented in 1999 about 40 000 ha. Sowings took place in the 
USA (30 000 ha), Canada (10 000 ha), Romania (1 000 ha) and Ukraine (1 
000 ha). The GM potato contains either a virus or an insect resistance trait.
Figure 1.9 Geographic breakdown of GM potato area in 1999
1.2.6.  Tobacco
GM tobacco is exclusively sown in China and contains a virus resistance trait. 
The area reported is about 1 Mio ha or 2.3% of total GM area.
1.3.  In the pipeline: quality/output traits crops
In the short term, the main improvement will result from inserting 2 genes in 
one cell ("stacked traits"). This is already the case for GM crops containing 
both the insect resistant and the herbicide tolerant genes.
In  the  medium  term,  traits  will  still  be  input-oriented,  but  they  should  be 
extended to new varieties, of which sugarbeet, rice, potato and wheat. New 
virus-resistant  varieties  are  expected  to  be  introduced  on  the  market  in 
particular for fruit, vegetables and wheat. Also fungus resistant crops are in 
the pipeline and this concerns fruit and vegetables, potato and again wheat. 
Nevertheless, in the medium term, the same crops as today will have the lead, 
that means soybeans, corn, rapeseed, cotton, tomato and potato.
In the longer term, new value-enhanced or output-oriented traits are likely to 
develop  among  field  crops,  mostly  created  through  biotechnology.  However 
to  succeed,  the  products  must  be  able  to  deliver  not  just  improved  quality, 
but also good agronomic performance. By contrast with first generation GM 
crops where farmers expected a direct impact on their use of pesticides and 
herbicides  (in  order  to  diminish  their  input  costs),  the  adoption  rate  of  the 
new  generation  may  proceed  more  slowly.  In  addition,  some  of  the  value 
enhanced GM crops will be limited to niche markets (see chapter 4).
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benefits  for  food  processors  and/or  for  consumers.  Hence,  the  adoption  by 
the consumers could be less conflictory.
GMOs also have potential in the non-food sector. One innovative example is 
that of Cynara Cardunculus-thistle grown in Spain for electricity generation.
Also GM poplars have been developed in France for paper production which 
demand  less  energy  and  produce  less  waste  during  processing.  Oil  and 
carbohydrate  crops  also  offer  opportunities  in  the  chemical  sector.  An 
example is high-erucic rapeseeds used for fuel, lubricants and plastics.
The  table  below  provides  an  overview  of  some  leading  developments.  Of 
course, this list is not exhaustive.
Table 1.7 Quality traits in the pipeline
Soybeans
1.  high oleic soybeans : this variety contains less saturated fat than conventional soybean oil. 
Moreover, this variety is more stable and requires no hydrogenation for use in frying or 
spraying. For that reason, this variety has a "health" image.
2.  soybeans with improved nutritional traits for animals : this variety contains higher levels of
2  amino  acids  (lysine  and  methionine)  which  will  reduce  the  proportion  of  higher  cost 
protein meals in the preparation of feed mixes.
3.  high-sucrose soybeans : this is one of the new varieties introduced to improve food quality. 
This variety has a better taste and a greater digestibility.
Rapeseed/Canola
1.  High-lauric variety produces an oil containing 40% of lauric acid for chemical and cosmetic 
purposes.
2.  High-stearate variety produces oil high in stearic acid, solid at room temperature without 
hydrogenation. It would be used for baking, margarine and confectionery foods that cannot 
use liquid oils.
Corn
Several researches, both conventional and biotech, aim to produce value-enhanced corn that will 
offer improved nutritional traits for livestock. Since grain is fed primarily as a source of energy, 
many of the new value-enhanced varieties aim to increase the content or availability of energy . But 
some new varieties will also include more protein and better amino acid balances, which would 
reduce the need to buy supplemental feed ingredients.
Cotton
Coloured cotton is already available on a niche market basis. This trait would reduce the need for 
chemical dyes.
Fibre quality improvement, such as polyester-type traits, would make sturdier fabrics.
Chinese researchers are breeding a new strain of cotton that includes rabbit keratin. Fibres of this 
cotton are longer and more resilient and they have an increased ability to maintain warmth.
Research is also carried out to develop wrinkle-resistant cotton and even fire-retardant qualities.
Nutraceuticals
The real bright prospect for GM is to produce varieties that could provide immunity to a disease or 
improve  the  health  characteristics  of  traditional  food,  like  canola  oil  with  high-beta  carotene 
content  or  vitamin  A  supplemented  rice.  This  3rd  generation  of  GM  called  nutraceuticals  or 
"functional foods" is designed to produce medicinal qualities and/or food supplements within the 
plant.
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Biotechnology has been developed by the “life sciences industries” which are active 
in human, animal and plant health. Their experience in pharmaceutical biotechnology 
and  their  crop  protection  activities  allowed  them  to  implement  and  amplify 
biotechnology for agriculture.
2.1.  From start-ups to global ’’life sciences” companies
Joly (1998) has analysed developments in the strategy of agri-biotech firms, 
from the early eighties up to 1998. Based on his approach, three stages can 
be identified, as illustrated in the following summary table.
Table 2.1 Stages in development of the agri-biotech industry
Years Stage Developments
1983-1994 Exploratory Spin-off, from Universities to SME's 
start-up SME's
late 80/early 90. economic and financial 
difficulties.
1994-1998 Consolidation Emerging life sciences trans-national 
companies progressively buy:
a) biotech SME's
b) seed companies.
1998-? Adding value Biotech industry seeking new agreements:
a) with research/development partners
b) with food processors
Source: based on Joly, 1998
2.1. 1. 1983-1994: the Pioneers
The first successful breakthroughs in agri-biotechnology were achieved in the 
mid-nineteen  eighties  Small  and  medium  sized  enterprises  (SME),  acting  as 
start-ups, have had an active role in initial developments, both in the United 
States  and  in  Europe.  Due  to  financial  (1987  Crash  on  Wall  Street)  and 
economic  (Early  Nineties  in  EU)  crisis,  these  SME's  had  experienced 
difficulties in finding sources of financing. Many of them have been bought up 
by the emerging "life sciences industries. A typical example is Plant Genetic 
Systems (PGS), a European (B) small enterprise, which succeeded in 1985 to 
integrate  Bt  genetic  material  into  a  tobacco  plant.  In  1996,  AgrEvo,  the 
newly formed merger between Hoechst and Schering bought PGS.
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Life  sciences industries  had  experience in  biotechnology, but for  most  part, 
this was limited to pharmaceutical applications. They were, however, able to 
transfer  this  knowledge  to  the  area  of  agri-biotechnology  and/or  to  take  on 
board the experience of the start-up SME's. In addition to creating common 
platforms for research and development, they were in a position to implement 
and amplify agri-biotechnology, on the basis of their plant protection activity. 
While  pharmaceutical  markets  are  more  or  less  narrow,  with  national 
specifications,  the  markets  for  agro-chemicals  are  wider  and  trans-national, 
even if authorisation procedures are somewhat different from one country or 
group  of  countries  to  another.  Experience  of  the  life  sciences  industries  in 
authorisation procedures, in patenting and also in introduction to the market 
has been another key factor for the extension of their biotech activities.
Authorisation  procedures  for  medicines,  pesticides  and  GM  crops  are  very 
different. According to Seralini (1998), if tests on mammals were required in 
the  authorisation  procedures  for  GM  crops,  as  it  is  the  case  for  pesticides, 
GM  crops  would  not  be  profitable  for  biotech  firms.  For  the  sake  of 
improved  safety  assessment,  Seralini  pledges  for  systematic  tests  on 
mammals, as GM crops which are on the market or which are under scrutiny 
for  authorisation  are  mainly  pesticide-like  crops,  ie  herbicide  tolerant  or 
insecticide-producing crops.
Patenting and origin of biotechnology
Patenting  of  agri-biotechnology  and  the  breakdown  between  private 
and public research have become new issues. Like previous agricultural 
innovations  (mechanisation,  chemicals..  ),  biotechnology  is  industry- 
driven. However, biotechnology uses and modifies living organisms. It 
has  been  developed  by  life  science  industries,  while  impetus  in 
conventional  breeding  had  been  initiated  by  public  research.  This 
translates  into  new  patenting  rules  on  plants:  patents  on  GMOs  are 
very  different  from  traditional  "obtainers'  rights".  Crop  varieties 
obtained through conventional breeding can only be produced and sold 
by their "obtainers", but other seed companies can use these crops for 
further genetic improvement (breeders' exemption).
Patents on biotechnology were first introduced in the US, following a 
1980 ruling of the Supreme Court, which authorised patents on living 
organisms.  According  to  Joly,  in  1993,  US  firms  owned  70%  of  the 
world  patents  on  plants.  Biotech  patents  apply  to  the  "genetic  event", 
that is  to  say, to  the transformation which has been introduced in the 
plant. They protect the private origin of the technology. In some cases; 
technological  fees  charged  by  biotech  companies  when  selling  their 
genes or GM-seeds allow for remunerating the new technology or trait.
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EU is  complex. The European  Parliament and the  Council adopted in 
June  1998  a  Directive  addressing  the  legal  protection  of 
biotechnology8.  This  Directive  foresees  several  exemptions,  in 
particular for human body, plant varieties and animal breeding. It also 
takes over farmers' exemption: farmers are allowed to save GM seeds 
for  the  purpose  of  own  production.  In  principle,  no  patent  can  be 
obtained for plant varieties, only for inventions (transformation event) 
relating  to  them.  Plant  varieties  are  covered  by  a  specific  regulation 
which  includes  breeders  and  farmers'  exemption.  However,  the 
European  Patent  Office  has  recently  indicated  that  patents  on  plants 
and animal are not excluded by the European Patent Convention. This 
issue is controversial and deserves further analysis.
Firms  considered  that  patents  were  not  protective  enough,  because  of 
possible  overlaps.  For  example,  there  are  many  types  of  Bt  transformation 
events. As a result, in addition to patents, registered trade names are usually 
used  to  further  protect  and  identify  the  new  technology.  Quite  often  trade 
names  of  GM  seeds  refer  to  corresponding  agro-chemicals,  in  particular  for 
herbicide  tolerant  crops.  Typical  examples  are  Liberty  Link  and  Round  Up 
Ready  crops.  Patents  on  herbicide  tolerance  are  often  seen  as  a  way  to 
prolong  the  effect  of  expired  patents  on  herbicides.  These  examples  of 
combined  products  illustrate  the  importance  of  another  synergy  between 
biotech and crop protection activities. Many biotech firms are selling both the 
GM technology/seed and the agro-chemical product to which it is combined. 
It  allows  for  "technology-package"  or  combined  marketing,  including 
adjusting  prices  of  both  products  and  using  the  existing  distribution  and 
consulting channels for crop protection products.
Beginning  in  the  last  quarter  of  1995  up  to  the  first  half  of  1999  the  life 
sciences  sector  has  been  characterised  by  a  large  number  of  mergers, 
acquisitions and joint ventures.
Four of the important factors that are driving this consolidation process are:
-  The  development  of  new  genetic  traits  that  are  able  to  (1)  increase  the 
efficiency  of  farm  production;  (2)  offer  new  product  specifications  for 
industrial or end users.
-  Synergies, whereby research capabilities and technology are shared across 
multiple product lines.
* Directive 98/44/CE OJ L 213 of 30.7.1998
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development in the area of agrigenomics9, marketing and a whole host of 
other  functions.  Such  economies  of  scale  are  of  strategic  importance, 
considering  the  need  to  invest  vast  sums  of  money  in  regard  to 
biotechnology to develop new GM traits.
-  Intellectual property rights create barriers to entry.
Extending and securing access to the seed market has been a driving force for 
a  second  wave  of  acquisitions  and  agreements,  resulting  in  a  further 
consolidation within the agri-biotech sector. Concentration has diffused from 
the agro-chemical sector to the seed sector as key "life science" players have 
become leaders in both fields, (see section 2.2).
2.1.3.  1998- ? Preparing for adding value
While  carrying  out  further  research  on  second-generation  GM  plants,  which 
will include quality traits, biotech firms have adopted a commercial strategy 
for preparing the introduction of these new generation plants.
On  their  upstream  side,  they  have  entered  new  agreements  with  genomics 
companies, to increase their research/technology portfolio.
On  the  downstream  side,  biotech  firms  seek  to  invest  further  down  in  the 
food  chain.  They  have  concluded  or  are  considering  agreements  with  food 
processors.  The  food  industry  is  in  a  key  position.  In  Europe,  many  food 
processors  are  trying  to  avoid  GM  ingredients  because  of  consumer 
reluctance.
Significant  changes  in  the  biotech  sector  have  occurred  in  1999.  Growing 
consumer concern, extended public debate and food suppliers' initiatives have 
had  a  feed-back  effect  on  the  biotech  industry.  There  has  been  a  gradual 
slowdown in  mergers and a  shift towards  joint ventures  or agreements with 
genomic  research  firms  or  institutes.  Some  biotech  companies  have  also 
offered  to  make  their  technology  or  experience  available  to  public  research 
centres,  in  particular  for  developing  countries  (several  examples  with  GM 
rice). By doing so, these firms are trying to respond to public criticism and to 
improve their strategy and image.
Another  significant  change  is  the  separation  of  the  pharma  and  agri-biotech 
activities of some leading biotech companies. This might represent the start of 
a  new  phase  in  restructuring  the  agri-biotechnology  sector,  the  move  away 
from a "global life sciences” strategy.
9  Agrigenomics specifically refers to the research of crop genomes and encompasses such areas as gene 
sequencing, gene mapping, molecular probes and bio-informatics amongst other things.
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“Zeneca Agrochemicals” and “Novartis’ Agribusiness” to create Syngenta. If 
implemented, this agreement will effectively mean a departure from the life 
sciences strategy that had been pursued by both companies and a move in the 
direction of “pure play” agribusiness with a high priority given to programs 
in gene technology and agrigenomics.
In December 1999, Monsanto and Pharmacia & Upjohn announced a merger 
of their pharmaceutical activities, for creating a common company. The agri­
business  part  of  Monsanto  remains  out  of  the  merger,  and  the  name 
Monsanto will only apply to this autonomous entity.
The separation  between pharma-  and  agri-biotech businesses  echoes the  gap 
in public acceptance between these two areas of biotechnology. It also echoes 
the  difference  in  profitability  and  can  mean  that  synergies  between  pharma 
and agri-businesses might not be as optimal as expected.
2.2.  Biotechnology has increased concentration throughout the agri-food 
sector
2.2.1.  Crop protection was already a highly concentrated sector
Generally, the share of biotechnology in the agri-business part of life sciences 
industries is not indicated in financial reports or in publications. The share of 
agriculture  in  life  sciences  activities  provides  a  first  identification  of  agro­
chemical and agri-biotech companies, as indicated in table 2.2.
Table 2.2 Importance of agriculture within ’’life sciences” business
Company Estimated % of total sales 
for the agri-business section, 
1998
AgrEvo 100%
Monsanto 47%
Novartis 26%
Rhone-Poulenc 19%
Astra-Zeneca 18%
DuPont 13%
Dow Chemical
(agri subsidiary is Dow Agrosciences)
9%
Source : own compilation, based on financial reports of the firms
These seven companies are the main players for agri-biotechnology as well as 
for  crop  protection.  Novartis,  Monsanto,  DuPont,  Zeneca,  AgrEvo  and 
Rhone-Poulenc (which have now merged to create Aventis) form the top 6 of 
crop protection sales, as shown in table 2.3.
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based on sales of crop protection products (US $Mio)
Rank Company 1998 1997 1996
1 Novartis 4,124 4,199 4,068
2 Monsanto 4,032 3,126 2,555
3 DuPont 3,156 2,518 2,472
4 Zeneca 2,895 2,673 2,638
5 AgrEvo 2,384 2,366 2,475
6 Rhone-Poulenc 2,286 2,218 2,203
7 Bayer 2,248 2,283 2,350
8 American Cyanamid 2,194 2,119 1,989
9 Dow Agrosciences 2,132 2,134 2,010
10 BASF 1,932 1,913 1,536
Source: Inverzon International Inc. (St Louis, US), in Papanikolaw, 1999 
Notes : AgrEvo and Rhone-Poulenc are merging into Aventis. AgrEvo figures include seed 
activities. Rank depends on average exchange rates used.
According  to  RAF  I  (Rural  Advancement  Foundation  International,  1999), 
these top 10 companies accounted for as much as 80% to 90% of the world 
market for agro-chemicals in 1997/98.
2.2.2.  With biotech, concentration has spread to the seed market
In the early nineties, the concentration rate in the seed sector was not as high 
as  for  agro-chemicals.  According  to  Joly,  in  1994,  the  Top  12  of  the  seed 
industry  accounted  for  20%  of  the  world  market  in  seeds.  RAFI  estimates 
that  the  Top  3  now  controls  20%  of  the  market.  The  commercialisation  of 
GM seeds that began in 1996 resulted in a series of mergers, acquisitions and 
alliances  between  gene  providers  and  some  of  the  major  seed  companies. 
Many  of  the  major  agri-biotechnology  companies  now  have  access  to  the 
seed market in which they can market their biotech products.
Based  on  Investext  Broker  reports  (in  Roberts,  1999),  table  2.4  provides  a 
brief  overview  of  the  major  seed  companies  acquired  by  large  agri­
biotechnology  companies.  As  can  be  seen  from  the  table,  DuPont  and 
Monsanto have the broadest access to the seeds markets. At the opposite end 
of  the  spectrum,  Rhone-Poulenc’s  strategy  has been to  invest heavily in  the 
genomics in order to develop traits without making the costly investment in 
acquiring a seed company.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 26Table 2.4 A selection of agri-biotechnology companies with access to 
seed markets in 1999
Agri­
biotech
company
Seed company acquired Corn Soy
beans
Other
oilseed
Cotton
AgrEvo Cargill X
Metía Pesquisa X
Sementes Ribeiral X
Sementes Fartura X X
Biogentic Technologies X
B.V. (BGT)
Zeneca Garst (50%) X
Novartis Northrup King X
Eridania Beghin X
DuPont Pioneer X X X
Protein Technologies X
International
Dow Mycogen X X X
Monsanto DeKalb X X
Asgrow X X
Holden’s X X X
Delta & Pine Land 10 X
Calgene X
Stoneville
Source: Wood Me Kenzie, Merill Lynch in Roberts, February 1999
Biotech  firms  have  adopted  different  strategies  with  regard  to 
commercialisation  of  seeds.  Some  are  mainly  commercialising  their  GM- 
products  via  their  seed  subsidiaries.  Others  have  concluded  agreements  with 
seed companies. In the framework of such agreements and generally against 
payment  of  a  technological  fee,  biotech  companies  are  selling  their  GM- 
products  to  seed  companies.  The  latter  integrate  the  genes  of  interest  in  the 
germplasm  of  their  leader  varieties,  via  conventional  breeding  or  back- 
crosses.  This  allows  for  further  improvements  in  the  performance  of  GM- 
crops. The availability of germplasms with characteristics which are adapted 
to local conditions or demand is also a key factor. In this respect, breeders as 
well as small and medium-sized seed companies still have a role to play. For 
this  reason,  many  agreements  concerning  seeds  are  implemented  on  a 
regional/national  basis.  While  there  is  a  global  consolidation  in  the  seed 
sector, there is still a regional/national dimension.
The case of Limagrain, a French group which ranks among the world top-5 
of  seed  companies,  is  illustrative.  While  being  a  world  leader  in  seeds,  this 
group  has  kept  a  strong  regional  implantation  (Centre  France).  It  has 
developed  on  the  basis  of  a  50  year-old  farmers'  co-operative  and  is 
independent from the main life-sciences players. It holds various subsidiaries. 
Limagrain  Genetics  international  is  active  in  seed  business  in  Europe  and 
Northern  America  for  arable  crops  and  another  subsidiary  (Vilmorin)  is  a 
leader for vegetable seeds. Other subsidiaries of Limagrain produce food
10  In early 2000, Monsanto announced that it would give up this acquisition plan, following an 
examination under the anti-trust law. and/or in the context of its merger with Pharmacia UJ.
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meet processor and consumer specific needs, in the framework of organised 
supply chains. In response to demand for non-GM seeds and crops in Europe 
and  in  Japan,  Limagrain  has  also  organised  non-GM  maize  supply  chains. 
Limagrain  sells  GM  seeds  in  Northern  America,  but  not  yet  in  Europe. 
(Limagrain, 1999).
Biotechnology  has  increased  concentration  in  the  seed  sector,  as  if  the 
existing  concentration  in  the  agro-chemical  sector  had  spread  to  the  seed 
sector.  Table  2.5  gives  a  breakdown  of  the  sales  of  the  worlds  major  seed 
corporations. Care should be exercised when interpreting the figures as these 
can change quite rapidly as consolidation continues apace. At the beginning 
of  1999,  according  to  RAFI,  the  Top  10  of  the  seed  industry  controlled 
around 30% of the world market.
Just  four  companies  (DuPont/Pioneer,  Monsanto,  Novartis  and  Dow) 
controlled at least 69% of the North American corn seed market. The same 
four companies control 47% of the American soybean seed market.
Table  2.5  The  World’s  Top  10  Seed  Corporations  by  Sales  Value 
_____________(1997 Revenue US Millions)_________________ ___________
(1) DuPont/Pioneer Hi-Bred International (US)
Sales US $1,800
DuPont now has a 100% stake in Pioneer Hi-Bred _____________________________ ____________
(2) Monsanto (US)
Sales US $1,800 Estimate
Estimate of total sales volumes of all Monsanto seed acquisitions made by October 1998 ___________
(3) Novartis (Switzerland)
Sales US $928
Formerly Ciba Geigy and Sandoz_________________________________________________________
(4) Groupe Limagrain (France)
Sales US $686
French co-operative____________________________________________________________
(5) Advanta (UK and Netherlands)
Sales US $437
Owned by AstraZeneca and Royal Van derHave___________________________________________ _
(6) Agri Biotech, Inc. (US)
Sales US $425
The company has completed over 30 acquisitions (forage and turfgrass) since 1995________________
(7) Group Pulsar/Seminis/ELM (Mexico)
Sales US $375
Pulsar is a giant agro-industrial corporation that owns Empresas La Moderna,
majority shareholder of Seminis, Inc.__________________ __________________________________
(8) Sakata (Japan)
Sales US $349
Vegetable/flower/turfgrass __________________________________________________ _____ _____
(9) KWS AG (Germany)
Sales US $329
Major sugar-beet seed company _______________________________________________________
(10) Takii (Japan)
Sales US $300 (estimate)
Privately-held____________ ____________________________________ _______ _____________
Source: RAFI
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increased concentration on the input side of the farming sector. Life sciences 
companies  form  an  oligopoly  for  supplying  inputs  for  crop  production, 
furthermore  after  having  completed  mergers  or  agreements  with  seed 
companies.
2.2.3.  Various strategies: from input to output-oriented
The  marketing  strategy  developed  by  biotech  firms  has  been  focused  on 
farmers, the first customers interested in agronomic traits of GM crops. They 
have shaped farmers profitability expectations. The importance of agriculture 
within the life sciences business provides a first view of the position of the 
agri-biotech firms. Further elements have been taken into account to establish 
profiles  and  to  assess  the  strategy  of  each  of  them.  In  particular,  they  have 
been  considered  from  the  upstream/downstream  perspective  with  regard  to 
agriculture.  The  aim  is  to  assess  whether  firms  had  an  input-  or  an  output- 
oriented  strategy.  For  example,  if  a  company  has  built  on  the  basis  of  an 
experience in crop protection and has heavily invested in the seed market, it is 
considered  to  be  more  input-oriented.  Farmers  are  key  customers  for  these 
firms. Conversely, if a firm has already developed quality-traits crops and has 
substantially  invested  downwards  in  the  food  chain,  it  is  seen  as  output- 
oriented. Food processors are key customers, but farmers remain partners for 
growing the crops.
About profiles of the main biotech firms (see Appendix A)
The profiles of the main biotech-players have been established on the basis 
of  key  financial  indicators  (e.g.  sales,  acquisitions...)  and  factual 
information  (e.g.  products)  available  in  their  annual  reports,  on  their 
internet  sites,  or  in  various  press  releases.  Each  single  source  is  not 
quoted,  but  references  to  articles  or  publications  analysing  the  strategy  of 
biotech firms can be found in the bibliography.
There  is  no  clear-cut  border  between  input-oriented  and  output-oriented 
strategies.
In recent years, most of the biotech firms have implemented an input-oriented 
strategy,  focused  on  the  farm  sector  rather  than  on  the  food-  processing 
sector.  In  their  global  life  sciences  strategy,  they  have  failed  anticipating 
differences  in  perceptions  of  science  in  various  countries.  They  have 
overlooked  the  question  of  consumer  acceptance  and  have  underestimated 
the  reactions  of  retailers  and  food  processors.  Market  structures  and 
organisation play a significant role. Retailers have a strong market power, in 
particular  in  Europe.  The  food  processing  industry  is  concentrated,  in 
particular in the US.
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generation of GM crops. Many biotech firms already have quality-traits crops 
in  their  pipeline,  and  rely  in  the  long  run  on  an  output-oriented  strategy. 
Some quality-traits crops are already on the market. They are of interest for 
the feed and livestock industries as well as for the non-food sector. The US 
meat industry is already concentrated. Biotech is inducing further integration 
on the upstream side of this industry, acting as a possible vector between the 
crop  and  the  livestock  sector,  via  GM  feedstuffs  or  animal  health  products 
like vaccines.
Heffeman  (1999)  analysed  the  "emerging  clusters  of  firms  that  control  the 
food system from gene to supermarket shelf1. He considered several clusters.
-  Cargill/Monsanto. Cargill did not have access to GM seeds, thus it formed 
a  joint-venture  with  Monsanto.  In  addition,  Cargill  enters  a  merger  with 
Continental grain, one of the 4 major grain elevators in the US (together 
with  Cargill,  ADM  and  Bunge).  This  merger  will  bring  them  in  a  key 
position for exports, hence it is also illustrative of globalisation. Together, 
these three firms own a complete food cluster.
-  Another  cluster  is  the  Novartis/ADM  connection.  It  was  established 
through the joint-venture between Novartis and Land O'Lakes to develop 
speciality com hybrids.
-  Conagra provides the emblematic example of wide ranging clusters, "with 
diversified interests ranging from farm gate to dinner plate". Conagra is a 
leader  in  the  US  for  grain  milling,  feeding  stuffs,  slaughtering  and  meat 
processing.  One  of  its  subsidiary,  United  Agri  Products,  is  a  leading 
distributor  of  crop  production  inputs:  fertilisers,  crop  protection  and 
seeds, including GM ones.
-  A  similar  case  is  DuPont,  a  trans-national  firm  for  which  the  activity 
spectrum  is  even  wider,  from  "dirt  to  dinner  plate",  dirt  referring  to  the 
chemical business of DuPont.
Biotech  has  already  generated  increased  concentration  on  the  input  side  of 
the  crop  sector.  Considering  the  emerging  “gene  to  supermarket”  clusters, 
biotech  finally  appears  as  a  driving  force  for  vertical  integration  and  for 
further  consolidation  throughout  the  agri-food  sector,  from  the  upstream  to 
the  downstream  side.  The  position  of  farmers  in  this  rapidly  consolidating 
context is an issue of concern.
2.3.  Consequences for farmers: increased dependency
With the development of biotech, farmers more and more depend on a limited 
number  of  suppliers  for  crop  protection.  In  addition,  farmers  adopting 
biotechnology are confronted with several constraints.
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preclude seed-saving by farmers. Some biotech companies have taken action 
against producers who attempt to save seeds, on the basis of "infringement of 
intellectual  property  rights"  (Monsanto,  1998).  Saving  seeds  for  further 
sowings is a long-established tradition, at least for crops allowing for doing 
so  (e.g.  wheat,  soybeans-25%  of  soybean  seeds  are  estimated  to  be  farm- 
saved).
Biotech firms have developed technologies that render GM crops sterile. The 
initial  name,  "Technology  Protection  System"  has  been  turned  into 
"terminator technology" by NGOs that have denounced the costs for farmers 
and  the  loss  of  independence.  Faced  with  overall  criticism,  Monsanto 
announced  in  late  1999  that  it  would  not  implement  the  terminator 
technology.  The  Technology  Protection/Terminator  System  had  also  been 
supported  by  public  research  (including  by  the  USDA).  Various  reasons  for 
justifying  sterility  of  GM  crops  have  been  put  forward,  in  particular 
protecting  the  research-value  of  GM  seeds  and  limiting  gene-flow  into  the 
environment.
When  selling  their  technology,  some  biotech  companies  are  charging  a 
"technological  fee".  The  technological  fee  is  presented  as  a  coverage  for 
research  costs  and  allows  for  a  margin  of  profitability  for  biotech  firms.  It" 
results  from  the  private  origin  of  the  new  technology  and  has  to  be 
considered  together  with  property  and  patenting  rights.  Generally,  the 
technological fee is first paid by seed firms (which are sometimes subsidiaries 
of biotech companies), and is later transferred to farmers.
The technological fee and the restriction on seed-saving imply increased seed 
costs-  as  such  costs  are  to  be  paid  each  year-  and  a  loss  of  autonomy  for 
farmers.
Some authors (Alexander and Goodhue, 1999) have analysed the breakdown 
of  profitability  of  GM  com  between  biotech/seed  firms  and  farmers.  For  Bt 
com,  "although  [their]  analysis  provides  suggestive  rather  than  conclusive 
evidence" they consider that "seed companies capture a significant, but by no 
means all of the net revenue advantage of Bt com" and that "the likelihood of 
monopolistic  pricing  of  the  technology  appears  limited".  For  HT  com,  they 
showed the sensitivity of profitability results to both the price of seeds and of 
herbicides,  hence  the  sensitivity  to  the  "combined  pricing"  strategy  of  the 
firms.
As  far  as  HT  soybeans  are  concerned,  the  American  Soybean  Association 
(ASA)  has  recently  complained  about  significant  differences  in  prices  of 
Round  Up  Ready  soybean  seeds  between  the  US  and  Argentinean  markets. 
According to ASA, a bag of such seeds costs 12 US $ more in the US, and 
part of this difference is attributable to the 6 US $ technological fee, which is 
apparently not charged in Argentina.
The combined pricing strategy and the observed variations in GM seed prices 
point to the existence of margin of manoeuvre for biotech firms. The market 
power of seed and agro-chemical suppliers deserves further assessment.
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concentration on the input side of the crop sector. This raises the question of 
increased  dependency  of  farmers  on  a  limited  number  of  suppliers  for  crop 
production.  Moreover,  some  biotech  firms  have  already  concluded 
agreements  with  grain  processors,  as  is  the  case  with  the  Monsanto/Cargill 
cluster.  The  downstream  side  of  the  food  chain  is  also  quite  concentrated, 
either  at  the  level  of  food  processors  or  at  the  retailing  industry.  In  this 
context,  farmers  risk  being  "squeezed”  between  two  (more  or  less) 
oligopolistic industries.
Heffeman (1999) drew conclusions on the future role of farmers: "the farmer 
becomes  a  grower,  providing  the  labour  and  often  some  capital  but  never 
owning the product as it moves through the food system and never making 
the major management decision".
At a first glance, this sentence may seem excessive. Nevertheless, more and 
more contracts are governing the supply of crops by farmers, from the seed 
to the wholesale or processing stages. Biotech is very likely to be a driving 
force in such a process, for two reasons.
-  GM seeds are often sold and sown under contract. GM crops require 
adjustments in growing and management practices.
-  If segregation or identity-preservation develop, crops, be they GM or not, 
will increasingly be grown and sold in the context of contracts.
For this reason, some farmers are considering GM crops as "another liability". 
To  strike  a  balanced  view  between  constraints  and  benefits  of  GM  crops, 
studies  assessing  their  farm-level  profitability  are  summarised  in  the  next 
chapter.
3.  Farmers: strong profitability expectations, mixed outcome
The adoption of  GM crops by  farmers  in the US, Canada and in Argentina 
has  proceeded  at  an  unprecedented  rate  compared  to  the  uptake  of 
conventional  hybrids.  The  economic  reasons  for  this  rapid  and  massive 
adoption are analysed in section 3.1. Farmers had strong expectations on the 
profitability of GM crops, in particular as regards yield and/or cost savings. 
However, as shown in section 3.2, GM crops do not prove to be significantly 
more  profitable  than  conventional  counterparts.  Other  factors  than 
profitability play role. They are reviewed in section 3 .3.
The  analysis  is  based  on  the  available  economic  literature,  which  mainly 
concerns  Northern  America.  It  is  limited  to  the  two  main  GM  crops  under 
cultivation  Herbicide-Tolerant  (HT)  soybeans  and  Insect-Resistant  (Bt)  com. 
Two Canadian studies on HT Canola11 have also been taken into account.
11 Canola = a type of rapeseed which has been developed in Canada. It is a registered trademark, corresponding to 
specified characteristics (low erucic acid and glucosinolate), equivalent to double 0 in Europe.
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3.1.1.  Profitability expectations mainly based on yields
Many  surveys  and  studies  have  been  carried  out  to  assess  reasons  for 
adopting  GM  crops.  They  have  confirmed  that  adoption  of  GM  crops  by 
farmers has been driven by profitability expectations.
According to an USDA survey (1997), the majority of farmers (50 to 75%) 
cited increase in yield as first reason for adoption. Savings in costs appear to 
be  the  second  reason,  mentioned  by  20  to  40%  of  the  respondents.  This 
survey was conducted in 1997, only one or two years after the introduction 
of  the  first  GM  seeds  on  the  US  market.  Therefore,  it  addressed  farmers' 
expectations.
The  quick  rate  of  adoption  in  the  first  years  is  explained  by  the  strong 
expectations of farmers as regards profitability. Whether they definitely adopt 
the new technology then depends on their degree of satisfaction, and in turn, 
on  the  effective  profitability  of  the  crop.  Biotech  firms  have  published 
encouraging  results  on  the  satisfaction  rate  of  farmers  having  adopted  GM 
crops (Monsanto, 1998).
In practice, the most immediate and tangible ground for satisfaction appears 
to  be  the  combined  effect  of  performance  (not  necessarily  measured  by 
yields)  and  convenience  of  GM  crops,  in  particular  for  herbicide  tolerant 
varieties. These crops allow for a greater flexibility in growing practices and 
in  given  cases,  for  reduced  or  more  flexible  labour  requirements.  Where 
labour  or  time  is  a  restriction,  this  convenience  effect  has  an  economic 
impact.  In  the  medium  term,  it  should  translate  into  increased  labour 
productivity  and  savings  in  labour  costs.  In  the  long  run,  it  might  have  an 
impact on farm restructuring, alongside with many other factors which play a 
role in this process.
The effective profitability of a GM crop can only be properly assessed on the 
basis of several years of cultivation and commercialisation. Several years have 
to  be  considered  for  two  main  reasons.  First,  many  other  factors  have  an 
impact on profitability. In particular, there are important yearly fluctuations in 
yields and prices. Second, effective profitability depends on developments on 
the supply and on the demand side.
The  first  generation  of  GM  crops  is  input-oriented.  The  primary  effects  of 
this new technology were expected and observed on the supply side.
Bullock and Nitsi (1999) consider five possible effects of technical changes in 
the field of plant breeding:
1.  Increase in the maximum yield
2.  Increase of the economically optimal yield
3.  Input-switching technical change, lowering the cost but yield neutral
4.  Quality-enhancing technical change
5.  Risk-reducing technical change.
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Tolerant soybeans rather have a type-3 effect. Both types of effects imply a 
shift in farmers supply functions. Under given prices, farmers produce more. 
If  the  demand  function  remains  unchanged,  prices  drop.  Only  type-4 
technological change induces a structural change in the demand function, and 
possible increases in prices. When assessing the profitability for farmers and 
the economic impact of biotechnology on agri-food markets developments in 
supply  and  in  demand  have  to  be  considered  together.  However,  it  appears 
that this has not always been the case, neither for farmers, nor for the leading 
biotech firms. Their approach has been supply-oriented.
3.1.2.  The effect of agricultural policy: limiting price risk
In  the  US  as  well  as  in  the  EU,  GM  and  non-GM  crops  are  not  treated 
differently  under  the  various  support  schemes,  both  are  eligible.  In  the  US, 
crops  for  which  GM  varieties  have  rapidly  developed  are  all  eligible  for 
support under the flexibility payments, the marketing loan system, as well as 
for crop insurance.
Soybeans  became  eligible  for  flexibility  payments  and  under  the  marketing 
loan system in 1996, which is the year of first commercial sowings of GM 
varieties.  Several  analysts  (FEDIOL,  1999)  consider  that  existing  support 
systems  have  favoured  the  development  of  soybeans  sowings.  In  particular, 
the  loan  rate  applied  to  soybeans  makes  this  crop  attractive  compared  to 
wheat and com. The area under soybeans is expected to reach a record level 
in 2000, while prices are low. By mid-November 1999, the USD A estimated 
that  90% of the 1998 soybeans crop had received a marketing loan benefit, 
and that the average value of this benefit was worth around 0.44 US $/bushel 
(14.5  €/t).  Oilseed  producers  are  also  eligible  for  the  1999/2000  emergency 
packages. A specific assistance programme was set up in early February for 
oilseeds  producers,  to  offset  record  low  market  prices.  Under  this 
programme,  payments  for  soybeans  could  average  0.141  US  $/bushel 
(5.3 €/t), according to calculation by private consultants.
Favourable  support  conditions  for  soybeans  could  have  played  a  role  in  the 
rapid  uptake  of  GM  technology  for  this  crop.  In  addition,  in  a  low  market 
price context, the expectation on cost savings is a further driving force for the 
adoption of the technology.
Eligibility of GM crops under various support schemes limits the price risk of 
the  productivity-enhancing  technology.  It  accounts  as  another  reason  for  the 
farmers to focus their planting decision on expected farm-level performance, 
on  cost-efficiency  of  inputs.  In  other  words,  farmers  also  had  an  input- 
oriented approach.
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difficult
Profitability  is  defined  as  the  margin  left  over  to  farmers  when  costs  have 
been deduced from receipts. The profitability of a GM crop is judged against 
corresponding conventional crops. Comparing the performance of both types 
of crops raises several methodological issues.
3.1.3.1.  On the cost side: the input-effect of GM crops
Generally  the  cost  comparison  of  GM  crops  and  their  conventional 
counterpart  is  limited  to  crop-specific  costs,  assuming  that  fixed  costs  are 
more or less the same.
GM seeds are sold at a higher price than conventional ones. The price wedge 
is mainly attributable to the value of GM technology or to the "technological 
fee".  According  to a  Monsanto communication  (1998),  the technological  fee 
reflects  "the  insect,  weed,  disease  control  value  of  the  inserted  gene,  and  a 
significant  part  of  the  fee  is used for  further research". This  difference also 
reflects  the  fact  that  markets  for  GM  and  conventional  seeds  are  separate. 
Furman  Selz  (1998)  reports  about  premia  observed  on  the  US  market  in 
1998: US $ 30 per bag of seeds for GM com and US $ 5 for GM soybeans 
seeds,  which  represents  a  30%  price-premium  compared  to  non-GM  seeds. 
They  also  give  an  indication  on  the  average  technological  fee  paid  by  seed 
companies  to  gene  providers:  US  $  27  (30%  of  GM  seed  price)  per  bag  of 
com  seeds  and  US  $  4.25  (21%  of  GM  seed  price)  for  soybean  seeds. 
Despite of the technological fee, GM seeds appear to be more profitable than 
conventional ones for seed companies.
The above-mentioned convenience effect of GM crops allows for reduced or 
more  flexible  working  requirements.  However,  the  related  savings  in  labour 
costs have not always been properly assessed. The valuation of family work is 
rarely broken down on a crop-specific basis. On the other hand, growing GM 
crops  requires  new  management  skills,  growing  practices  and  possible 
constraints.  GM  seeds  are  generally  sold  and  sown  in  the  context  of 
contracts. These changes entail transaction and management costs, which are 
not easy to assess.
GM crops are expected to allow for cost-savings through reduced insect and 
weed  control and/or to achieve higher yields. Under the assumption that the 
price  of  non-GM  and  GM  crops  is  the  same12,  the  latter  will  become  more 
profitable for farmers if the increased seed costs are offset by savings in weed 
and/or pest control costs and/or by higher yields.
12  This assumption needs to be reconsidered : see chapters 4 and 5. 
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Yield  is  a  key  factor  for  profitability  expectations  and  results.  In  fact, 
available  figures  on  crop-specific  costs  are  often  broken  down  on  an  area 
basis,  while  prices  are  paid  on  a  quantity  basis.  Based  on  yields,  costs and 
prices are brought on a common basis, often per acre/ha. In other words, the 
effect of possible increase in yields is taken into account on the receipt side
Comparing  yields  of  GM  and  non-GM  crops  is  not  a  straightforward 
exercise. Yields depend on a large number of factors, and the inserted trait of 
GM  crops  is  only  one  factor  amongst  others.  It  is  worth  recalling  (OECD, 
1999)  that  first  generation  genetic  modifications  address  production 
conditions (pests, weeds), they do not increase the intrinsic yield capacity of 
the  plant.  In  other  words,  referring  to  Bullock's  classification,  they  do  not 
induce  a  type  1  (maximum  yield)  technical  change.  Not  surprisingly  yield 
performance  of  GM  crops  against  their  non-GM  counterparts  depends  on 
growing conditions, in particular on the degree of infestation in insects or in 
weeds. Data about yields of GM crops are widely available, however, often 
specifications  on  factors  which  influence  yields  are  missing,  such  as 
temperature13, weed control applied etc.
The USD  A  (1999)  has examined different factors  affecting the adoption of 
GM crops. These include farm size, education and experience, location of the 
farm,  use  of  production  or  marketing  contracts.  In  the  case  of  herbicide 
resistant soybeans, the USD A has concluded that "larger operations and more 
educated operators are more likely to use herbicide tolerant soybean seeds". 
Such  differences  between  adopters  and  non-adopters  of  biotechnology  have 
to be taken into account when comparing yields and returns obtained on both 
types  of  farms.  This  study  on  factors  of  adoption  served  as  a  first  step  for 
assessing the impact of GM crop on farmers' returns and on the environment. 
It  allowed  for  controlling  statistically  these  exogenous  factors  and  carrying 
out multivariate regressions for assessing aggregate impacts of GM-crops on 
yields,  profitability  and  the  environment.  Results  of  this  USD  A  study  are 
indicated below, for each type of GM crop.
Another  key  factor  on  the  receipt side is  the  market price  of GM crops. In 
many profitability  studies, prices of GM and  non-GM  crops are assumed to 
be equivalent. Most of the available studies are based on 1997 or 1998 data. 
In  these  first  years  of  commercialisation  of  GM-crops,  their  impact  on 
commodity  prices  has  not  been  manifest  or  is  difficult  to  assess.  Different 
pricing  developments  between  GM  and  non-GM  crops  have  only  been 
observed  in  1999.  However,  very  few  market  reviews  report  on  a  regular 
basis  about  such  developments.  The  question  of  price  premiums/discounts 
will be addressed in chapter 5.
13  Glyphosate-resistant soybeans seem to be more vulnerable to high temperature than conventional or 
other GM soy varieties. BT-Cotton also seems to be sensitive on high temperature.
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crops, including effects on welfare as well as non-market effects, particularly 
risk assessment and management. However, the studies reviewed below only 
cover on farm profitability in the short term.
3*2. Costs and benefits for farmers for selected GM crops
The  results  of  various  North-American  publications  on  the  profitability  of 
GM  crops  are  summarised hereafter. The review is limited to  the two  main 
crops  under  cultivation,  respectively  Herbicide  Tolerant  (HT)  soybeans  and 
Insect  Resistant  (Bt)  com.  In  addition,  some  Canadian  studies  on 
rapeseed/Canola have also been included.
3.2.1.  Herbicide Tolerant Soybeans
Three different types of GM soybeans have been authorised in the US. Two 
of them are tolerant to different herbicides. Soybeans tolerant to glyphosate, 
Monsanto's "Round up Ready"(RR) soybeans, have been on the market since
1996  and are the most widely grown (estimated 80% share in GM soybeans). 
The third one is a high oleic soybean variety.
3.2.1.1.  Lower yields
One  of  the  reasons  for  the  rapid  adoption  of  GM  soybeans  has  been  the 
expectation  of  a  higher  yield  than  for  non-GM  soybeans.  A  number  of  US 
research  projects  have  addressed  this  issue.  Results  seem  to  indicate  the 
reverse: in most field trials the GM crop shows lower yields than the non-GM 
crop,  as  indicated  in  the  table  below,  in  the  case  of  Roundup  Ready  (RR) 
soybeans.
Table 3.1 Differences in yields between conventional and GM soybeans
States Yield (t/ha) Difference in % 
(RR- conventional)
Conventional Roundup Ready
Illinois 3.90 4.04 +3.5%
Iowa 4.10 3.83 -7%
Michigan 4.44 4.30 -3%
Minnesota 4.44 4.10 -8%
Nebraska 3.90 3.43 - 12%
Ohio 4.04 3.90 -3%
South Dakota 3.30 2.96 - 10%
Wisconsin 4.77 4.64 -3%
Source: Benbrook, 1998, based on Oplinger
Similarly,  according  to  Benbrook  (1998)  in  South  Minnesota,  average 
performance of top yielding Roundup Ready soybean varieties was 3% lower 
than the top yielding conventional varieties, yet in Central Minnesota the yield 
drag was as much as 13% and in Southern Wisconsin 6%. While indicating 
lower  yields  in  each  case,  these  sub-regional  results  point  to  the  great 
variability in yield performance.
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soybeans, as indicated by Hofer et al. (1998):
Table 3.2 Differences in yields between conventional and GM soybeans, 
Kansas
Location Yield (bu/ac) Yield (t/ha) Difference
(%)
Conventional Roundup
ready
Conventional Roundup
ready
Ashland
Bottoms
57.1 52.1 3.84 3.50 -9%
Manhattan 35.6 34.8 2.39 2.34 -2%
Belleville 35 31.2 2.35 2.10 - 11%
Duffy  &  Ernst  (1999)  conducted  a  "cross  sectional  survey"  among  800 
farmers in Iowa, based on interviews and field observations. It was not a side 
by  side  observation  of  GM  and  non-GM  crops  and  should  provide  reliable 
estimates  at  state  level.  The  average  yield  reported  was  3.43  t/ha  for  those 
farmers  who  grew  non  GM-soybeans  versus  3.29  t/ha  for  those  who  grew 
GM-soybeans.
The USD A estimated, on the basis of the 1997 data, that the increased use of 
HT soybeans produced only a small global increase in yields.
One  of  the  explanations  given  for  the  lower  yield  of  GM-crops  is  that  the 
GM-traits  were  initially  not  introduced  in  the  top  yielding  varieties  of 
soybean.  Seed  companies  are  now  incorporating  these  traits  in  their  yield- 
leading varieties. If this is indeed the case, then the yield drag should diminish 
in the coming years.
3.2.1.2.  Reduced herbicide use and costs
In the 1960s herbicide use started to replace tillage and cultivation practices 
as  a  primary  means  of  weed  control.  At  that  time,  these  were  mainly  pre­
emergence herbicides.
The use of post-emergence herbicide in the production of soybean has been 
rising  steadily  since  they  became  available  in  the  80s.  In  1988,  44%  of 
soybean acres were treated, by 1994 this share had risen to 72%. Quite often, 
they were used in combination with pre-emergence herbicides.
However these classical herbicides had a number of drawbacks:
-  difficult management
-  risk of crop damage
-  development of herbicide resistant weeds
-  some herbicides limit the possibility of crop rotation.
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("Roundup")  has  a  significant  impact  on  the  use  of  other  herbicides.  For 
instance,  the  use  of  imazetaphyr  ("Pursuit"),  one  of  the  most  widely  used 
post-emergence herbicides has declined from 44% of soybean acres in 1995 
to 17% in 1998. The main advantages of using Roundup on HT soybeans are:
-  a wider window of application, both in terms of stage of growth of 
soybeans and effective control of larger weeds,
-  the easier management of weed control programs,
-  the fact that there is no carry over, thus giving growers more rotation 
options.
The use of this product has increased drastically. In 1990, about 10% of all 
soybean  acreage  were  treated  with  Roundup  (at  that  stage  used  only  as 
"bumdown"  treatment).  This  figure  has  risen  to  45%  in  1998  (Carpenter  & 
Gianessi*  1999).  According  to  the  USD  A,  the  use  of  other  synthetic 
herbicides have declined by a larger amount, and the net impact of increased 
cultivation of HT soybeans is a decrease in overall herbicide applications.
The  cost  of  a  program  of  Roundup  on  HT  soybeans  was  14.7  €/acre 
(36.6  €/ha)  in  1998,  compared  to  12€/acre  (29.8  €/ha)  for  a  conventional 
program  with  pre-plant  treatment  alone,  or  22.3€/acre  (55.2  €/ha)  for 
programs using other combinations).
However,  due  to  emergence  of  resistance  in  the  future  additional  treatments 
may be needed. From 1998 to 1999, an increase from 15 to 25% in terms of 
average  pounds  of  Roundup/acre  was  observed.  Benbrook  reports  an 
increase  from  24  ounce/acre  to  32-48  ounce/acre  in  the  dose  of  Roundup 
Ultra  required  to  gain  adequate  control  of  velvetleaf  and  ragweed  species. 
This would clearly have an impact on the cost of GM crops.
Nevertheless, in the short term, the cost saving effect seems to be dominant. 
In  the  Duffy  report,  farmers  who  used  GM  crops  reported  spending  nearly 
30%  less  than  those  who  grew  non-GM  soybeans.  Reduced  herbicide  costs 
was listed by 27% of farmers as one of the reasons for planting GM crops. 
Furman Selz reports a 33 to 35 €/ha lower herbicide cost for HT soybeans.
Moreover,  following  the  introduction  of  GM  crops,  there  is  a  notable 
reduction  in  the  price  of  weed  control  programs  for  non-GM  crops.  A 
University  of  Illinois  study  revealed  that  compared  to  1995,  the  least 
expensive  non-glyphosate  herbicide  program  was  between  4.5-6  €/acre  (11- 
14.9 €/ha) cheaper in 1999. As indicated by Bullock et al. (1999), this means 
that non-adopters  of HT crops might also benefit from an induced effect on 
cost savings.
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It  is  difficult  to  quantify  the  convenience  effect  of  choosing  HT  crops. 
However, there are some clear advantages. For example:
-  The ease of the glyphosate-herbicide use and the large time window for 
spraying, which increases flexibility.
-  HT  crops  make  the  adoption  of  no-till  or  conservation  tillage  easier. 
According  to  Monsanto,  in  1997,  nearly  half  of  the  acres  planted  in  RR 
soybeans  are  not  tilled  anymore.  The  absence  or  limitation  of  tillage 
implies  lower  use  of  crop-specific  resources  (labour,  fuel  etc).  It  is  also 
considered  to  be  more  environmental  friendly,  in  particular  as  it  reduces 
soil erosion.
Indeed, in a survey by Duffy and Ernst, 12% of the farmers listed increased 
planting-flexibility as a reason for going for GM soybeans.
3.2.1.4.  Increased seed price
Because  of  the  "technology  fee",  seed  for  GM  soybeans  is  more  expensive 
than  conventional  seed.  The  Duffy  and  Ernst  study  showed  a  seed  cost  of 
57  €/ha  for  GMO  soybeans,  versus  42  €/ha  for  non-GMO  soybeans.  This 
difference  corresponds  to  the  technology  fee  of  15  €/ha  reported  by 
Carpenter  &  Gianessi  (1998).  Other  sources  report  somewhat  lower figures, 
but still in the same order of magnitude 13.5 €/ha (University of Illinois,
1999)  and  14  €/ha  (Furman  Selz,  1999).  This  means  that,  in  average,  GM 
soybeans seeds are 35% more expensive than conventional seeds.
3.2.1.5.  No significant profitability effect?
At this stage, there are two counterbalancing elements in the growing of GM 
soybeans. On the one hand, seed prices Of GM crops are higher while yields 
(and  thus,  in  a  hypothesis  of  the  same  price  for  both  variants,  income)  are 
lower, on the other hand, input costs are lower as well.
The  Iowa  survey  (Duffy  et  al1999)  showed  that  differences  in  costs  and 
yields  between  GM  and  non-GM  varieties  do  not  result  in  significant 
differences  in  return  on  land  and  on  labour  (at  price  5.27  US  $/bu 
=172.9 €/t).
However,  if  HT  soybeans  allow  for  savings  in  labour  through  their 
convenience  effect,  the  same  return  for  less  labour  means  an  increase  in 
income per working hour.
Table 3.3 Comparison of returns for GM and conventional soybeans
Crop Yield (t/ha) Seed Cost 
(€/ha)
Total cost 
(excluding 
land/labour)
(€/ha)
Return on 
land/labour
(€/ha)
GMO 3.295 57 254 320
Non-GMO 3.430 42 274 322
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study  are  reported  to  be  8%  higher  than  for  GM-crops.  However,  these 
higher costs are offset by the higher yields.
Similarly, in simulations of the University of Illinois, the variable costs/acre 
for non-GM crops were estimated to be 6 to 8% higher than for GM crops. 
However,  the  assumption  of  no-yield  drag  made  in  this  study  seems  not  to 
hold, taken into account the results of different studies as indicated above.
The USD A has found no evidence of a significant change in variable profits in 
1997, following the dramatic increase in GM soybeans sowings.
Before  drawing  definitive  conclusions,  the  comparison  of  profitability 
between  herbicide-tolerant  and  conventional  soybeans  systems  deserves 
further analysis, in particular on the following elements:
-  Efficiency of different weed control systems: prices, herbicides quantities, 
management constraints versus convenience.
-  Will the yield drag close following the insertion of herbicide tolerant genes 
into top yielding varieties?
-  Are there divergent price developments between GM and non-GM 
soybeans?
3.2.2.  Bt corn
Profitability  studies  are  mainly  available  for  Bt-com,  which  is  the  leading 
GM-com and has been grown on a wide basis for two or three years.
3.2.2.1.  Evidence on yield gains
By their stalk tunnelling action, com borers are significantly damaging to com 
crops. During one growing season, up to three generations of com borers can 
affect a given crop. To be effective, insecticide applications have to be carried 
out at the appropriate stage of development. Hence they require scouting, or 
in  other  words,  farmers  have  to  follow  developments  regarding  population 
and  to  make  their  applications  decision  on  this  basis,  in  due  time.  For 
cost/effectiveness reasons, uses of insecticide sprays against com borers vary 
greatly from one production region to another, or even, from one grower to 
another.
A soil bacterium, the Bacillus thuringiensis (Bt) produces toxins that kill the 
European  Com  Borer.  Bt  com  includes  gene  material  from  the  Bt  bacteria, 
which  allows  own  production  of  insecticide  during  the  growth  stage  of  the 
plant. Hence it is expected to have a yield and convenience advantage against 
non-Bt  com.  A  survey  carried  out  in  Iowa  has  shown  that  80%  of  Bt-com 
growers  had  chosen  this  option  because  of  the  expected  yield  advantage 
(Duffy, 1999).
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1996-1998 data of the Agricultural Resources Management Data, the USD A 
has observed that adopters of Bt com had obtained higher yields than non­
adopters.  This  might  however  been  partly  explained  by  performance 
differences  between  these  two  groups  of  farmers.  Gianessi  and  Carpenter 
(1999) report about average gains of 0.73 t/ha in 1997 and 0.26 t/ha in 1998, 
respectively, + 9% and +3% compared to 97/98 average yield for com.
The gap between 1997 and 1998 results can be explained by the difference in 
weather conditions and in insect pressure. Infestation was low in 1998. Other 
studies  (ilike  Alexander  and  Goodhue,  Hyde  and  al.,  1999)  show  the 
sensitivity of Bt performance to these two factors.
3.2.2.2.  No clear savings in input costs
According  to  an  USD  A  case-study,  insecticide  treatments  are  significantly 
lower  for  Bt  com  than  for  conventional  com.  Globally,  insecticide  use  for 
com  was  lower  in  1998  than  in  previous  years.  However,  as  previously 
mentioned 1998 had been a low infestation year. It is difficult to assess the 
role of Bt-technology in this reduction.
Other  studies  (Rice,  1999)  give  more  details  on  farmers'  practices:  an 
increasing percentage of farmers (13% in 1996, 26% in 1998) having adopted 
Bt com indicate that they use less insecticide. Insecticides were not used at all 
by  50%  of  farmers.  However,  it  is  not  clear  whether  the  absence  of 
applications  results  from  Bt  technology  or  if  it  was  already  the  case  with 
conventional  varieties.  Some  farmers  still  spray  insecticide  on  Bt  com, 
because its performance against second or third generation infestation is more 
limited. In addition, insecticide may still be needed against other pests.
Considering that most of the farmers do not apply insecticide for controlling 
ECB,  Furman  Selz  (1998)  conclude  that  the  value  of  Bt  com  is  not 
insecticide cost savings, but rather yield protection.
The net effect regarding insecticide use and price is not clear-cut. Based on 
the  1998  Iowa  survey14,  Duffy  (1999)  reports  reduced  applications  but 
increased insecticide costs: "Farmers applied insecticides in 12% of their Bt 
com  fields  at  an  average  cost  of  17US  $/acre.  They  applied  insecticides  to 
18% of their non-Bt com fields at an average cost of 15US $/acre". In this 
case, the advantage of Bt com is not significant.
In  addition,  Duffy  observed  that  Bt  fields  required  slightly  higher  weed 
control (+ 6 €/ha) and fertiliser (+11 €/ha) costs.
14  "Cross  sectional  survey",  based  on  interviews  and  field  observations,  which  should  provide 
"statistically reliable estimates at the state level". It is not a side by side comparison of GM and non- 
GM crops. It covered corn/maize and soybeans (see also section on soybeans).
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To  prevent  resistance  in  ECB  populations,  farmers  planting  Bt  crops  have 
been  advised  to  keep  "refuges"  with  non-Bt  crops  next  to  the  Bt-fields.  In 
early 2000, the US Environmental Protection Agency specified requirements 
which have to be observed in this respect. Refuges should cover at least 20% 
of  the  area  planted  in  Bt  com.  Where  Bt  com  is  grown  near  Bt  cotton, 
refuges have to cover an area equivalent to 50% of the Bt area. This should 
translate into increased cultivation constraints.
It  has  been  argued  that  resistance  to  Bt  could  raise  problems  for  organic 
farming,  which  traditionally  uses  sprays  or  granulates  of  Bt  preparations 
within pest control programmes.
Furthermore,  since  findings  on  sensitivity  of  the  Monarch  Butterfly  to  Bt 
toxin  have  been  published  and  debated,  the  effect  of  this  toxin  on  insects 
other than com borers has become an issue.
3.2.2.4.  Increased seed price
GM seeds are more expensive than conventional ones. This reflects both the 
technological  fee  charged  by  some  biotech  firms  and  the  fact  that  GM  and 
conventional  seeds  are  sold  on  different  markets.  Alexander  and  Goodhue 
(1999) report on GM-seed premiums for 20 GM com varieties ranking from 
3 €/ha for high yield varieties to 35 €/ha for some Bt varieties. The figure of 
22  €/ha  can  be  found  in  the  Furman  Selz  paper  (1998)  as  well  as  in  the 
Gianessi and Carpenter publication.
3.2.2.5.  Contrasted results on profitability
As explained  by Hyde et al  (1999),  the profitability  of Insect resistant crop 
will depend on whether the "value of the protection" is less or more than the 
highest seed price. Results obtained by this research team for Indiana suggest 
that  this  is  generally  not  the  case.  However,  results  depend  on  the  level  of 
infestation. Hyde and al have found that "when the probability of infestation 
increases from 25 to 40%, Bt com value increases by about 69%". Therefore, 
Hyde  considers  that  in  areas  where  infestation  is  more  likely  or  where 
average yields are higher, Bt com should be profitable.
Several other studies show that profitability of Bt is higher where infestation 
is high. The calculations carried out by Furman Selz (1998) are summarised 
in the following table.
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Degree of infestation
Units Light Medium Heavy
Yield loss if untreated 5% 10% 20%
Price €/tonne 98.4 98.4 98.4
Yield gain t/ha 0.471 0.941 1.883
Gain in receipts €/ha 46.3 92.7 185.3
Additional cost €/ha 21.8 21.8 21.8
Net gain/loss €/ha 24.5 70.9 163.5
Source: Furman and Selz
Compared  with  other  studies, Furman and  Selz calculations on income  gain 
appear  over-estimated,  in  particular,  the  relative  high  yield  gains  under  the 
medium and heavy infestation scenario.
Different  results  are  outlined  in  table  3.5  Gianessi  and  Carpenter  have 
assessed  net  gains/losses  for  the  years  1997  and  1998.  They  have  assumed 
that there was no cost-saving effect for lower insecticide applications. Results 
obtained by Duffy for Iowa are also summarised in the table.
Table 3.5 Net gains and losses for Bt corn
Gianessi&Carpenter Duffy
Bt Maize Units 1997 1998 1998
Price
Yield gain 
Gain in receiDts
€/tonne
t/ha
€/ha
84.5
0.73
62.0
68.6
0.26
18.1
66.8
0.80
53.2
Additional costs
€/ha
€/ha
€/ha
€/ha
€/ha
21.8 22.1 21.3
-1.3
6.2
11.1
7.2
seed
insecticide
weed
fertiliser
others
not available
Gain/losses €/ha 40.20 -3.99 8.8
The  results  of  the  two  studies  are  not  directly  comparable.  As  already 
mentioned,  Duffy  has  estimated  the  insecticide,  weed  and  fertiliser  effects, 
while Gianessi and Carpenter have not.
In the Gianessi and Carpenter study, the combined effect of lower yield gain 
and com prices in 1998 resulted in net losses for Bt-com growers. These first 
results show that profitability of Bt com is highly dependent on the extent of 
yield  gains  and  on  prevailing  market  prices  for  com.  This  also  explains  the 
gap in the results of different types of calculations.
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have been no cost savings. However, as a result of yield gains, Bt-com has 
been  slightly  more  profitable  than  conventional  corn.  Duffy  nevertheless 
considers that the 9 €/ha gain is not significant.
The cost of GM seeds is also a key factor in the relative profitability of GM 
crops. Alexander and Goodhue have examined the relationship between seed 
price and profitability, as well as the likely breakdown of profitability between 
firms and farmers for various types of GM com in Iowa. They found that the 
ranking of net revenue performance matched the ranking of seed costs. Under 
their simulations, Bt com appears to be the type of GM com most likely to 
allow  profits  for  farmers.  A  possible  factor  of  explanation  might  be  the 
number of Bt  Com types on the  market (7  transformation  events have been 
authorised  in  the  US).  There  is  a  competition  between  these  types  of  Bt, 
which are later incorporated into various hybrids. Hence, the authors consider 
that  the  likelihood  of  monopolistic  pricing  of  the  technology  appears  more 
limited.
However,  as  explained  in  chapter  2,  biotech  companies  are  considered  to 
form  an  oligopoly  on  the  input-side  of  the  farm  sector,  furthermore  after 
having  acquired  seed  companies  or  concluded  agreements  with  them.  Their 
margin  of  manoeuvre  as  far  as  prices  of  GM  seeds  and  associated  agro­
chemical  products  are  concerned  is  a  key  factor  in  the  breakdown  of 
profitability  of  GM  crops.  Farm-gate  profitability  of  GM  crops  is  very 
sensitive to input prices.
To quote again Alexander and Goodhue, "analysis provides suggestive rather 
than  conclusive  evidence".  There  is  evidence  on  yield  gains  of  Bt  com, 
compared  to  conventional  varieties,  which  are  exposed  to  com  borers.  The 
extent of the gain and hence, the cost-effectiveness of Bt technology, depends 
on the degree of infestation. The decision to plant Bt com or conventional is 
a complex one, as it has to take into account the likelihood of infestation and 
various adjustments in crop management.
3.2.3.  Herbicide Tolerant Canola
Canola  is  a  type  of  rapeseed  which  has  been  developed  and  is  grown  in 
Canada. It is a registered trademark, corresponding to specified low contents 
in  erucic  acid  in  oil  and  in  glucosinolates  in  meals.  It  has  initially  been 
obtained  through  conventional  breeding,  but  in  recent  years,  GM  herbicide 
tolerant varieties have been developed.
The  importance  of  Canola  has  increased  drastically:  barely  grown  twenty 
years  ago,  it  became  the  third  most  important  crop  in  Canada  in  1994,  its 
value  representing  29%  of  all  grains  and  oilseed  receipts  (Agricultural 
Institute of Canada, 1999). Canola production in Canada is mainly limited to 
the provinces of Alberta, Manitoba and Saskatchewan. These three provinces 
produce more then 98% of the Canadian Canola output.
The production of GM Canola has risen spectacularly over the last years: In
1996,  it  represented  only  4%  of  the  output,  in  1999  it  was  estimated  by 
Fulton & Keyowski at 69%.
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Canola yields have gone up throughout the 1980s and 1990s, for example, in 
the province of Ontario yield has doubled between 1983 and 1996’
Yield data comparing herbicide tolerant (GM) Canola to conventional Canola 
does not prove to be convergent. Estimations in Alberta vary between 15% 
lower  to  15%  higher  yields  for  GM  crops  than  for  conventional  crops, 
depending on region and variety. Manitoba figures show higher yields (up to 
15%) in most cases.
3.2.3.2.  A convenience effect
Typically, the production of Canola requires two herbicide applications: one 
pre-emergent  and  the  other  post-emergent,  the  latter  controlling  only  for  a 
limited spectrum of weeds. The characteristic of herbicide resistance offered 
by GM Canola therefore improves potential in two ways:
-  removing competition for moisture and nutrients between Canola and 
weed.
-  eliminating costs for additional machine movements over the field (Fulton 
& Keyowski, 1999).
3.2.3.3.  Unclear results on costs and profitability
Comparing  costs  and  margins  of  conventional  and  GM  canola  is  not  a 
.straightforward  exercise.  Based  on  1998  accountancy  data,  the  production 
economics and statistics branch of Alberta Province carried out a comparison 
between  different  Canola  varieties  grown  on  two  types  of  soil,  black  and 
brown  ones.  There  are  two  species  of  conventional  Canola  with  different 
agronomic  characteristics:  "Argentine"  Canola  provides  good  performance 
under  frost-free  conditions,  while  "Polish"  Canola  is  more  resistant  to  frost 
and drought, but more vulnerable to diseases. The yield of Polish Canola is 
generally  lower  than  for  Argentine  Canola.  The  result  of  the  comparison 
between these varieties and GM ones on the two types of soils are outlined in 
table 3.6.
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Type of Soil Black soil Dark brown soil
Type of Canola HT Argentine Polish (*) HT Argentine
Gross return 342 379 307 278 259
Crop sales receipts 328 353 296 240 255
Insur. receipts 7 5 0 29 0
Misc. receipts 4 8 7 9 2
Govt, programs 2 9 4 0 3
Straw/Grazing 0 4 0 0 0
Variable costs 182 190 185 181 184
of which seeds 36 18 36 27 21
of which fertilizer 42 44 43 36 48
of which chemicals 32 51 25 31 35
Capital costs 75 92 102 66 63
Total Prod, costs 257 281 287 248 247
GROSS MARGIN 131 163 76 84 48
Yield (Bu/acre) 27 29 24 20 21
yield (bu/Ha) 67 71 59 50 53
Avg area (Ha) 86 65 70 102 73
(*}= number of observations lower than 10
Source: Alberta Simulations, 1998
This table illustrates the difficulty of comparing profitability of these varieties, 
due to the number of factors which might have an effect.
-  Black soil areas allow for higher yields.
-  In the dark brown zone, there is no significant difference in yields and in 
total  costs  between  the  Argentine  and  the  HT  variety.  Differences  appear 
on the receipt side, lower sale receipts for HT crops, but higher insurance 
revenue.
-  In the black soil area, there are significant differences in yields, costs and 
receipts.  The  "Argentine"  variety  achieves  the  highest  yield,  with  the  HT 
variety  coming  close  to  that  level.  Total  costs  for  HT  Canola  are  lower 
than  for  conventional  varieties,  and  this  is  mainly  the  result  of  reduced 
capital costs. However, due to higher receipts, Argentine Canola turns out 
to be more profitable.
Although  variable  costs  of  HT  and  conventional  Canola  are  broadly 
equivalent, even from one zone to another, the breakdown is different. While 
costs are higher for GM seeds, those for fertiliser and herbicides are lower for 
HT  than  for  "Argentine"  Canola.  The  convenience  effect  of  HT  Canola  is 
reflected in the lower labour and fuel costs.
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prudent and stresses the fact that whether or not it is economically advisable 
to  grow  GM  Canola  varies  from  farm  to  farm.  This  points  to  a  possible, 
source  of  bias  in  the  Alberta  study:  the  average  size  of  plots  sown  in  HT 
Canola  is  higher  than  for  conventional  varieties.  The  Fulton  &  Keyowski 
assumption  that  HT  Canola  has  lower  costs  and  lower  yields  than 
conventional varieties appears to be confirmed by the Alberta data.
Table 3.7 Conventional and GM canola production systems
Canola product line: a system comparison, 1999
Roundup
Ready
Smart Open 
Pol
Liberty
Hybrid
Conventional 
Open Pol
Costs
Total system costs 84 97 102 94
Of which. Seed €/ha 40 40 53 29
Herbicide 11 57 49 65
Yield (bu/ha) 82 78 88 88
Commodity price 18 18 18 18
Expected Gross 571 545 618 618
Less System Costs -84 -83 -102 -95
Gross Return 487 462 515 523
Source: Fulton & Keyowski - the producer benefits of herbicide resistant canola
There  again,  no  clear-cut  conclusion  regarding  the  effects  of  the  use  GM 
canola  can  be  drawn.  There  is  only  limited  availability  of  data  and  all 
simulations  start  from  different  premises.  Results  depend  on  varieties 
compared,  on  growing  and  marketing  conditions.  However,  the  rapid 
adoption  of  GM  Canola  indicates  that  the  variety  is  very  attractive  to  the 
farmer.
3.3.  Mixed outcome, many factors, longer-term assessment needed
The results of different studies on profitability of the main GM crops can be 
summarised as follows:
-  Herbicide Tolerant soybeans allow for cost savings thanks to reduced use 
and cost of herbicides. This could offset the higher seed price. However, 
the  yield  of  GM  soybeans  is  still  lower  than  for  conventional  varieties. 
When  comparing  returns  per  ha  or  per  labour  unit,  no  significant 
difference  appears  between  the  two  types  of  crop.  In  this  context,  the 
convenience effect of HT crops appears to be the main driving force.
-  For Bt-com. significant yield gains have been observed. However the cost- 
effectiveness  of  Bt  com  depends  on  growing  conditions,  in  particular  on 
the  degree  of  infestation  in  com  borers.  Applications  of  insecticide  have 
decreased  globally.  Some  studies  show  increased  total  costs  for  Bt- 
technology, first for seeds but also for weed control and fertiliser. Results 
regarding  profitability  are  contrasted,  none  can  be  considered  as 
significant.
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Tolerant Canola with non-GM crops.
These  rather  contrasted  and  unclear  results  indicate  that  short-term 
profitability  is  not  the  only  driving  force  for  the  adoption  of  GM  crops  by 
farmers.
Other  factors  have  played  a  significant  role  in  the  rapid  extension  of  GM 
sowings.
The convenience effect seems to be a significant advantage, in particular for 
herbicide  tolerant  crops.  This  benefit  does  not  directly  translate  in  terms  of 
profitability, but rather in terms of attractiveness of GM crops for efficiency 
purposes. This convenience effect has to be further assessed in particular, the 
valuation  of  the  labour  effect.  In  the  longer  run,  it  should  imply  increased 
labour  productivity  and  savings  in  crop-specific  labour  costs.  Further 
efficiency assessments, including price and use of herbicide over a longer time 
frame, would also be useful.
The profile of adopters of the new technology also plays a role. First adopters 
were  mainly  young,  educated  and  well-performing  farmers,  established  on 
large holdings. The adoption of biotech crops is not size neutral. The higher 
than  average  farm  size  of  adopters  might  be  a  factor  explaining,  amongst 
others, the dramatic increase in areas sown to GM crops. Theoretically, more 
benefits  are  accruing  to  early  starters.  Those  already  having  adopted  the 
technology are likely to have gained from it. In the case of HT crops, gains in 
efficiency  should  translate  into  improved  labour  productivity.  In  the  case  of 
Bt com, yield gains mean enhanced productivity of land. Under given prices, 
enhanced  productivity  leads  to an  increase in supply. While  more and more 
producers  are  adopting  biotech  crops,  thus  contributing  to  the  increase  in 
supply, on the demand side, concerns about GM food are emerging. This may 
lead  to  a  drop  in  prices.  Hence,  gains  for  late  adopters  are  expected  to  be 
lower  than  for  early  adopters.  In  the  long  run,  enhanced  productivity  will 
have an impact on farm restructuring, alongside with other factors playing a 
role in this process.
The  reviewed  studies  only  compare  farm-level  and  short-term  profitability. 
Profitability of GM crops should be analysed over a longer timeframe. First, 
there are important yearly fluctuations in yields and prices, and it is difficult 
to  isolate  the  possible  effect  of  biotechnology.  Results  are  very  sensitive  to 
the  price  of  seeds  and  agro-chemical  products  on  the  one  hand  and  to 
commodity prices on the other hand. In most profitability studies, prices for 
GM and conventional crops are assumed to be equivalent.
Developments on the supply and on the demand side of the food chain have 
to be considered together, and this is another reason for assessing profitability 
over  several  years.  As  a  result  of  consumer  concerns  and  preferences, 
segregation  between  GM  and  non-GM  crops  is  developing,  which  implies 
differentiation  in  costs  and  prices. The economic implications of segregation 
and  identity  preservation  are  analysed  in  chapter  5.  They  might  change  the 
outset as regards profitability of GM versus non-GM crops.
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support  schemes,  have  reduced  the  price  risk  of  the  new  technology.  Until 
recently, no significant differences in prices between GM and non-GM crops 
have been systematically recorded, expect on niche markets. Hence, growers 
have  mainly  based  their  planting  decisions  on  expected  farm-gate 
performance, on cost-efficiency of inputs. In other words, they had an input- 
oriented approach.
The marketing strategy developed by biotech firms must also be considered. 
It has been focused on farmers, the first customers interested in input traits. 
In the case of herbicide tolerant crops, the marketing strategy was based on 
the  concept  of  "technological  package"  (the  GM  seed  and  the  product  to 
which it is resistant), which allows for "combined pricing". Benefits of GM 
crops  have  been  extensively  advertised  throughout  key  production  areas 
(Com  Belt).  Biotech  firms  have  been  present  up  to  the  field,  providing 
commercial  and  technical  assistance  to  farmers,  whether  directly  or  through 
their subsidiaries. They have shaped famers’expectations.
The  supply-oriented  approach  of  both  biotech  companies  and  farmers  has 
been  quickly  confronted with reactions  stemming  from the  downstream side 
of  the  food  chain.  Consumer  concerns  have  been  echoed  and  amplified  by 
NGOs  and  retailers,  and  they  had  a  cascading  effect  on  the  upstream  side. 
These reactions are analysed in the next chapters.
4.  Consumers, Retailers: cascading effects
The  demand  can  be  analysed  at  the  level  of  consumers,  the  retailing  industry,  and 
food processors. Of these three actors, the retailing industry has a pivotal position by 
amplifying  consumer  preferences  and  relaying  them  to  the  food  industry.  Whether 
retailers choose to label products containing GMOs, eliminate GM ingredients from 
own-label  food,  or  go  GM-free,  their  approach  has  cascading  effects  on  food 
processors,  grain  companies,  and  ultimately  on  farmers.  Today,  the  organisation  of 
the world food market more and more reflects the variable public opinion and power 
of  civil  society  groups  from  one  region  to  another  and  their  unequal  influence  on 
supermarket chains.
The  main  argument  of  this  chapter  is  that  the  global  food  market  is  undergoing  a 
reorganisation  which  transcends  the  European  context,  where  public  awareness  and 
debate  of  GMOs  first  emerged.  European  retailers’  restrictive  stance  on  GMOs  is 
giving birth to a bifurcated market leading food processors to adapt their products to 
regional conditions, and US grain elevators to segregate commodities.
The  chapter  first  surveys  consumer  preferences  in  different  regions  of  the  world 
through an overview of available public opinion studies and mobilisation campaigns 
(section  4.1).  The  second  section  explores  the  strategy  of  the  retailing  industry  as 
evidenced by their degree of anticipation and the nature of their reactions (section
4.2).
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of  GMOs  with  those  of  European  consumers.  While  Americans  and 
Canadians  would  hold  benevolent  views  or  simply  be  indifferent,  European 
consumers would display more scepticism for reasons which are said to be: 
cultural (degree of faith in science, relation to food...), historical (recent food 
scares in Europe), and political (degree of trust in public/private actors).
This dichotomy reflects clear regional cleavages, yet needs qualifying for at 
least three reasons. First, civil society groups have early on organised global, 
transregional  mobilisation  campaigns  against  GMOs.  Second,  some 
differences  that  once  appeared  readily  between  European  and  North 
American  public  opinions  have  eroded  with  time.  Finally,  the  two  blocks 
overlap only loosely with geographic boundaries. Not all European countries 
share  the  same  concerns  over  GMOs;  conversely,  some  countries  outside 
Europe—Australia,  New  Zealand—have  joined  in  the  mobilisation  against 
transgenic food.
4.1.1.  Mobilisation campaigns
Public controversy over GMOs crystallised in the middle of the 1990s, as the 
first  GM  crops  were  being  harvested.  Mobilisation  emerged  at  the  global 
level  around  the  “Pure  Food  Campaign,”  later  known  as  the  “Campaign  for 
Food  Safety.”  At  the  core  of  these  campaigns,  international  NGOs  such  as 
Greenpeace,  Friends  of  the  Earth,  RAF  I  and  others  co-ordinated  the 
movements and set up discussion fora and comprehensive GMO databases on 
the internet (Examples can be found in the internet database referred to in the 
bibliography).  At  the  local  level,  grassroots  participated  in  the  campaign: 
women’s  networks,  environmental  groups,  consumer  associations,  farmers, 
and youth.
The “Global Days of Action Against Gene-Foods” organised in the spring
1997  evidenced the transnational, and multi-faceted character of mobilisation. 
Table  4.1  illustrates  the  regional  and  political  diversity  of  this  campaign. 
According  to  the  organisers,  “activists  from  twenty-seven  nations  organised 
actions  and  press  events  against  gene-foods  and  genetic  engineering”  (Pure 
Food  Campain  1997).  In  addition,  the  interests  represented  in this campaign 
ranged  from  the  promotion  of  sustainable  development,  to  the  protection  of 
consumers, through the advancement of ethical considerations with regard to 
genetic research.
4.1. Consumers : moving fast
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{source: Pure Food Campain, 1997)
Regions Countries Groups (not exhaustive)
Africa Ethiopia Institute for Sustainable Development
Asia Australia Australian GeneEthics Network 
Australian Consumers Association
India Research Foundation for Science, Technology, and Natural Resource Policy
Japan Network for Safe and Secure Food and Environment 
Consumers Union
Malaysia Third World Network 
Consumers Association
New Zealand Natural Food Commission 
Greenpeace
Philippines Center for Alternative Development Initiatives
Europe Austria Global 2000
Belgium European Farmers Coordination (CPE) 
Pesticide Action Network
Croatia Green Action
Denmark Ecotopia
France Ecoropa
Germany Green Party 
Greenpeace 
Gen-Etisches Network 
AntiGen
Georgia Greens
Elkana
Greece Greenpeace
Hungary ANPED Sustainable Production and Consumption Project
Energy Club
ETK
Biokultura
Italy n/a
Netherlands Dutch Coalition for a Different Europe
Natuurwetpartij
ASEED
Norway GATT WTO Campaign 
Ungdom for Bonder 
Mat-helse-miljo-alliansen 
Dovefjellaksjonen 
Vi og Vaart
Poland Green Federation
Spain AEDENAT
Sweden Greenpeace
Switzerland No Patents on Life
United Kingdom Women’s Environmental Network
Latin America Brazil Brazilian Institute for Consumer Protection
North America USA Consumers’ Union 
Greens
Learning Alliance
Noclone
Greenpeace
Institute for Ag and Trade Policy 
COACT
Pure Food Campaign 
Safe Food Link 
Food not Bombs
Canada Council of Canadians 
GreenpeaceNatural Law Party
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spectacular actions. A second “Global Days of Action Against Genetic Engineering” 
took place in October 1997. In February 1998, the “Physicians and Scientists Against 
Genetically  Engineered  Food”  issued  a  declaration  in  which  they  demanded  a 
“moratorium on the release of Genetically Engineered organisms and the use of GE- 
food”  (Physicians  and  Scientists  Against  GE  Food  1998).  In  September  1999, 
activists  from  thirty  countries  (Latin  America,  North  America,  Asia  and  Europe) 
launched  a lawsuit against major biotech companies, claiming a multi-billion dollar 
compensation  for  monopolistic  practices  (Financial  Times,  13  September  1999).  A 
month later, Monsanto CEO Robert Shapiro announced the decision of his company 
“not to pursue technologies that render seed sterile.” The decision, a testimony to the 
power of organised movements, was “based on input from you and a wide range of 
other  experts  and  stakeholders,  including  our  very  important  grower  constituency” 
(Open Letter from Robert Shapiro, 4 October 1999).
NGO mobilisation on issues raised by biotechnology was also strong in the context 
of  the  WTO  Ministerial  meeting  in  Seattle  in  November/December  1999.  Specific 
actions were organised in Montreal in January 2000 in the event of the conference 
for the Protocol on Biosafety (see chapter 5).
While protest against GMOs acquired a global dimension, interest groups and NGOs 
intensified  their  pressure  in  three  regions:  in  Europe,  in  Australasia,  and  in  North 
America. The most notable differences between these regions pertain to the timing of 
mobilisation—Europe  was  the  first  mover—and  the  degree  to  which  counter­
mobilisation  has  organised  (table  4.2).  Counter-mobilisation  was  stronger  in  North 
America  where  it  centred  around  the  agri-food  business  and  some  scientist 
communities.  On  the  other  hand,  there  was  little  counter-mobilisation  in  Europe.15 
This difference appeared clearly in the public hearings on GE foods organised by the 
FDA  this  year,  where  participants  described  the  European  “scientific 
establishment...[as]  less  protective  of  genetic  engineering...  [than]  their  US 
counterparts” (Congress Daily, 1/12/99).
15  Counter-mobilisation emerged in Australia, probably explaining why Australia has moved a bit 
slower on labelling than New-Zealand despite the fact that both are members of the ANZFA.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW  53Table 4.2. Sample of Recent GMO Actions in Europe, North America, and Australasia
Europe North America Australasia
Mobilisation 1997: DUTCH SUPERMARKET SUED
The  Dutch  Natural  Law  Party  files  a suit against 
Dutch retailer Albert Heijn for misrepresenting GM 
food.
Dec. 1997: FGSO CAMPAIGNS AGAINST GMOs
The Federation of Greek Supermarket Owners
(FGSO) and Greenpeace launch a campaign against 
GE  food.  Greenpeace  and  FoE  organise  actions 
against supermarkets and food processors.
April 1997: ANTI-GM PETITION IN AUSTRIA
1,226,551 Austrians (20% of eligible voters) sign a 
petition opposing GM food, the release of GMOs in 
the country, and life patenting.
Sept. 1997: UK PETITION AGAINST GM FOOD
16,000 people sign a petition opposing GM food.
May 1999: UK DOCTORS DEMAND BAN
The British Medical Association calls for a ban on
GE  foods  and  crops  and  judges  that  “antibiotic 
resistant  genes  in  GE  foods  is  a  completely 
unacceptable risk.”
May 1998: LAWSUIT AGAINST FDA
A  coalition  of  scientists,  religious  leaders,  chefs,  health 
and  consumer  groups  files  a  lawsuit  against  the  FDA’ 
testing  and  labelling  procedure.  Alliance  for  Bio- 
Integrity;  and  the  International  Center  for  Technology 
Assessment coordinate the action.
June 1999: PETITION ON GE LABELLING
500,000  US  citizens  sign  a  petition  to  demand  the 
mandatory  labelling  of  GE  foods.  The  Natural  Law 
Party  submitted  the  petition  to  House  Minority  Whip 
David Boniors (D-MI), as well as the US President, the 
USD A, the FDA, and the EPA.
Sept. 1999: ACGA RECOMMENDATIONS
The  American  Corn  Growers  Association  recommends 
that farmers buy non-GM non-GM seed.
Oct. 1999: CWB STRESSES CAUTION
Canadian Wheat Board Chairman Greg Arason declares 
“the customer is always right, even when they might be 
scientifically  wrong”  and  recommends  caution  towards 
GM  crops  which  “have  only  limited  consumer 
acceptance” (SCI 28/10 and 9/11).
May 1999: GM-FREE FOOD LIST
The list contains “100 foods in NZ claimed 
to be genetic-engineering free.” It is used by 
the  Green  Party,  RAGE,  and  St  Martin’s 
New World.
July 1999: SUPERMARKET ACTION
Green Party of New Zealand, together with 
RAGE,  and  Safe  Food Campaign  initiates 
a  week  of  action  against  supermarkets 
selling GM food.
Sept. 1999: WAFF’S OPPOSITION
The  Western  Australian  Farmers 
Federation opposes “the release of ‘Genetic 
Modificaiont’  of  both  livestock  and  other 
farm  produce  and...  continues  to  promote 
R&D of those products by natural means” 
(PSRAST 15/10/99).
Counter-
mobilisation
May 1999: UK farmers' & industry initiative 
SCIMAC  (Supply  Chain  Initiative  on  Modified 
Agricultural  Crops)  an  initiative  of  farmers,  seed 
trade, plant breeders, and biotech companies. It seeks 
to establish a code of practice for the introduction of 
GM crops, in particular, to provide information for 
consumer choice.
Oct. 1999: BETTERFOODS CAMPAIGN 
The Grocery Manufacturers of America (GMA), the 
American Farm Bureau, and 30 US companies launch a 
campaign to restore public confidence in GM food.
Nov. 1999: SCIENTISTS DEMAND SUPPORT 
A coalition of over 100 Canadian scientists demand more 
active support for biotechnological research.
May 1999: AGRIFOOD ALLIANCE 
The National Farmers’ Federation, 
Grains Research and Devel. Corpor., the 
seed industry... launch the Agrifood 
Alliance in Australia to increase public 
acceptance of biotechnology.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 54Mobilisation  campaigns  at  the  global  and  at  the  regional  level  display  the 
salience of biotechnological issues among interest groups and NGOs. Yet, the 
level of activism on GMOs is an imperfect indicator of public perceptions as 
knowledge and concerns may not reach the larger public. Public opinion polls 
and  surveys  show  that  the  global  mobilisation  around  GMOs  masks 
contrasting  “moods”  in  North  America  and  Europe.  While  consumers  in 
Europe  and  Australasia  are  unambiguously  suspicious  of  genetic  engineered 
food,  North  American  consumers’  perceptions  are  much  less  clearly 
characterised. Until recently, the global mobilisation around GMOs was thus 
anchored  on  more  fragile  bases  in  North  America.  There,  the  discourse 
against transgenic food found only limited resonance with the public at large 
for reasons which have yet to be researched. However, one must be cautious 
as the public debate is emerging in the US and may be moving closer to the 
European debate.
In Europe, data can be found in the Eurobarometer studies on biotechnology, 
which  provide  comparative  data  across  countries; and  in a  series of surveys 
conducted  by  private  polling  institutes  for  the  retailing  and  food  industry, 
NGOs,  or  the  media.  This  corpus  of  studies  evidences  some  differences 
among  European  countries,  with  Italians,  Spaniards,  and  Portuguese 
displaying  more  positive  perceptions  of  biotechnology  in  general  than  their 
fellow Europeans (Eurobarometer 1997 and 2000; Menrad 1999).
Beyond these variations, clear regularities emerge:
-  High  level  of  concern:  A  large  majority  of  Europeans  is  worried  about 
transgenic  food.  More  than  60%  of  the  1997  Eurobarometer  respondents 
are  concerned  about  the  risks  associated  with  GM  food,  compared  with 
40% in the case of the medical applications of biotechnology. This result is 
consistent  with  those  of  private  polling  institutes.16  The  2000 
Eurobarometer has helped assessing the reasons for consumer concerns on 
GM  food.  Items  gaining  the  highest  support  are:  "even  if  GM  food  has 
advantages, it is against nature"; "if something went wrong, it would be a 
global  disaster";  "GM  food  is  simply  not  necessary".  The  share  of 
respondents  thinking  that  food  production  is  a  useful  application  of 
biotechnology decreased from 54% (1997) to 43% (2000).
4.1.2. Evolving Public Opinions
16  March 1997: a survey conducted by the University of Lancaster for Unilever finds “significant unease 
about the technology as a whole... and much such unease is latent rather than explicit.” August 1997: 
a survey conducted by Market Measures Ltd. for Sainsbuiy’s reveals that UK consumers do not favor 
GM foods because they are “unnatural”; “Over half of those aware of genetically engineered food said 
they would ‘probably not’ or ‘definitely not’ buy such food.” (AgBiotechNet 1997). March 1998. a 
Gallup poll commissioned by Iceland shows that 63% of respondents who are aware of GM food have 
reservations. Yet, a MORI poll indicated a lower degree of distrust of GE food in Britain: 53% would 
not  eat  GE food,  against 63%  of  Danes, 65% of Italians and Dutch, 77% of French and 78% of 
Swedes (wu’w.centerfoodsafetv.orR/facts&issues/poIls.htm).
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degree  of  knowledge.  Both  pessimism  and  optimism  increase  with  the 
degree  of  knowledge  of  respondents  (Eurobarometer,  1997).  This  is 
consistent, with a recent survey showing that “the level of knowledge and 
familiarity  with  [biotechnology]...  are  not  so  decisive  in  shaping  general 
attitudes” (Menrad, 1999). According to the 2000 Eurobarometer, the use 
of  biotechnology  in  food  production  is  the  most  commonly  known 
application.  However,  only  11%  of  the  respondents  feel  adequately 
informed on biotechnology. Factual knowledge has hardly improved since
1997.  Asked  about  the  source  of  information  they  mainly  trust, 
respondents cite consumer organisation first (26%), just ahead of medical 
profession  (24%)  and  environmental  protection  organisations  (14%). 
International  organisations  and  national  public  authorities  record  poor 
results (respectively 4 and 3%).
-  If  knowledge  is  not  a  key  variable,  “cultural  factors  seem  to  prevail  in 
shaping  personal  attributes  towards  modem  biotechnology...  the 
attachment  of  consumers  to  their  national  food  traditions  is  seen  as  an 
important  factor  in  the  process  of  acceptance  of  food  technology” 
(Menrad, 1999).
-  Demand  for  labelling  and  non-GM:  Only  18%  of  the  respondents  judge 
GM labelling useless; 8% do not have an opinion; and 74% favour a clear 
labelling of GM food (Eurobarometer 1997). 53% of the respondents say 
that  they  would  pay  more  for  non-GM  food,  36%  would  not 
(Eurobarometer, 2000).
For North America, the main surveys stem from the USD A, Novartis (1997),
Time magazine (1999), the International Food Information Council (1999)
and some Canadian organisations. Two broad tendencies emerge:
-  Eroding  trust  in  GM  food:  A  1995  USDA  study  of  604  New  Jersey 
residents found that 60% would “consider buying fresh vegetables if they 
were labelled as having been produced by genetic engineering” (Center for 
Food Safety, 1999). In 1997, Novartis found that only 25% of Americans 
“would be likely to avoid labelled GE foods". Yet two years later, the poll 
commissioned  by  Time  magazine  indicated  that  58%  of  American 
consumers  “would  avoid  purchasing  [labelled  GE  foods]"  (Center  for 
Food Safety, 1999). These results show a certain erosion in the consumers' 
trust in GM food 17.
17  In  contrast  with  the  results  of  the  Time  magazine  poll,  IFIC  President  Sylvia  Rowe  declared  in 
October that “The vast majority of American consumers still place a great deal of confidence in the 
benefits  of,  and  current  regulatory  climate  for,  agricultural  biotechnology”  (IFIC  1999).  In  the 
October 1999, 51% of the respondents declared they would be likely to buy a “variety of produce... 
[which] ha[s] been modified by biotechnology.” Yet, the question was framed as follows: “All things 
being equal, how likely would you be to buy a variety of produce, like tomates or potatoes if it had 
been modified by biotechnology to taste better or fresher?” (IFIC 1999) (emphasis added).
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labelling  of  GE  foods  has  been  high,  and  fairly  stable:  84%  of  the 
respondents favored it in the 1995 USDA study; 93% in the 1997 Novartis 
survey;  and  81%  in  the  Time  magazine  poll.  In  Canada,  a  1994  survey 
showed that “83% to 94% of Canadians polled... want labelling on foods 
that are produced using biotechnology” (Center for Food Safety, 1999).
This cursory review is sufficient to stress the contrast between European and 
North  American  perceptions  of  agricultural  biotechnology.  While  Europeans 
are  critical  of  GM  foods  and  wish  to  keep  them  at  bay  as  long  as  detailed 
studies  of  the  risks  have  not  been  conducted,  North  American  consumers 
have  placed  greater  confidence  in  agricultural  biotechnology.  Recently 
however,  changes  have  been  visible  in  US  consumers'  perceptions.  North 
American  consumers  have  lent  a  more  critical  support  of  this  research,  and 
they have clearly mandated GE labelling. The recent public hearings on GE 
labelling organised by the FDA have kick-started the public debate. The turn­
out was high (Financial Times, 18 November 1999), and debates have shown 
“little  middle  ground”  between  the  representatives  of  civil  society,  the 
industry,  and  scientists  (Detroit  News,  19  November  1999).  Protesters  have 
staged media-oriented demonstrations outside the conferences, and seized the 
coincidence  of  the  second  FDA  hearing  with  WTO  ministerial  meeting  in 
Seattle  (November,  December  1999)  to  attract  world  media  coverage.  These' 
trends have put pressure on retailers and the food industry.
4.2.  Retailing industry: following and shaping the demand
The retailing industry is the linchpin in the food market due to its proximity 
with  consumers.  Over  the  last  years,  a  global  concentration  process  has 
increased  the  market  power  of  retailers.  The  first  point  of  contact  between 
consumers  and  the  food  industry,  retailers  do  more than simply  transmitting 
consumer  preferences  to  food  processors  and  grain  elevators.  They  amplify 
or  moderate  market  signals,  contain  or  anticipate  consumer  expectations. 
Whatever  their  strategy,  it  has  cascading  effects  on  the  rest  of  the  food 
industry at home and abroad.
The  contrasts  in  regional  mobilisation  described  above  have  had  direct 
consequences  on  the  strategy  of  retailers.  While  European  and  Australasian 
retailers  have  early  on  been  faced  with  vehement  protest  against  GM  food, 
their North American counterparts have not been exposed to direct consumer 
pressure.  As  a  result,  European  retailers  have  moved  to  meet  and  shape  the 
demand  for  non-GM  food,  in  contrast  with  the  “wait-and-see”  approach 
adopted by the bulk of North American retailers.
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organised  in  1997  a  campaign  against  the  introduction  of  GM  foods  in 
supermarket  (see  Friends  of  the  Earth  Supermarket  Letter).  Given  the 
absence  of  regulation  of  GM  food,  retailers  were  pressed  to  take  quick 
actions,  probe  consumer  preferences,  and  anticipate  the  development  of  a 
non-GM  food  market.  Sainsbury’s  commissioned  a  consumer  survey  in  the 
very  early  stages  of  grassroots  mobilisation.  This  move  earned  the  retailer 
“congratulations  from  Friends  of  the  Earth]  on  carrying  out  and  publicising 
this  timely  and  valuable  research”  (AgBiotechNet,  1997).  Food  and 
Biotechnology  Campaigner  for  Friends  of  the  Earth  Adrian  Webb  declared: 
“Sainsbury’s  promotes  itself  on  providing  ‘good  food’...  All  the  major 
retailers  should  now  act  on  these  findings”  (Friends  of  the  Earth,  Press 
Release 1997). This domino effect did take place and UK supermarket chains 
unveiled their plans on GM food one after the other, starting with Sainsbury’s 
and  Iceland  (May  1998),  Tesco  (September  1998),  and  other  major  food 
chains.  In  fact,  a  leaked  Monsanto  report  showed  that  the  move  towards 
adopting a restrictive stance on GMOs was well under way at the end of
1998, retailers being determined to resist the introduction of GM foods.18
The movement spread to continental Europe in 1999. In March, Sainsbury’s 
announced  the  formation  of  a  consortium  with  six  European  supermarket 
chains to organise the supply chain: Carrefour (France); Delhaize (Belgium); 
Esselunga  (Italy);  Marks  &  Spencer  (UK);  Migros  (Switzerland)  and 
Superquinn  (Ireland)  joined  in.  In  May,  Spain’s  biggest  retailer,  Pryca, 
announced its policy, followed by Rewe in July; Edeka (under the pressure of 
Greenpeace) in August; and Aldi in October 1999 (the list is not exhaustive).
In  the  Netherlands  however,  the  biggest  retailer,  Albert  Heijn,  is  a  notable 
exception  to  this  trend.  In  1997,  the  Dutch  supermarket  chain  took  a 
proactive  stance  to  enhance  consumers’  acceptance  of  GMOs.  In  one  of  its 
free  monthly  brochures,  the  chain  advertised  GM  soya  as  having  the  same 
quality as conventional soya. The Dutch Natural Law Party brought the case 
before  the  Advertisement  Code  Commission  for  “false  and  misleading 
advertisement” (Campaign to ban genetically engineered foods, Press Release 
1997)  and  won  it.  On  that  occasion,  the  environmental  organisation  noted 
that  “In  contrast  with  the  food  retailers  in  some  other  countries  the  Dutch 
branch  forms  a  closed  front,  which  in  fact  is  against  the  interests  of  its 
customers”  (Campaign  to  ban  genetically  engineered  foods,  Press  Release 
1997).
4.2.1. Amplifying consumer preferences
18  The report describes the retailers’ “resentment of Monsanto for badly mismanaging the introduction 
of biotechnology in Europe and for allowing the issue to be decided in the supermarkets” (Friends of 
the Earth 1998).
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restrictive policy on GM food. Contrary to common views, they did not align 
on a single non-GM model. Rather, they adopted various types of actions.
4.2.2.  Types of supermarket actions
Faced  with  legal  uncertainties  on  GM  food  labelling19  and  growing  popular 
pressure  to  phase  out  GMOs,  retailers  have  adopted  different  strategies. 
Table 4.3 illustrates the variations that currently exist between chains' policies 
on  GM  food  20.  Some  supermarket  chains,  like  Sainsbury’s  and  Marks  & 
Spencer, have adopted fairly comprehensive strategies whereby they commit 
themselves  to  phase  out  GE  ingredients  from  their  own-label  products  and 
eventually  to  sell  non-GM  fed  meat.  Other  supermarkets,  like  Asda  and 
Safeway, have chosen narrower policies to eliminate GE ingredients in their 
own-brand  products, but also label own-brand products for which they have 
not been able to do so.
Table 4.3 Some Examples of Supermarket Actions on GMOs
“Consortium on 
GM-fed meat”
“GM-free
working
group”
“Consortium to 
eliminate GE 
ingredients from own- 
label foods”
Individual actions to 
eliminate GE 
ingredients from own- 
label products
Label own-brand 
products 
containing GE 
ingredients
Sainsbury’s;
Marks & Spencer; 
Safeway,
Northern Foods;
Adeg;
BML Group; 
Hofer;
Spar (Austria)
Sainsbury’s;  Delhaize; 
Carrefour; Superquinn; 
Esselunga;  Migros; 
Marks & Spencer
Auchan; Systeme U; 
Aldi; Edeka;
Spar (Germany); 
Tengelmann; Pryca; 
Coop; Iceland; Tesco; 
Leclerc
Asda; Safeway
This table combines three axes along which supermarket chains’ actions can 
be differentiated:
-  group  v.  individual  initiatives:  Group  initiatives,  such  as  the  Sainsbury 
consortium  or  the  GM-free  working  group,  enable  group  members  to 
share  the  burden  of  reorganisation  of  the  supply  chain  and  give  them 
additional  weight  with  respect  to  the  food  processing  industry.  On  the 
other  hand,  individual  initiatives  are  likely  to  diminish  the  negotiating 
power of the chain with regard to food processing.
-  GM labelling v. non-GM  labelling: some chains have opted for labelling 
products  containing GMOs  (Safeway; Asda), others for labelling non-GM 
products (Leclerc).
19  See section 5.2.2 on EU legislation.
20  The typology adopted in table 4.3 does not reflect current legislative work (see juridical differences 
between “GM-free” and “non-GM’). Notably, it is difficult to know whether the “GM-free” products 
advertized by the operators contain no GMOs, or a feeble amount of GMOs.
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(Safeway;  Asda);  others  will  not  sell  products  labelled  as  containing 
GMOs  (Adeg;  BML;  Hofer).  Yet,  other  like  Aldi  and  other  discount 
chains do not officially exclude GM labelled foods, but give the consumer 
little  choice  as  own-label  products,  from  which  they  have  eliminated 
GMOs, represent 90% of their product range.
Given the current state of affairs, this review is necessarily incomplete. Yet, it 
displays  the  variety  of  actions  deployed  by  European  supermarket  chains. 
Options  exist  beyond  the  “choice”,  “no  choice”;  however,  the  general 
tendency  of  chains  is  to  phase  out  GM  food.  Given  the  transnational 
character  of  supply  chains,  the  restrictive  stance  of  European  supermarkets 
has triggered a reorganisation that transcends Europe. Food processors and 
grain  companies  have  been  hard  pressed  to  segregate  GM  from  non-GM 
products and regionalize their production.
5.  Markets: Segregation, Identity Preservation and Labelling
The  introduction  of  GM  crops  has  until  now  mainly  addressed  the  supply  side  of 
agricultural  crops  and  food  markets.  The  development  of  efficiency  enhancing  GM 
crops dominates the agricultural applications in most countries where GM crops are 
grown. The EU debate on GMOs, on the other hand, has been dominated by demand 
factors, such as food safety concerns. In the EU, consumer demand for a continuous 
supply of agricultural raw materials and processed products at a certain price and a 
certain quality is seen as the underlying force for the agricultural sector to adapt and 
to innovate  production techniques. Furthermore,  the recent reforms of EU Common 
Agricultural  Policy  provide  several  incentives  to  adapt  production  quantities  to 
market  demand  and  to  put  emphasis  on  quality  aspects,  both  of  products  and 
production methods.
Further  technological  developments  and  continued  increase  in  GM  crop  production 
could  affect  the  future  competitiveness  of  conventional  non-GM  production. 
Nevertheless,  consumer  reaction  to  GM  food  has  given  rise  to  uncertainty  about 
market  developments,  in  particular  the  short  term  prospects  for  GM products. As a 
result  to  consumer  concerns,  the  regulatory  framework  concerning  GMOs  has 
developed and is partially still under review not only in the EU but also in many other 
countries including the USA.
Labelling  has  been  recommended  as  a  tool  to  enable  consumer  choice  between 
products  and  to  avoid  further  market  and  trade  disruptions.  However,  labelling 
systems  in  which  consumers  have  confidence  would  require  at  least  segregation  of 
product  lines  throughout  the  processing  system.  Moreover,  Identity  Preservation 
would  be  required  to  distinguish  the  different  types  of  products  according  to  their 
contents  of  GM  material  or  the  way  they  have  been  produced  whether  using  GM 
technologies or not. Segregating and Identity Preservation are attempts to create and 
establish a separate market for a “new” product, a specific crop. The success of such 
attempts will depend on supply and demand concerning the new product.
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are  addressing  a  specific  demand  and  the  opportunities  for  supply  are  highly 
dependent  on  innovations,  e.g.  new  varieties,  which  provide  enhanced  quality.  On 
such markets competition and market transparency are generally less advanced than 
for commodity markets.
Since  segregation  and  Identity  Preservation  appear  to  be  means  to  offer  choice 
between  GM  and  non-GM  products  to  the  consumer,  this  chapter  will  start  with  a 
discussion  of  the  key  features  of  these  systems  compared  to  the  commodity  trade 
system  (section  5.1).  Three  systems  for  Identity  Preservation  and  labelling  in  the 
GMO context, based on current EU legislation, will be identified in section 5.2. The 
available studies and information about additional costs of IP have been summarised 
in section 5.3. Furthermore, the distribution of these additional costs along the food 
production chain is discussed in section 5.4. The following section 5.5 provides some 
background information about EU markets for soybeans and corn, about the supply 
to serve potential non-GMO demand and about the different stance on food and feed 
use. Finally, some trade issues are briefly outlined in section 5.6.
5.1.  Key features of agricultural trade systems
Trade of agricultural products today is based on the commodity system. Any 
system of identification which goes beyond the common specifications would 
require  additional  handling  effort  and  would  thus  create  additional  costs. 
Segregation  and  Identity  Preservation  are  possible  responses  to  consumer 
demand for specific products.
5.1.1.  Commodity System
The  bulk  commodity  system  works  on  the  basis  that  crops  from  different 
farms are sufficiently alike to be traded at a common price and to a common 
grading  specification.21  Usually,  commodities  from  different  origins  are 
blended  to  meet  specific  grades.  For  example  in  the  case  of  wheat  protein 
content,  moisture,  falling  number,  specific  weight  and  percentage  of 
extraneous material are taken into account. On its journey to a milling plant, 
the  wheat  can  be  sampled  and  blended  several  times  and  there  is  no 
traceability  back  to  the  producer.  Commodity  prices  are  fixed  on  spot 
markets, futures markets or by contracts.
International  trade  of  agricultural  products,  in  general,  is  based  on  the 
commodity system, which covers about 200 Mio t of grains per year. In the 
oilseeds sector about 50 Mio t of soya, sunflower and rape seed are traded 
annually across borders, in addition to 13.5 Mio t of oil from the different 
seeds and 43 Mio t of meal. Furthermore, many more millions of tonnes are 
traded on domestic markets under the commodity system.
21  Commodities have been defined as substances sold in very large quantities, such as raw materials or 
foodstuffs such as com, rice, butter (Dictionary of agriculture 1990).
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Bulking up the produce of many producers means that transport and handling 
costs can be reduced. For example, Cargill has calculated that ocean transport 
from the US to Europe may only add 13 € to the price of a tonne of soybeans 
(180  -  225  €)  if  50  000  tonnes  are  shipped  at  a  time.  The  total  cost  of 
transportation from a US mid-west farm to European harbours is estimated at 
10% of the farm-gate price of soybeans (Cargill, 1999).
Furthermore,  bulk  transport  enables  a  continuous  flow  for  processing,  since 
taking a processing plant down and firing it up again can be time consuming 
and costly.
5.1.2.  Segregation
Segregation  refers  to  a  system  of  crop  or  raw  material  management  which 
allows one batch or crop to be separated from another (House of Commons,
2000).
Segregation  is  an  attempt  to  create  and  establish  separate  markets  for 
differentiated  products  or  to  set  up  a  “new”  market  for  a  “new”  specific 
product.  This  corresponds  to  a  dis-aggregation  of  the  supply  and  demand. 
Some possible economic effects of market segregation are shown in figures
5.1 and 5.2.
Figure 5.1: Economic Effects of Market Segregation
aggregated market  p specific market A  p specific market B
In figure 5.1 it is assumed for simplicity reasons that the aggregated supply 
for a certain crop would be subdivided equally among the specific markets A 
and B (dotted lines SAi and SBi). Assuming further that demand would follow 
the  same  pattern  for  both  sub-markets  (DA  =  DB),  the  price  on  market  A 
should be the same than on market B (pAi = pBi).
However,  due  to  lower  quantities  produced  and  traded,  potential  economies 
of scale may not be used and production cost per unit might be higher than on 
the  aggregated  market.  In  figure  5.1  this  effect  is  captured  by  shifting  the 
supply  curves  from  SAi  to  S^  and  from  SBi  to  SB2.  The  effect  will  be  a 
reduction of quantity produced (q^ and qB2) and an increase in prices on both
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welfare  can  be  expected  because  the  potential  for  trade  and  specialisation 
gains will remain partially unused.
Moreover,  the  assumption  of  equal  pattern  of  demand  on  both  sub-markets 
will be unrealistic. More realistic would be the situation as shown in figure
5.2  with different demand functions on the respective sub-markets (Da3 and 
Dbs)-
In  our  example,  the  price  increase  caused  by  segregation  would  be 
outweighed by a price reduction due to a low demand on specific market A. 
This  effect  would  be  accompanied  by  a  reduction  in  quantity  supplied 
compared  to  figure  5.1.  On  specific  market  B,  a  high  demand  (DB3)  would 
lead to a further increase in price to pB3 and an increase in quantity supplied 
to qB3.
Figure 5.2 Different demands on segregated markets
aggregated market  p specific market A  p specific market B
In  addition,  the  application  of  new  cost-saving  or  output  enhancing 
technologies on one of the specific markets would result in a rightward shift 
of  the  supply curve.  New  technologies  thus  result in  price reduction and  in 
higher  equilibrium  quantity  on  that  specific  market.  Biotechnology  is 
expected  to  provide  such  technological  effects,  at  least  in  the  long-run  (see 
chapter 3).
Segregation implies that specific crops and products are kept apart, but does 
not  necessarily  require  traceability  along  the  production  chain.  In  the  GMO 
context, this may pose major problems of liability and consumer confidence. 
A French investigation identified the absence of labelling requirements at all 
the stages of a production chain to be the most important difficulty to apply 
segregation  along  the  production  chain  and  to  operate  the  current  labelling 
requirements  for  GMOs  (Ministère  de  l’Economie,  des  Finances  et  de 
l’industrie, 1999).
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 63Marketing  experts  have  stated  that  “Identity  Preservation  programs  are  the 
best  alternative  and  the  most  economical  way  to  meet  customer  and 
regulatory  requirements”  (Young,  1999).  Identity  Preservation  (IP)  is  a 
system of crop management and trade which allows the source and/or nature 
of  materials  to  be  identified  (Buckwell,  et  al.  1998).  Thus  it  goes  beyond 
segregation,  since  it  implies  a  stronger  positive  desire  to  know  about  the 
origin of a crop or a product.
The  objective  of  IP  is  to  ensure  that  a  particular  crop  is  monitored 
throughout  the  food  chain  and  thus  to  guarantee  certain  traits  or  qualities 
which might command a premium (House of Commons 2000). IP requires a 
set  of  actions  to  allow  traceability  and  is  usually  communicated  to  the 
consumer  by  a  label.  Thus,  IP  causes  additional  cost  in  supply  which  are 
illustrated in figure 5.3.
Figure 5.3 Economic effects of Identity Preservation cost
5.1.3. Identity Preservation Systems
Introducing  Identity  Preservation  on  specific  market  A  would  result  in  a 
further  shift  of  the  supply  curve  from  Sa2  to  Sa4.  The  effect  will  be  a 
reduction of quantity produced from qA3 to qA4 and a reduction in price to pA4 
on market A.
Currently  IP  is  used  to  identify  crop  varieties  which  provide  additional 
features  concerning  the  content  or  composition  of  products  (eg,  protein 
content, starch level, oil content). In addition, EP is also applied for features 
which  are  not  related  to  the  contents  but  to  the  method  of  production 
(organic food or animal welfare standards) or the geographical origin of the 
product.
A common example of an IP grown crop under contract is the production of 
certified seed. Contamination by foreign pollen or other seed varieties has to 
be avoided and inspections take place to verify purity. The premium for seed 
wheat production is about 15-20% of the price of a normal wheat crop. This 
premium should cover the extra work involved for identity preservation.
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rapeseed, grown for technical use, waxy com for starch production and flint 
com  for  breakfast  cereals.  Identity  preservation  systems  have  also  been 
established for certain other specialised (niche) markets, organic produce for 
example or special varieties of soybeans for tofu production. These products 
are  transported  in  smaller  quantities,  reserved  trucks  or  reserved  holds  of 
smaller ships.
Compared  to  the  main  commodity  markets,  the  quantities  currently  traded 
under  IP  systems  are  small.  Organic  food  is  for  instance  representing  a 
market share of less than 5%, often less than 1%, in most EU Member States 
(Michelsen  et  al.,  1999).  The  highest  market  shares  are  obtained  for  dairy 
products in Denmark (14.2%) and in Austria (8-10%).
In  the  US,  about  100  000  tonnes  of  soybeans  are  identity  preserved, 
compared  to  75  Mio  t  harvested  under  the  commodity  system  (Rawling, 
1999).
However,  variety  choice  through  IP  is  seen  as  contributing  more  than  any 
other  factor  to  improve  the  market  value  of  grains  (Clarkson,  1999).  A 
comparison  of  recent  US  prices  shows  that  the  premium  paid  for  certain 
quality  traits  and  for  organic  products  is  much  higher  than  the  current 
premium for conventional non-GM crops (s. annex). In the health food sector 
the price for IP grains and soybeans is about 200 - 300% of the commodity 
price (Cargill, 1999).
The  following  analysis  will  concentrate  on  IP  systems  since  their  degree  of 
compliance  with  consumer  concerns  appears  to  be  higher  than  for 
segregation.
5.1.4.  Some specific issues of Identity Preservation Systems
Testing  and  control:  An  important  element  to  establish  IP  systems  is  the 
technical possibility to test samples for the preserved identity (e.g. its physical 
or chemical contents). Random or regular tests can be carried out for the final 
product  delivered  to  the  consumer  or  the  processor.  To  enhance  the 
performance,  control  mechanisms  might  be  applied  not  only  to  the  final 
product but also at different stages of production and transportation.
For IP relating to production methods or regional origin, testing of the final 
product is generally not possible and the consumer has to rely on the integrity 
of the  supplier and  the robustness  of the IP system  (Buckwell et al. 1998). 
Controls  would  then  have  to  verify  this  integrity  at  different  stages  of 
production in order to establish consumer confidence.
Tolerances:  Ensuring  absolute  purity  of  a  food  product  would  be  related  to 
prohibitively  high  costs  in  practical  processing  and  handling  chains.  The 
principle of fixing a tolerance level (threshold) in purity standards is therefore 
a long-established feature for IP systems throughout the food industry.
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difficulty of eliminating all commingling throughout the production chain, a 
5  %  tolerance  level  of  non-organic  material  is  allowed  in  some  processed 
food derived from and labelled as being made from organic ingredients.
The costs of an IP system can be expected to increase with a reduction of the 
tolerance  level.  Thus,  the  setting  of  a  certain  tolerance  level  will  be  an 
important factor to determine the costs of an IP system.
Contracts:  Identity  preservation  often  involves  advance  contracts  with 
farmers who commit themselves to keep the crop separate during harvesting 
or  to  produce  only  under  certain  rules  (quality  labels,  organic  farming). 
Furthermore,  seed  varieties,  growing  specifications,  chemical  treatments  or 
handling and storage requirements may be subject to specific contracts. With 
an  increasing  degree  of  specification  for  an  agricultural  product,  which  is 
reflected by a price difference, the likelihood of establishing a contract can be 
expected to rise.
5.2.  Identity Preservation and labelling in the context of GM crops
This section first summarises the reasons to consider IP systems in the GMO 
context, then reviews the current EU legislation on labelling and finally - with 
this  background  -  identifies  three  approaches  for  IP  related  to  the 
introduction of GMOs.
5.2.1.  Reasons to consider IP systems in the context of GMOs
The  fear  of  consumers  that  GMOs  could  have  negative  impact  on  their 
personal health can be a reason to require traceabilitv. This would allow the 
identification  and  if  necessary  eradication  of  a  harmful  modification  or 
product and could be a way to increase confidence in the new technologies.
Most  crops  are  living  organisms  which  are  able  to  reproduce  a  plant. 
Biosafety  considerations  require  traceability  of  GM  crops  to  avoid 
uncontrolled  gene  transfer  and  possible  danger  for  biodiversity,  (see  box  on 
Biosafety Protocol in section 5.6).
There  is  a  need  for  processors  and  traders  to  meet  emerging  mandatory 
GMO-labelling  requirements  in  certain  countries,  in  particular  the  EU,  but 
also in Switzerland, Australia, New Zealand, Japan etc. The tolerance levels 
for  labelling  may  differ  among  countries  or  still  have  to  be  decided.  EU 
legislation on labelling is summarised in the following section.
The  set  of  GMOs  approved  in  different  countries  is  not  the  same.  For 
instance, some corn varieties grown in the US include transformation events 
not  yet  approved  in  the  EU.  Thus,  IP  could  help  to  avoid  trade  disruptions 
due to differences in the approval status.
Consumer  demand  for  non-GM  or  GM  free  food  provides  an  economic 
incentive  for  farmers,  processors  and  distributors  to  supply  such  products 
which require IP to be accepted by the consumer.
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GMOs,  i.e.  specific  traits  addressing  the  consumer  and  the  procession 
industries, IP will become necessary to ensure providing the specific traits to 
the consumer and to enable a premium for the enhanced value.
5.2.2.  EU legislation concerning GMOs, in particular labelling
The release of GMOs in the environment and their placing on the EU market 
are  governed  by  Directive  90/220.  GMOs  can  only  be  introduced  onto  the 
market after having been assessed and authorised to this end. In February
1998  the  Commission  tabled  a  proposal  to  amend  this  Directive,  which  is 
subject  to  the  co-decision  procedure  between  the  European  Parliament  and 
the Council. The main objective of this revision is to increase the efficiency 
and  the  transparency  of  the  decision-making  process  whilst  ensuring  a  high 
level  of  protection  for  human  health  and  the  environment.  With  this  view, 
Member States will be required to ensure labelling and traceability of GMOs 
at all stages of the placing on the market.
Sector-based  legislation  covers  products  derived  from  GMOs,  in  particular 
GM  food.  This  legislation  has  to  be  further  specified  and  extended,  in  line 
with the revision of Directive 90/220. The Commission will table a proposal 
on  Novel  Feed,  including  GM  feedstuffs,  in  the  second  half  of  2000.  The 
White  Paper  on  Food  Safety22  identified a  number of actions to  re-establish 
public  confidence,  in  particular  completing  and  harmonising  labelling 
requirements.
•  The Novel Food Regulation23 and the seed legislation24 already provide for 
mandatory  labelling  of  food  and  seeds  containing  or  consisting  of  GMOs. 
Two GM varieties, one of com and one of soya, and their derived products 
were already on the EU market before the Novel Food Regulation came into 
force.  Therefore  these  two  varieties  were  not  subject  to  additional  labelling 
requirements.  In  order  to  ensure  the  labelling  of  these  varieties  it  was 
necessary to ensure the appropriate labelling through a specific regulation.25
With  the  adoption  of  this  labelling  regulation,  the  Council  invited  the 
Commission to study the practicability of setting down a de minimis threshold 
which  takes  account  of  the  problem  of  adventitious  contamination.  In 
response  to  this  request  the  Commission  has  adopted  a  regulation26  which 
fixes a tolerance level of 1% for each single ingredient on the condition that 
the  operator  has  taken  appropriate  steps  to  avoid  the  use  of  GMOs  as  a 
source.
22  COM(99)719 of 12/0 J2000.
23  Regulation (EC) No 258/97.
24  Commission Directive 98/95/EC.
25  Regulation (EC) No 1139/98.
26  Regulation (EC) No 49/2000.
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ingredient in which neither protein nor DNA resulting from GM is present, 
shall be drawn up. The negative list is a concept applicable to processed GM 
products in which no genetically modified material can be detected any more. 
These products would be exempted from compulsory labelling.
In  January  2000  the  Commission  also  introduced  labelling  requirements  for 
additives  and  flavourings  that  have  been  genetically  modified  or  have  been 
produced from GMOs.27
The Commission White Paper on Food Safety proposes the harmonisation of 
labelling  rules  for  food,  additives,  flavourings,  clarification  of  the 
authorisation procedures in the Novel Food Regulation and the establishment 
of  a  legislation  concerning  food  and  food  ingredients  produced  without 
genetic engineering.
5.2.3.  Three approaches to labelling and Identity Preservation in the GMO 
context
Following the current EU legislation on labelling and the general features of 
Identity  Preservation  systems,  three  different  approaches  to  IP  have  been 
identified in the GMO context (figure 5 .4).
Figure 5.4 Labelling and Identity Preservation
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non-GM
GMO
input
traits
quality
traits
EU legislation in preparation no rules obligatory labelling
on labelling
v threshold to be fixed threshold 1 %
IP approach voluntary
(voluntary IP possible 
to avoid compulsory 
GMO labelling)
voluntary
compulsory with 
traceability
JL
segregation
27  Regulation (EC) No 50/2000.
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crops  that  have  a  specific  value  to  their  consumer,  for  example  through 
improvements  in  nutritional  value,  colour,  texture,  flavour  or  processing 
properties.  With  the  development  of  new  traits  by  biotechnology,  the 
economic  incentive  for  IP  would  increase.  In  addition  to  the  labelling 
requirements  under  the  novel  food  regulation,  there  would  be  a  clear 
incentive  on  the  supply  side  (farmers,  processors  and  retailers)  to  introduce 
IP  and  thus  to  preserve  the  additional  value  or  quality  of  such  a  GM  crop 
through  the  processing  chain.  IP  would  distinguish  a  product  for  which 
consumers are expected to pay more than for a conventional product.
Testing:  The  economic  viability  of  a  GM  product  with  consumer  oriented 
traits will depend largely on the ability to identify these specific values in a 
cost efficient way. In general, detection and quantification of modified DNA 
and protein depend on the availability of appropriate reference material (Lipp 
et al., 2000).
Tolerance:  GMOs  offering  specific  qualities  to  the  producer  and  the  final 
consumer will only be accepted if these qualities can be guaranteed within a 
certain  tolerance  level.  Tolerances  will  have  to  be  fixed  in  accordance  with 
the purity expectations of the buyers of these products.
2.  Voluntary IP of GMO-free products: The second approach for IP is to 
preserve  and  label  GM-free  products  in  order  to  enhance  consumer  choice. 
Current  EU  legislation  already  requires  compulsory  labelling  for  food 
containing  GMOs.  Thus,  the  introduction  of  labelled  GMO-free  food  would 
in theory enable the choice between three categories of foodstuffs: novel GM 
food; conventional non-GM food and GMO-free products (figure 5.4).
Some  European  food  trade  companies  which  are  trying  to  serve  the  non 
GMO market niche are claiming that they are supplying non-GMO products 
However,  the  explanations  and  guarantees  given  to  the  consumer  sometimes 
lack  a  sufficient  transparency.  A  Wall  Street  Journal  article  (October  26, 
1999) stated both confusion and legal risk in the current labelling which can 
be  found  in  supermarkets.  An  investigation  of  94  companies  by  the  French 
Ministère de l’Economie, des Finances et de l’industrie (1999) revealed that 
more  than  50%  of  the  enterprises  had  modified  the  composition  of  their 
products  to  avoid  GMO  labelling.  Most  of  them  had  attestations  by  their 
suppliers,  14  enterprises  were  able  to  present  traceability  documents  and  19 
got analytical certificates.
However, it can be expected that the share of conventional food will diminish 
over  time,  since  the  pay  off  for  GMO-free  products  can  be  expected  to  be 
higher than  for conventional  non-GM products. If  producers  decide to make 
an  effort  to  segregate,  the  additional  costs  to  comply  with  GMO-free 
standards  might  be  low  compared  to  the  additional  premia  achieved  on  the 
market.  On  the  other  hand,  if  at  least  part  of  the  consumers  accept  labelled 
GM food, some conventional raw material would enter into GM-labelled final 
products.
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contain or contains only a limited percentage of GM material. A workshop on 
GMO  research  perspectives held in  the context  of the EU Fifth Framework 
Programme  identified  the  “development  of  rapid,  reliable  detection  methods 
for  GM  foods  and  their  derivatives”  as  one  of  the  top  priorities  for  further 
research in the GMO context (External Advisory Groups, 1999).
For  international  trade  a  standardised  test  would  help  to  avoid  liability 
conflicts and  trade distortion in  case of different labelling  requirements and 
approval  status  (Brookins  2000).  The  American  National  Grain  and  Feed 
Association,  for  instance,  has  called  for  the  introduction  of  an  accurate, 
repeatable  and  low  cost  test  to  distinguish  between  conventional  and  GMO 
products.  USD  A  has  recently  announced  that  it  will  establish  a  reference 
laboratory  to  evaluate  the  validity  of  analytical  procedures  and  to  establish 
sampling  procedures  for  use  in  testing  bioengineered  grains  and  oilseeds 
(USDA, 2000).
The more expensive testing for GMO, the more likely will be arrangements 
based on declaration of honour concerning the GMO-free status of a product. 
This would imply a certain system of field and production control to satisfy 
consumer confidence.
Example for IP system based on producer declarations and testing:
Champagne céréales, non-GM corn (Oustrain 1999)
•  GMO survey among suppliers: to be completed by all the com producers 
before their first delivery;
•  at reception: control of the declaration of the supplier (checking GMO 
survey);
•  without signed commitment:
-  on the spot signature of the requested commitment and acceptance 
of the shipment;
-  refusal  of  the  supplier  to  sign  any  commitment  (or  detection  of 
GMOs): isolation of this shipment outside the silo or directing to a 
dedicated dryer;
•  representative testing of all silo compartments, strict and detailed 
sampling plan.
Tolerance:  Most  crops  can  easily  be  contaminated  with  other  material  by 
pollen  drift  or  by  mechanical  commingling  during  harvest,  storage  or 
transportation.
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non-GM status of a plot or farm on which GM crops have been grown. The 
argument is that inherited modified genetic sequences are likely to persist on 
the  farm  -  for  example  in  the  case  of  rape  -  even  after  the  crop  has  been 
harvested  and  sold.  Standards  for  non-GM  or  GM-free  lines  will  have  to 
address this question.
Contracts:  To sell  IP  crops  farmers  will  have  to agree  on terms  of contract 
with  their  trading  partners.  Such  contractual  arrangements  always  imply  the 
question  of  liability.  Some  proposed  voluntary  certification  procedures  have 
been  developed  for  producers  wishing  to  segregate  non-GMO  commodities 
in response to a premium offered.
Currently  most  US  extension  services  have  warned  farmers  to  be  careful 
when  signing  a  contract  to  supply  non-GM  or  GMO-free  products,  since 
accidental contamination cannot be excluded (Charpentier, Hazouard, 1999).
3.  Compulsory IP for GM products (GM traceability): Trading GM crops 
as part of a commodity system would result in losing their track within the 
transportation and processing chain. Thus any commodity sample originating 
from  a  region  or  country  where  GM  and  conventional  crops  are  grown  in 
parallel  might  contain  GM  crops.  Traceability,  i.e.  a  compulsory  IP  system, 
has been introduced as a strategy to re-establish consumer confidence in the 
EU beef sector following the BSE crisis. Traceability could also be a strategy 
to  monitor  the  environmental  and  health  effects  of  GMOs  and  to  enable 
choice to those consumers who want to avoid GMO consumption.
According  to  the  EU  Council  Common  Position  with  a  view  to  amending 
Directive 90/220/EEC on the deliberate release of GMOs28 traceability will be 
required: “It is necessary to ensure traceability at all stages of the placing on 
the market of GMOs ...” (Common Position, recital No. 40). Member States 
are invited to ensure traceability at all stages.
Testing:  In  general  the  testing  requirements  for  GMO  traceability  would  be 
the  same  as  for  GM-free  products.  However,  the  objective  will  be  to  detect 
the  presence  of  specific  modifications  and  not  to  measure  the  quantity 
versus a threshold. Reference material and genetic sequence information will 
be needed to develop reliable tests.
Tolerance:  The  tolerance  approach  can  be  expected  to  be  very  strict  if  the 
objective  is  to  ensure  traceability.  Every  bunch  containing  only  a  minimum 
trace of a certain GMO would have to be identified.
28  Common Position (EC) No 12/2000 adopted on 09/12/2000
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handling,  storage,  transport,  processing,  cleaning,  and  administration 
(Buckwell  et  al.,  1998).  They  would  apply  to  all  three  IP  approaches 
identified  above,  independently  of  their  voluntary  or  compulsory  character. 
However, the magnitude of IP costs will depend on several factors which will 
be summarised at the end of this chapter.
Many opportunities for mixing and contamination exist along the production, 
processing  and  distribution  chain  of  an  IP  product.  Thus,  IP  costs  arise  on 
different  stages  of  the  chain:  seed  production,  farm,  transport,  further 
storage,  processing,  labelling  and  distribution.  The  following  overview  of 
additional  costs  corresponds  to  the  structure  suggested  by  Buckwell  et  al. 
(1998).  Some  empirical  experience  has  been  added  to  illustrate  the 
magnitude.
5.3.1.  IP costs for seed production
Already  under  conventional  systems  basic  and  certified  seed  is  normally 
distributed separately bagged and labelled. No difference would occur for an 
IP system.
The  two  main  sources  of  mixing  seed  varieties  are  through  pollen  and 
through other seeds. Avoiding such contamination is a usual feature of seed 
breeding.  The  EU  has  fixed  minimum  distances  from  neighbouring crops  of 
' different varieties or inbred lines of the same species (table 5 .1). For instance, 
certification of basic seed requires a minimum distance of 400 m for cross- 
pollinating oilseeds, 300 m for rye and of 200 m for com.
The minimum varietal purity for basic seed of oats, barley, wheat, spelt and 
rice has been fixed at 99.9% and at 97% for soybeans. Several other purity 
criteria  are  provided  by  the  seed  directives  concerning  the  minimum 
germination  rates,  analytical  purity  and  the  maximum  content  of  seeds  of 
other plant species.
Purity criteria applied for seed multiplication (certified seed) are partially less 
restrictive  than  for  basic  seed  (table  5.1).  The  cordon  sanitaire  for  the 
production  of  certified  oilseeds  for  instance  amounts  to  250  m  for  certified 
rye  seed  and  to  200  m  for  corn  and  for  cross-pollinating  oilseeds.  The 
minimum varietal purity for oats, barley, wheat, spelt and rice has been fixed 
at 99.7% for first generation certified seed and at 99% for second generation.
At least for certified seed of soybeans and beets, the current EU standards for 
varietal purity might conflict with the tolerance levels for GMO labelling. For 
soybeans,  the  EU  seed  marketing  standards  require  a  minimum  purity  of 
95%. This means that seed could contain up to 5% of other varieties, possibly 
including GM varieties. During the last years, the EU has imported soybean 
planting  seed  from  the  US,  where  the  purity  norm  for  soybean  seed  runs 
about  98%  (Blumenthal,  1999).  For  beet  seeds,  the  varietal  purity  has  been 
fixed at 97%.
5.3. Costs of Identity Preservation in the GMO context
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Crop Category
Minimum 
distance from 
neighbouring 
crops
Minimum 
varietal 
purity (%)
Source
Com basic seed 
certified seed
200 m 
200 m
Directive No 
66/402/EEC
Rye basic seed 
certified seed
300 m 
250 m
Directive No 
66/402/EEC
Oats, Barley, 
Wheat, Spelt
basic seed 
certified seed
1. generation
2. generation
99.9
99.7
99.0
Directive No 
66/402/EEC
Cross-pollina- 
ting Oilseeds
basic seed 
certified seed
400 m 
200 m
Directive No 
69/208/EEC
Soybeans basic seed 
certified seed
97
95
Directive No 
69/208/EEC
Sugar and 
fodder beet *)
basic seed 
certified seed
1000 m 
600 m
97
97
Directive No 
66/400/EEC
*) Distance from other subspecies of Beta vulgaris. Minimum distances from other 
types and varieties of sugar beet are lower.
The  crucial  variable  to  determine  the  additional  costs  in  seed  production  is 
the tolerance level applied for IP. Currently farmers obtain a premium of 15 
to 20% for the extra work required for the production of wheat crop for seed 
compared  with  growing  normal  wheat  crop  for  commercial  sale  (Cargill, 
1999).  Representatives  of  the  seed  industry  have  confirmed  that  they  could 
provide  seeds  at  any  desired  tolerance  level.  However,  costs  would  rise 
following  rather  an  exponential  than  a  linear  function  with  a  tolerance  level 
approaching zero percent.
5.3.2.  IP costs on the farm
Four potential sources of mixing GM and non-GM crops on a farm have been 
described by Dale (1999):
-  contamination of seed used by the farmer (within the limits of genetical 
purity);
-  crop mixing with volunteer GM plants that are already present in the soil 
when the crop is sown;
-  mechanical commingling in sowing, harvesting and storage;
-  cross  pollination  with  other  varieties  which  varies  with  the  distance, 
sexual  compatibility  between  crops  and  the  method  of  pollen  transport 
(wind, insects).
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mechanical commingling and the distance to avoid cross pollination.
The  number  of  volunteers  can  be  reduced  by  cultivation  practices  or  by 
herbicides. In fields where rapeseed has been grown, volunteers are likely to 
grow  during  a  period  up  to  seven  years.  Volunteers  of  herbicide  tolerant 
variants should be treated by alternative non-selective herbicides (SCIMAC, 
1999).
To  avoid  mechanical  commingling,  the  planting  and  harvesting  equipment 
must  be  thoroughly  cleaned  before  use.  Furthermore,  the  on-farm  storage 
facilities  must  be  cleaned or  new  facilities  must be  provided  to  separate IP 
crops. The costs of cleaning, in particular the amount of time spent on this 
mainly depends on the required tolerance level. Due to cleaning breaks, there 
may be additional cost associated with a reduction in work time during which 
the  harvest  machine  is  operational.  Moreover,  a  particular  low  tolerance 
could require the use of separate machinery for each crop.
Physical  distance  between  the  pollen  donors  and  the  crop  is  the  most 
important  factor  to  avoid  cross  pollination  among  specific  varieties.  The 
amount of cross pollination also depends on the amount of outbreeding in the 
crop,  the  overlap  of  flowering  periods  and  the  area  of  the  crops  grown 
(Moyes and Dale, 1999).
In  the  UK  context,  SCIMAC  has  set  up  guidelines  for  good  agricultural 
practice  for  growing  herbicide  tolerant  crops  which  provide  minimum 
distances  from certified seed crops, organic crops and conventional crops of 
the  same  species.  Basic  guidelines  for  growing  GM  crops  with  specific 
agronomic traits are currently under development (SCIMAC, 1999). On the 
other  hand,  the  standards  for  organic  farming  provided  by  the  UK  Soil 
Association  require  minimum  distances  from  GM  crop  plantings  which  are 
significantly higher than the SCIMAC provisions (Soil Association, 1999).
Cross  pollination furthermore may affect the relationship between neighbour 
farms.  GM  cropping  on  one  plot  may  affect  the  non-GM  status  of  another 
plot, and more controversially, the GM status of other farms. The possibility 
of litigation with neighbours could also influence the economic considerations 
of  a  farmer  (Griffiths,  1998).  SCIMAC’s  guidelines  propose  that  “the  onus 
lies  with  the  GM  grower  to  notify  neighbouring  farms  in  writing  of  his 
planting intentions.” This issue is of particular importance if the neighbour is 
growing  organic  food,  where  GMOs  are  prohibited  in  general.  Failure  to 
reach agreement must be notified to SCIMAC and has to be solved by further 
consultation or through normal legal channels (SCIMAC, 1999).
Cross-pollination  and  commingling  raise  a  number  of  legal  and  economic 
issues  concerning  the  coexistence  of  three  production  systems:  GM, 
conventional, and organic.
IP  products  would  be  very  likely  to  be  grown  at  a  contractual  basis. 
Contracting  requires  certain  transaction  costs  for  all  contracting  parties 
involved, such as the time devoted to negotiations and probably some fees.
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keeping  might  result  in  additional  work  for  the  farmer.  Cargill  (1999)  has 
pointed out that farmers growing IP crops also face additional price risks and 
their options for selling the crop might be reduced.
Table 5.2 indicates some examples for additional cost at the farm level and 
the  available  information  about  premia  currently  paid  to  farmers.  However, 
the  premia  may not only  reflect  the additional costs  of segregation  but also 
the additional value of a certain trait or a certain production system.
The  examples  for  soybeans  indicate  that  US  producers  have  received  a 
premium  of  5  -  9  €/t  for  non-GM  soybeans  in  the  last  years.  This  amount 
corresponds  to  the  IP  costs  for  GM  soya  with  specific  traits  and  represents 
about 4% of the farmgate price. More recent sources signal a lower premium 
level  of  3  -  7.5  €/t  which  corresponds  to  1.5  -  4.4%  of  the  average  price 
received  by  US  farmers.  European  farmers  are  offered  a  slightly  higher 
premium  of  11  -  12  €/t  for  non-GM  soya  and  in  1998  some  buyers  also 
seemed to be willing to pay a premium up to 24 €/t above the conventional 
US price to get Brazilian non-GM soya.
However, according to US grain handlers, the premium paid for food quality 
soya was much higher than the non-GM premium. The average price of food 
use was estimated to be 35 €/t higher than the commodity price for soybeans 
(Bender  et  al.,  1999).  In  autumn  1999,  the  IP  premium  for  quality  traits 
ranged from 20 €/t for medium high protein contents to more than 140 €/t for 
sugar balanced soybeans compared to an average commodity price of 170 €/t 
(Clarkson, 1999).
Table 5.2 Soybeans: IP costs and segregation premia at the farm level
IP approach country Year IP cost/ 
premium
% of 
price*)
GM quality traits: low linolenic, 
high oleic, low saturate, high 
protein, high sucrose
USA (1997) 8 - 9 €/t 4% (1)
non-GM herbicide resistant 
(DuPont STS programme)
USA 1998 5 - 8 €/t 
(premium)
(2.4-
3.8%)
(2)
(3)
non-GM
herbicide resistant
Brazil 1998 24 €/t **) 10% (1)
non-GM France Spring
1999
11 - 12 €/t 
(premium)
(4)
non-GM herbicide resistant 
(ADM)
USA 1999 6 - 7 €/t 
(premium)
(3.5-
4%)
(3)
non-GM
commodity grade US#1
USA Autum
nl999
7.5 €/t 
(premium)
4.4% (5)
non-GM USA Sept 99 
Feb 00
3.6 €/t 
2 - 3 €/t 
(premium)
(2%)
(1 -1.5%)
(6)
non-GM USA (1999/
2000)
3.8 - 5.7 €/t 
(premium)
(2-
3.2%)
(7)
*) farmgate price (percentages in brackets have been calculated by DG Agriculture)
**) due to higher average price for Brazilian soybeans
Sources: (I) Buckwell et al. 1998; (2) Bender et al. 1999; (3) Deutsche Bank Alex. Brown 
1999; (4) Circuits culture 1999; (5) Clarkson 1999; (6) Brookins 2000; (7) Lin 2000
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quality).  This  means  producers  of  organic  soybeans  received  a  premium  of 
almost  150%  of  the  commodity  price  (Clarkson,  1999).  Thus,  farmers  who 
are  thinking about  entering into non-GM  production might consider  as well 
to switch to organic farming in order to realise the higher market price.
In  contrast,  GM  soybeans  (without  specific  quality  traits)  are  being 
discounted  by  up  to  10%  of  the  farmgate  price  in  many  parts  of  the  USA 
because foreign buyers and some US companies have announced not to buy 
GM  material.  Therefore  many  grain  elevators  are  discounting  not  only  GM 
varieties  but  all  varieties  because  they  cannot  separate  due  to  a  lack  of 
facilities to handle both types.
While  quality  trait premia (high oil contents)  for  com  range between 4  and 
6€/t,  non-GM  premia  appear  to  be  slightly  lower.  They  range  between  1.8 
and 5.6 €/t. IP premia range between 2.5 and 9% of the farmgate price for 
com.  However,  when  these  price  differences  per  tonne  are  translated  into 
price  differences  per  hectare  the  farmer  will  have  to  take  account  of  yield 
differences.  Yields  of  quality  trait  varieties  are  often  lower  than  average, 
while  several  studies  have  found  evidence  on  yield  gains  for  Bt  com 
compared to conventional varieties (see chapter 3).
Table 5.3 Corn: segregation premia at the farm level
IP approach country year IP cost/ 
premium
%of 
price *)
Quality trait (conventional) 
high oil contents
USA 1997 5.3 €/t 
(premium)
5% (1)
Quality trait (conventional) 
high oil contents
USA 1998 4.2 €/t 
(premium)
(5%) (2)
Quality trait (conventional) 
high oil contents 
(Optimum Quality Grain)
USA 2000 6.1 €/t 
(premium)
(7.5%) (7)
Non-GM USA Autumn
1998
1.8 - 2.8 €/t 
(premium)
(2.5-
4%)
(3)
Non-GM
commodity grade US#2 
yellow
USA Autumn
1999
5.6 €/t 
(premium)
(9%) (5)
Non-GM USA (1999/
2000)
2 - 4 €/t 
(premium)
(3-
4.5%)
(7)
*) farmgate price
Sources: (1) Buckwell et al. 1998; (2) Bender et al. 1999; (3) Deutsche Banc Alex. Brown 
1999; (5) Clarkson 1999; (7) Lin 2000
As well as for soybeans, the premium for com used for food was much higher 
than  the  non-GM  premium.  In  1998  the  food  use  premium  was  more  than 
12  €/t,  i.e.  more  than  double  the  non-GM  premium.  For  very  high  protein 
contents  US  farmers  could  receive  a  premium  of  50%  of  the  commodity 
price,  which  was  at  about  75  €/t  in  autumn  1999  (Clarkson,  1999).  The 
premia for organic com ranged from 75 to more than 110 €/t.
Some examples for other crops, i.e. sunflower and oilseed rape, unveil that a 
premium of 3.5 to 5% of the farmgate price is paid to the farmer for cropping 
(conventional)  quality  trait  varieties  (Buckwell  et  al.,  1998).  However,  a 
Canadian example for GM herbicide-tolerant oilseed rape (Canola) shows
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of the farmgate price.
The  crucial  factors  to  determine  IP  costs  at  the  farm  level  will  be  the 
tolerance  level  to  be  achieved,  the  physical  ability  of  cross  pollination  and 
rules  and  legislation  concerning  neighbouring  farms.  However,  most  of  the 
additional  costs  at  the  farm  (and  the  processing)  level  would  be  avoided,  if 
the full production could be switched to a single type of IP.
5.3.3.  Costs for testing
The  easiest  and  probably  cheapest  way  to  segregate different  grain  varieties 
would be to use grain confetti for identification. Nevertheless, qualitative and 
quantitative  testing  may  be  required  to  control  for  particular  specifications 
and GM contents. For GM crops providing quality traits testing will refer to 
these  specific  modifications.  GMO  traceability  would  extend  the  need  for 
testing to all genetic modifications, including agronomic traits. For GMO-free 
products,  the  testing  would  not  be  limited  to  determine  the  presence  or 
absence of GMOs,  but would  also have to  confirm that  the tolerance levels 
have been respected.
GMO testing methods
A Genetically Modified Organism can be distinguished from a non-GMO by the fact that 
it  contains  either  unique  novel  deoxyribonucleic  acid  (DNA)  sequences  and/or  unique 
novel  proteins  not  present  in  its  conventional  counterpart.  Two  methods  are  actually 
applied: a PCR (Polymerase Chain Reaction) test based on DNA detection and the ELISA 
(Enzyme  Linked  ImmunoSorbent  Assay)  test  based  on  protein  detection.  Validation 
programmes for both methods are currently exercised by the EU Joint Research Centre 
(Lipp et al. 2000).
PCR
The  polymerase  chain  reaction  is  based  on  the  detection  of  DNA  fragments  that  are 
inserted in the plant genome. This method allows amplification in a few hours of specific 
DNA fragments to a degree that they can be analysed qualitatively and quantitatively by 
common  laboratory  techniques  (e.g.  electrophoresis).  However,  it  requires  specialised 
equipment and training. PCR testing is applicable and extremely sensitive in the case of 
unprocessed food where the DNA is still intact. This is not the case for processed food 
where it is more difficult to isolate high quality DNA and where GM material from more 
than one GM species can be present. In the latter, the method is laborious and costly. PCR 
requires little reagent development time compared to immuno-logical assays, but it can 
still take 1 to 3 days to receive results from a testing laboratory. The test is estimated to be 
about 99.9% accurate.
ELISA
This method is able to detect and to quantify the amount of a certain protein which is of 
interest in a sample that may contain numerous other dissimilar proteins. ELISA uses 
antibodies  to  bind  specific  proteins.  Antibodies  are  soluble  proteins  produced  by  the 
immune system of animals in response to exposure to a foreign substance (called antigen). 
For  GMOs,  the  antigen  can  be  the  newly  synthesised  protein.  A  colorimetric  or 
fluorometric reaction can visualise and measure when the antigen and specific antibody 
bind together. One restriction for using the ELISA test is the denaturation of proteins in 
some food processes. Similar to PCR, the ELISA method requires trained personnel and 
specialised equipment. This method also requires high investments to develop the assay 
and to generate antibodies and protein standards. However, once reagents are developed, 
the cost per sample is low. The test is reported to be 95% reliable.
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The  ELISA  test  takes  only  2-8  hours  and  may  cost  up  to  10  €  per  test.  A 
faster and simpler ELISA dipstick test to provide a “yes or no” result takes 5- 
10 minutes and costs only 3.6 € per test (ACPA 1999, Lin 2000).
In  order  to  compare  the  different  cost  elements,  testing  costs  have  been 
calculated per tonne, although testing is not only applied to raw products but 
also  to  processed  foodstuffs.  The  additional  cost  per  tonne  of  soya  or  com 
for testing the presence of a specific biotech trait by the ELISA technique has 
been  estimated  at  0.4  €  (Lin  2000).  However,  since  current  ELISA  testing 
methods  require  a  separate  test  for  detection  of  each  unique  trait,  several 
tests may be required to determine if a shipment is free of biotech material, in 
particular for com. At subterminals and export elevators, PCR testing is more 
common than ELISA because it is more sensitive and can be used to detect 
presence of several genetic modifications by one set of tests. Furthermore, it 
becomes more efficient with larger volumes of grain to be tested (Lin 2000).
Cost for an IP testing system have been estimated to range from 1 €/t for a 
simple  checking  to  as  much  as  20  €/t  for  the  most  disciplined  systems  of 
overlapping  documentation,  field  inspections,  product  sampling  and 
laboratory  testing  by  third  parties  (Clarkson  1999).  A  1996  Canadian  IP 
example  for  herbicide  resistant  GM  oilseed  rape  indicates  a  total  cost  for 
testing, administration and monitoring the IP system of 2.9 €/t (Buckwell et 
al. 1998, p.65). An alternative to expensive tests could be the introduction of 
additional  genes  that  provide  visual  markers  to  facilitate  identification. 
However, IP documentation is likely to reduce the need for testing compared 
with,  for  example,  on  the  spot  testing  of  commodities  for  GMO 
contamination or specific traits.
5.3.4.  IP costs for transportation andfurther storage (merchandising)
Additional  costs  will  occur  with  the  need  to  find  separate  storage  at  local 
elevators and with possible restrictions in the delivery schedule. An IP system 
for non-GM crops would require traditional elevators to handle at least four 
types of grains - two types of corn (more likely three incl. high oil com) and 
two types of soybeans. This reduces their capacity to quickly and efficiently 
receive grain at harvest time and will reduce their effective storage capacity. 
If transportation and storage  facilities in  silos, trains, trucks  or ships cannot 
be fully used by IP crops, further costs might occur per unit.
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Crop IP approach count
ry
Year IP cost
€/t
% of 
price*)
Soybean GM quality traits: low 
linolenic, high oleic, 
low saturate, high 
protein, high sucrose
USA (1997) 1.6 - 3.3 €/t 0.6-
1.3%
(1)
Soybean Non-GM
STS herbicide tolerant
USA 1998 6 €/t (2)
Soybean Non-GM 
(ERS estimation)
USA 2000 20.6 €/t **) (7)
com/
maize
Quality trait (convent.) 
waxy maize
Euro
pe
(1997) 3.2 - 8.0 €/t 2 - 5% (1)
com/
maize
Quality trait (convent.) 
high oil content
USA 1997 1.0- 1.8 €/t 1.0-
1.7%
(1)
com/
maize
Quality trait (convent.) 
high oil content
USA 1998 2.1 €/t (2)
com/
maize
Non-GM 
(ERS estimation)
USA 2000 9 €/t **) (7)
Oilseed
rape
GM traceability 
herbicide resistance
Cana
da
1996 4.7 - 6.9 €/t 2.8-
4.1%
(1)
Sun­
flower
Quality trait 
high oleic
USA 1997/
1998
1.6 - 3.3 €/t 0.6-
1.3%
(1)
*) farmgate price **) marketing cost from country elevator to export elevator, incl 
testing
Sources: (1) Buckwell et al. 1998; (2) Bender et'al. 1999; (7) Lin 2000
For  IP  crops  the  transport  and  storage  means  have  to  be  cleaned.  Avoiding 
any  co-mingling  during  the  loading  or  unloading  process  would  require 
cleaning  the  equipment  and  would  entail  labour  downtime  costs  during 
cleaning. The costs incurred would mainly depend on the tolerance level.
Another cost element for IP appears for seasonal crops. EU soybean imports 
generally  come  from  Brazil  and  Argentina  during  the  summer  and  from  the 
US in winter. If it would not be possible to set up IP chains both in the US 
and  in  South  America,  some  material  would  require  storage  to  ensure  a 
constant stream of supplies (Cargill, 1999). However, storage would be more 
expensive than transportation and might add 15 - 25% to the price of the raw 
material (Cargill, 1999).
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 79A spring 1998 survey of 84 US firms trading speciality com and soybeans (of a total 
of about 200 US firms) reports that 56% of the speciality (IP) crops traded by these 
firms were from local origin (max. 15 miles away) and only 5% originated more 
than 250 miles away. The data suggest that as the percentage of speciality crops 
handled by a firm increases, they must be collected from an increasingly larger 
radius. On average, 96% of speciality crops were delivered by truck, 3% were 
delivered by rail, and 1% by other methods.
Speciality crops handled include 61% stored on farm, 23% stored at the country 
elevator, and 14% received at harvest. The average percentage of speciality crops 
purchased through farmer contracts was 85%. Contracts with country elevators 
accounted for 8% of specialty crop purchases and only 5% were purchased through 
the  open  market.  The  contracts  varied  between  basic  contracts  with  quality 
adjustments (26%), flat price contracts (23%), basic contracts (20%), acreage 
contracts (16%) or forward contracts (12%). Quality tests are made at delivery 
(93%), at the farm (56%), for the required variety (83%) or at seal bins (18%).
About 80% of the speciality crop was shipped in bulk, 20% in bags, in particular 
soybeans for food. The primary market for speciality crops was the export market 
(47%); 33% went to processors (STS soybeans and food com), 6% went to brokers 
and 7% to livestock feeders (in particular high oil com).
. The additional costs incurred in handling speciality com have been estimated to be 6 
€/t. Average cost increase for handling was less for high oil traits (2.1 €/t) than for 
food use com (13.7 €/t).
For soybeans the additional costs of handling has been estimated to average 15.8 €/t. 
The additional costs for food use was 20 €/t and for non-GM STS soybeans it was 6
€/t.
Distribution costs to different cost items shows that all of them were higher for 
speciality soybeans than for com, except for the analysing and testing cost which 
were at the same level (see table in annex B).
US survey on firms handling speciality crops (Bender et al. 1999)
The additional transport cost range from 1 to 9 €/t for the different products 
and  IP  approaches.  These  costs  represent  about  0.5  -  5%  of  the  farmgate 
price.  Lin  (2000)  reports  the  results  of  an  ERS  survey  that  the  cost  for 
segregating non-GM crops could be higher than for speciality crops but does 
not present any data.
The  key  factors  will  be  the  amount  of  crop  traded  under  the  different  IP 
systems and the tolerance level for contamination.
Internet  marketing:  Several  actors  are  offering  trade  contracts  on  their 
websites.  Buyers  are  thus  asked  to  submit  requests  in  good  time  to  allow 
farmers  to  adjust  their  planting  decisions  and  order  the  appropriate  seed 
(Young, 1999 for DuPont).
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to the end user. This would allow multiple IP and marketing systems to exist.
The internet is also used to call for a buying networks of farmers to combine 
their  negotiation  power.  Registration  of  farmers  and  quantity  indication  by 
each  member  would  allow  to  concentrate  selling  negotiations  and  organise 
transportation needs. (Progressive Ag Marketing 1999).
5.3.5.  Additional Costs for the processing industry (feed andfood)
Storage  tanks  of  processing  plants  have  to  be  cleaned  prior  to  use  for  IP 
products. Very low tolerance levels might require dedicated storage facilities. 
A feed mill would probably not want both GM and non-GM supplies of the 
same ingredient, because of the difficulty of keeping them apart.
Table 5.5 Some examples for IP costs at the processing level
Crop GM / non-GM Countr
y
year IP cost
€/t
%of
price*)
Soybean Quality trait (convent.): 
crushing level
USA (1997) 1.6 - 3.3 €/t 0.6-1.3% (1)
Soybean Quality trait (convent.) 
refining level
USA (1997) 3.9 - 7.8 €/t 1.5-3.1% (1)
Com high oil content 
(non-GM) milling
USA 1997/
1998
8.9 €/t (1)
Sun-flower high oleic 
crushing level
USA 1997/
1998
1.6 - 3.3 €/t 0.6- 1.3% (1)
Sun-flower high oleic 
refining level
USA 1997/
1998
3.9 - 7.8 €/t 1.5-3.0% (1)
Oilseed
rape
GM: herbicide resistant Canada 1996 1.7 - 2.9 €/t 1.0-1.7% (1)
*) farmgate price
Sources: (1) Buckwell et al. 1998
The capacity of larger US processing plants for soybeans and com is between 
2000  and  8000  tonnes  a  day  (Cargill,  1999).  Normally,  they  are  run 
continuously  except  for  annual  cleaning  or  repair  breaks.  Stopping 
production and cleaning the facilities would cause additional cost. Therefore, 
the solution for the processing plants could be to use a certain quantity of IP 
grains to “clean” the plant and to sell the product mixed with non-IP output. 
Only after a certain period of IP grain use, the IP supplies run through would 
be  guaranteed  to  retain  their  identity.  The  cost  of  this  solution  clearly 
depends on the quantity of IP supplies put through.
The cost of IP processing would further depend on the number of secondary 
products produced from the raw material. If only one of the output products 
is required to be IP, e.g. the soya oil, it will bear the whole cost of IP. If there 
is  a market  for all  the products  of IP however, then the costs of IP will be 
spread across all end products.
If  there  is  sufficient  IP  supplies  of  a  crop,  it  may  be  possible  to  dedicate  a 
plant to processing such supplies, in which case there would be no additional 
costs involved from separate processing and storage.
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check for the required level of tolerance. Ensuring correct product labelling 
would require additional time and costs as well as the re-setting, re-designing 
and printing of labels.
The examples given in table 5.5 indicate additional costs of 1.5 - 9 €/t, which 
is about 0.5 - 3% of the farmgate price of the product concerned.
5.3.6.  Total costs for IP systems
Summarising  the  different  costs  along  the  production  chain  allows  the  total 
costs of IP to be estimated. According to the examples available, they range 
from 5 to 25 €/t depending on the different grains and the IP systems. Thus, 
IP  would  increases  the  grain  price  by  6  -  17%  compared  to  the  farmgate 
price.  These  results  confirm  the  conclusions  of  Buckwell  et  al.  (1998)  for 
quality  traits.  Since  such  a  range  corresponds  to  the  experience  with  well 
established IP systems for value added market segments, it can be taken as a 
reliable estimation of IP costs.
For modifications that focus on agronomic traits, Buckwell et al. stated some 
difficulties to assess the representativity of the examples. However, the more 
recent examples confirm  a similar  range of additional costs  compared to IP 
systems for quality traits.
Summarising the main factors which determine IP costs, the following have 
been identified:
-  Tolerance: The more stringent the purity requirements, the more expensive 
will be the IP system. For the farmer, the size of the premium will also 
vary  with  the  degree  of  purity  required  in  the  crop  (Cargill,  1999).  The 
tolerance  level  is  an  important  cost  factor  for  all  three  IP  approaches 
discussed  in  this  report.  Fixing  a  threshold  will  particularly  concern  the 
cost  of  seed  production,  the  costs  for  testing,  storage  and  transportation 
and the decision to switch a whole farm and a whole processing plant to 
specific (IP) production.
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GM/non-GM crops
Crop GM / non-GM country Year IP cost % of 
price
Soybean GM quality traits: low 
linolenic, high oleic, 
low saturate, high 
protein, high sucrose
USA (1997) 15 - 22 €/t 6-
9%*)
(1)
Soybean non-GM:
herbicide resistant
USA 1998 Soyameal 
protein: 
119 €/t
50% (1)
Soybean non-GM Italy 1999 Soyameal
> 23 €/t
(9)
Soybean non-GM UK (1999) 17.2 €/t (8)
Soybean 
/ com
Any type of identiy 
preservation
USA 1999 4.7-21.4 €/t (4)
Com post harvest chemical 
free
USA (1997) 14 €/t 16% *) (1)
Com high oil content Europe 1997/9 17.6 €/t 17% *) (1)
Oilseed
rape
GM: herbicide 
resistant
Canada 1996 10.4-13.3
€/t
6 - 8% 
*)
(1)
Oilseed
rape
GM herbicide 
resistant (limited 
acreage:5% of total 
acreage in CAN)
Canada 1996 19.7-21.4
€/t
9.5%
*)
8.5-9%
(3)
Sun­
flower
high oleic USA 1997/
1998
16.0-23.0
€/t
7- 
10% *)
(1)
*) farmgate price **) commodity price
Sources: (1) Buckwell et al. 1998; (3) Van Wert (AgrEvo) 1996; (4) Clarkson 1999; (8) 
House of Commons 2000; (9) Brookins 2000
Choosing  a  severe  level  of  tolerance  may  increase  the  cost  to  such  a  high 
level  that  they  would  override  the  possible  benefits  of  IP  production.  An 
extremely low tolerance level for GMO-free products could thus be a strong 
disincentive  to  establish  GMO-free  production  and  would  reduce  the  GMO- 
free market to niche production for high income households.
-  Agronomic  traits:  The  genetic  disposition  for  cross  pollination  and  for 
volunteers will determine in particular the costs on the farm.
-  Market  volume:  Economies  of  scale  can  be  expected  for  any  IP  system. 
The  more  crops  are  traded  under  such  a  system,  the  higher  will  be  the 
potential to reduce costs. Furthermore, if an entire stream can be devoted 
to an IP system, additional costs should be quite low.
-  Seasonality:  A  strong  seasonality  of  market  supply  could  increase  the 
storage costs of an IP system, in particular if the IP crop is grown only in a 
particular region or country.
-  Derived products: IP costs per unit depend on the share of all processing 
products which can be marketed as IP. If only one of a whole range of the 
output products is to be identity preserved, it will bear the whole costs of 
IP.
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the  particular  circumstances.  Buckwell  et  al.  (1998)  concluded  that  first,  IP 
costs are likely to be overstated by those who might not be convinced of the 
need of an IP system and second, they are “likely to change as the industry 
learns  how  best  to  organise  IP  and  as  the  volume  of  material  involved 
increases.”
5.4.  Distribution of costs along the production chain - who pays for IP?
Additional costs for segregation and IP systems have been shown to occur on 
the  different  stages  of  the  production  process.  However,  these  costs  can  be 
shifted between the different stages along the chain. Analysing their allocation 
is  important  to  understand  the  economic  effects  of  IP.  Four  factors,  which 
determine  the  sharing  out  of  costs  have  been described  by  Buckwell et al., 
(1998):
-  Price responsiveness (own-price elasticity): Depending on the responsive­
ness of demand and supply to price at each of the stages additional costs 
can be shifted - at least partially - to the previous or to the following stage 
of the production chain. Generally the less price-responsive demand is at a 
certain  stage,  the  more  of  the  additional  costs  will  be  absorbed  by  the 
consumer at this stage. Equally, the less price-elastic is supply, the more of 
the additional costs have to be absorbed by the producer (Buckwell et al., 
1998).
Availability  of  substitutes:  The  more  substitutes  are  available,  the  more 
responsive  would  be  the  price.  Thus  for  products,  which  can  easily  be 
substituted, additional costs will hardly be shifted to the processor or the 
final consumer. In this case, it will be the farmer who has to bear most of 
the  additional  costs  of  IP.  On  the  other  hand,  if  a  product  is  difficult  to 
substitute, it will be the consumer who has to bear the IP costs.
-  Market structure: Price-responsiveness can be affected by the competitive 
structure  of  the  industry.  The  more  concentrated  the  structure,  the  more 
likely that any additional costs are passed over to the previous or the next 
stage  of  the  chain.  In  the  food  sector,  the  market  power  is  in  general 
stronger at the food processing and retailing levels compared to the farmer 
and consumer level. Thus IP costs are very likely either to be passed back 
to  the  farmer  through  lower  prices  for  his  products  or  to  be  passed 
forward to the consumer in the form of higher food prices.
-  Agricultural price policy: Agricultural policy measures, in particular those 
established  to  control  agricultural  prices  may  have  an  adverse  impact  on 
the  transmission  of  additional  costs  to  the  consumer.  On  the  other  hand, 
price policy may also reduce the transmission of benefits of cost reductions 
by  new  technologies  and  thus  reduce  the  economic  incentives  to  apply 
these innovations.
These factors apply to all three IP approaches which have been identified in 
the context of GMOs.
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to the consumer, these crops have to be handled separately, in order to 
preserve their value through the chain. Price elasticity of supply can be 
expected  to  be  high.  On  the  demand  side,  the  new  trait  will  create  a 
situation in which the scope for substitution is limited and thus demand 
gets fairly price inelastic. The effect will be that most of the additional 
cost  can  be  passed  on  to  the  consumer.  The  market  will  be  a  niche 
market - at least in the beginning - for each of the new traits introduced 
by genetic modifications.
Thus it is very likely that the consumer will be charged a premium which 
covers  not  only  the  intrinsic  additional  value  of  the  new  product,  but 
also the costs to handle them separately through the food chain.
2.  Voluntary  IP  of  GMO-free  products:  If  GMO-free  products  have  a 
specific value to consumers, they are willing to pay a premium for these 
products, which are handled separately or identity-preserved.
With a voluntary IP system for GMO-free products, additional costs will 
be  borne  by  the  producers,  processors  and  consumers  of  these  GMO- 
free  products.  The  scope  for  passing  over  the  costs  of IP for a  GMO- 
free  product  will  depend  upon  how  strong  the  demand  for  GMO-free 
products will be. The stronger the demand, the less responsive will it be 
to price change. This would increase the scope for suppliers to pass over 
the costs of IP in the form of higher prices (Buckwell et al., 1999). Thus 
it will be more likely that the consumer bears the costs than the farmer 
of GMO-free crops.
For  the  short-term  development,  however,  some  impact  on  the  market 
for  GM  crops  cannot  be  excluded.  In  a  short-term  analysis  supply  of 
GM and  GM-free products is assumed  to be fixed. Consumers without 
specific  preference  for  non-GMO  products  will  not  care  whether  they 
consume  GMO  or  GMO-free  products.  However,  GMO-free  demand 
will  not  accept  GMO  supply.  So  there  will  be  one-way  situation  for 
substitution and the magnitude of demand for IP products relative to the 
demand  for  commodities  will  be  the  crucial  factor  to  determine  the 
distribution  of  the  additional  costs  as  well  as  of  the  price  of  GM  and 
GMO-free crops (see also section 5.3.2).
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distinguished:
Scenario 1: The share of total demand for GMO-free crops is greater 
than the share of GMO-free market supply.
In this case, severe market disruptions may occur as processors strive 
to  locate  and  purchase  GMO-free  crops.  With  a  high  demand  for 
GMO-free  crops,  their  prices  would  increase  rapidly  and  a  surplus  of 
GM products is likely to be build up. Substitution of GMO-free by GM 
products  would  in  general  be  rejected  by  consumers  or  processors 
which are looking to avoid GMOs. However, the increasing price gap 
might  be  an  incentive  for  some  of  them  to  change  their  minds  and 
accept purchasing GM products.
Furthermore, a surplus of GM crops could only be avoided by offering 
a  discount  which  makes  customers  buy  more  GM  crops.  Processors 
will  be  forced  to  develop  a  price  schedule  that  reflects  the  relatively 
low value of GMOs in the market. The discount would be applied to all 
GMOs  and  not  just  to  the  proportion  of  GMOs  that  are  in  surplus. 
(Miranowski et al. 1999)
Scenario  2:  The  demand  for  GMO-free  products  is  relatively  small 
compared to the available supply.
The  marketing  of  the  GM  crop  would  not  be affected by  the relative 
surplus of GMO-free crops. Any GMO-free crop would be accepted by 
the conventional production chain. In this case, the purchasers will not 
pay  a  premium  or  discount  for  GMO-free  products  and  producers  of 
GM-products will not have to take a discount.
However, farmers have to invested in producing GMO-free crops and
-  at least for some of them - the additional costs will not be covered by 
the  conventional  marketing.  It  would  be  those  farmers  and  the 
consumers of GMO-free products who are very likely to bear the costs 
under scenario 2.
3.  Compulsory  IP  for  GM  products:  Since  most  of  the  quality  traits 
introduced by genetic engineering can be expected to rely on voluntary 
IP  to  preserve  the  additional  value,  GMO  traceability  would  mainly 
affect crops with modification of agronomic traits.
Agronomic  traits  address  the  producer  and  the  crops  are  marketed 
similar  to  conventional  crops.  Thus  any  consumer  without  particular 
preference  for  GMO-free  food  should  be  indifferent  when  comparing 
GM  and  GMO-free  products.  A  high  degree  of  substitutability  can  be 
supposed,  because  the  consumer  could  easily  switch  completely  to  the 
conventional  product  if  additional  cost  for  IP  would  increase  the  price 
of  a  product.  This  would  mean  that  IP  costs  would  be  passed  back  to 
primary producers and processors of GM crops. The producers of
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the farm level would reduce the profitability of GM crops.
The relative position of GM and conventional crops could be altered, if 
the  agronomic  trait  is  sufficiently  advantageous  at  the  farm  level.  As 
soon as the GM crop accounts for a significant proportion of all traded 
crops, it becomes the norm and will set the baseline for the commodity 
price of this  crop (Buckwell  et al.  1999,  p.21). This would reduce the 
competitiveness  of  conventional  crops  and  increase  the  incentive  to 
adapt the production programme.
5.5.  Market implications
5.5.1.  EU markets for soybeans and corn
Soybeans: The EU is the world's leading importer of soybeans and soymeals. 
Domestic production of soybeans is covering only a small percentage of EU 
consumption  (table  5.7).  The  degree  of  self-sufficiency  varies  between  6% 
(soymeal) and 18% (soya oil) in 1998/99.
Table 5.7 EU balance sheets for soya beans, meals and oil (1000 t)
Soybeans 1995/96 1996/97 1997/98 1998/99
EU Production 907 978 1 578 1 843
Imports 15 212 14 313 14 189 13 948
Exports 25 28 58 26
Availabilities 16 094 15 263 15 709 15 765
Self-sufficiency (%) 6 6 10 12
Cake and
cake equivalent (meal) 1995/96 1996/97 1997/98 1998/99
EU Production 
- from Community seed 688 741 1 185 1 417
- from imported seed 11 865 11 164 11 067 10 880
Imports 12 678 10 544 10 673 14 110
Exports 735 737 1 253 1 399
Availabilities 24 496 21 712 21 673 25 007
Self-sufficiency (%) 3 4 6 6
Oil and oil equivalent 1995/96 1996/97 1997/98 1998/99
EU Production 
- from Community seed 159 171 274 327
- from imported seed 2 738 2 576 2 554 2 511
Imports 3 15 8 4
Exports 511 816 919 1 008
Availabilities 2 389 1 946 1 916 1 834
Self-sufficiency (%) 7 9 15 18
Source: European Commission 2000
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small  share  (less than  1  Mio  tonnes) is used for food. The EU main - and 
nearly exclusive - trading partners for soya beans and meal imports are Brazil, 
Argentina and the US (table 5.8). During the last years, soybean imports from 
the  USA  have  been  reduced,  while  imports  from  Brazil  increased.  On  the 
other  hand,  soymeal  imports  from  Brazil  decreased  and  imports  from  USA 
and Argentina increased.
The European market is of particular importance for Brazil and Argentina. 40 
to 50% of their soya production is sold to the EU. The USA as the world’s 
leading  soybeans  exporter,  are  sending  10  to  15%  of  their  production 
towards the EU, which, is equal to around 30% of USA soya exports. Thus, 
for soya bean and meal trade, there is a mutual dependency between the three 
main exporters and the EU as the main importer.
Table 5.8 EU imports of soybeans and soymeals
(in soymeal equivalents - soybeans = 79% meal)
1995 1996 1997 1998 1999
Total EU 
imports
mio t 25.5 22.2 20.8 24.8 23.5
of which 
USA
million t
% of total
8.5
33.1%
7.1
32.1%
7.2 
34.7%
7.0
28.2%
4.9
20.9%
Brazil million t
% of total
10.0
39.4%
8.9
40.2%
8.6
41.5%
10.2
41.2%
9.8
41.5%
Argentina million t
% of total
5.8
22.8%
5.2
23.4%
4.0
19.1%
6.1
24.6%
8.0
34.0%
others million t 
% of total
1.2 
4.7%
0.9
4.2%
1.0
4.7%
1.5
6.0%
0.9
3.6%
Source: European Commission 2000
Given this mutual dependency, and taking into account that:
-  more than 50% of the US soybean area and almost three quarter of the 
Argentinean soybean area are under GM crops,
-  segregation of GM and non-GM crops is still limited in the US and there is 
no evidence on segregation in Argentina,
it  is  very  likely  that  animal  feedstuff  in  the  EU  consisting  of  or  containing 
soya  imported  from  these  countries  contain  GMOs.  Soymeals  represent  an 
important  source  of  proteins  for  poultry  and  pigs.  Therefore  it  must  be 
assumed  that  currently  most  chicken  and  pigs  fed  in  the  EU  have  already 
eaten some GMOs.
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which  is  around  100%  (table  5.9).  Imports  contribute  4  -  8%  to  total 
availability on the internal market. Feed use absorbs about 75 - 80% of the 
EU market volume, industrial use accounts for 4.2 Mio t each year (11-12%), 
and human consumption for 2.6 Mio tonnes (7%).
Table 5.9 EU balance sheets for corn (Mio t)
1996/97 1997/98 1998/99 1999/2000 *)
EU Production 34.3 38.1 34.7 36.6
Imports 2.4 1.4 2.9 1.9
Exports **) 1.8 2.1 1.8 1.8
Availabilities 34.9 37.4 35.8 36.7
Self-sufficiency (%) 98 102 97 100
*) estimation **) includes 85-95% processed products and animal feed 
Source: European Commission, Grains Outlook March 2000
However,  imports  of  com  by-products,  in  particular  com  gluten  feed, 
surmount the imports of com grains. In 1999, around 4.7 Mio tonnes of com 
gluten  feed  was  imported  by  the  EU.  The  value  of  EU  com  gluten  feed 
imports  from  the  US  (1998:  500  million  €)  for  instance  is  higher  than  the 
value of com imports (1998: 240 million €).
Table 5.10 EU imports of corn
EU imports 1995 1996 1997 1998 1999
total Mio t 3.9 2.7 2.7 2.0 2.6
of which Mio t 3.3 2.0 1.7 0.2 0.06
USA % of total 86% 77% 64% 12% 1.1%
Argentina Mio t 0.5 0.6 0.9 1.4 2.0
% of total 14% 22% 35% 74% 78%
others Mio t 0.02 0.04 0.03 0.4 0.53
% of total 0.5% 1.5% 1.3% 14.3% 20.4%
Source: European Commission, Comext, 2000
For com the USA is the worlds leading producer and exporter, although only 
20%  of  the  US  com  production  is  exported.  The  main  part  is  sold  on  the 
domestic  market  for  feed  (60%)  or  non-food  uses  (ethanol)  (USDA,  2000). 
EU imports of US com have decreased dramatically. The share of US in EU 
com  imports  dropped  from  86%  in  1995  to  12%  in  1999.  Meanwhile 
Argentina has become the major supplier for EU imports.
ECONOMIC IMPACTS OF CM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 89Table 5.11 EU imports of corn by-products
1995 1996 1997 1998 1999
Total EU imports Mio t 7.0 5.8 5.8 5.4 5.4
of which 
Corn Gluten Feed Mio t 6.1 4.7 4.8 4.6 4.661
Brewers grains Miot 0.9 0.5 0.6 0.7 0.628
Corn germ cake Mio t 0.53 0.39 0.10 0.129
Source: DG Agriculture /Member States
5.5.2.  Market supply to serve potential EU non-GMO demand
Soybeans:  World  production  of  soybeans  is  expected  to  be  153.5  Mio  t  in 
1999/2000  (USDA  forecast).  Neglecting  any  difference  in  average  yield 
between  GM  and  non-GM  varieties,  GM  soybean  production  can  be 
estimated to exceed 50 Mio tonnes in the marketing year 1999/2000. Cross­
pollination  is  not  a  concern  for  soybeans,  and  refuge  stripes  have  not  been 
requested.  Nevertheless,  even  if  co-mingling  is  very  likely  to  reduce  the 
available non-GM quantity, non-GMO production should be sufficiently large 
to supply EU import demand.
The main producers, in particular the US have already reacted to the EU and 
•the Japanese demand. The Iowa State  University has estimated that  the US 
market should handle the situation quite easily, if about of 7 to 10% of EU 
demand  would  switch  to  non-GMO  soya  products.  However,  if  EU  food 
retailers  and  consumers  should  decide  to  reject  meat  from  animals  fed  with 
GM  soymeal,  a  significant  price  difference  between  GM  and  conventional 
soya would emerge. Therefore, the consumer attitude on meat from animals 
fed with GMO feed-stuff will be a crucial factor for the price development.
Furthermore,  other  factors  may  influence  EU  import  demand  for  non-GM 
soybeans:
-  there is certain scope to substitute soya by other products,
-  EU soymeal import demand has proven to be quite price elastic.
-  Sourcing non-GM soybean suppliers often implies establishing new trade 
partnership, including contracts governing identity preservation, which has 
a cost (e.g. transaction) and requires time. When the number of significant 
exporters is limited as is the case for soybeans, it is even more difficult to 
find alternative suppliers.
Corn:  The  usable  percentage  of  non-GM  com  crops  is  uncertain,  although 
the  percentage  of  GM  plantings  is  quite  well  known.  Farmers  have  been 
requested  to  plant  alternating  stripes  of  Bt  and  non-Bt  com  to  provide 
refuges  for  com  borers  and  to  reduce  the  probability  of  building  up 
resistance. Thus some of the non-GM com would be cross-pollinated and co­
mingled with the GMO crop during harvest.
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specific clusters like baby food.
According to a recent survey of nearly 1200 US elevators about a quarter of 
the respondents will segregate GM and non-GM com and 20% will segregate 
soya in autumn 2000. One out of ten elevators has declared to offer a price 
premium  for  conventional  com  and  14.3%  are  planning  to  offer  a  premium 
for conventional soya. The resistance to buy GM crops also differs among the 
two crops. Only 12% of the elevators are planing to refuse biotech soybeans 
in  fall  2000  and  18.4%  of  the  elevators  will  refuse  to  buy  biotech  com 
(Pioneer Hi-Bred International, 2000).
According to a Reuters5 survey of 400 US farmers, 15% of them have made 
or  are  planning  to  make  investments  to  handle  or  segregate  GM  crops. 
(Reuters Business Brief 13 Jan 2000).
US reaction to non-GM demand
For the USA, some estimations of possible market share have been made: If 
the entire US food processing industry switched to non-GM com, the market 
for  non-GM  com  would  constitute  8%  of  the  1998  US  com  market.  If  the 
sweetener  and  the  ethanol  (by-product  of  com)  industries  joined,  non-GM 
com  would  constitute  20%  of  the  US  com  market.  Finally,  17%  of  the  US 
1998  production  was  exported  of  which  80  to  90%  is  fed  to  livestock  and 
only a small percentage is directly processed into food products. This implies 
that an  upper limit of the  market share  for non-GM  com in  the US is 37% 
(Miranowski et al., 1999).
A  French  research  team  (Valceschini,  1999)  is  assessing  the  economic 
relevance and the technical feasibility of non-GM supply chains. Preliminary 
results  on  consumer  reaction  with  regard  to  GM  food  were  presented  in 
December 1999. The researchers observed the buying decisions of consumers 
when  choosing  between  GM  and  conventional  products, the GM ones being 
properly  labelled.  Based  on  the  observed  sample,  one  third  of  consumers 
reject  GM-labelled  products,  another  third  would  buy  them  if  they  were 
cheaper than presently and a last third does not care and buys them. On this 
provisional  basis,  the  authors  assumed  that  appropriate  labelling  of  the  GM 
nature/origin  of  foodstuffs  will  have  a  significant  impact  on  consumer 
demand. However it is difficult to quantify this impact.
It  is  interesting  to  note  that  three  consumer  groups  of  the  same  size  are 
identified.  This  could  echo  the  three-tiers  market  previously  identified:  GM, 
non-GM and GM-free. The "middle" group of consumers shows a very price- 
elastic behaviour. If GM foodstuffs are cheaper than presently, which means 
cheaper  than  conventional  food,  these  consumers  could  adopt  them.  This  is 
another  factor  suggesting  a  possible  decline  in the  market share of the non- 
GM tiers.
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The EU  balance  sheets  for  soya  and  com  have  shown  that  the  main  use of 
soya and com is in the feed sector, which will have a significant effect on the 
breakdown  of  demand  between  the  GM,  conventional  and  GMO-free 
segments.  The  EU  Commission  has  announced  to  table  a  proposal  dealing 
with novel feed, including GM feed in the second half of 2000. The labelling 
rules and in particular the level of the tolerance threshold will be key elements 
influencing market behaviour.
In  Europe,  some  operators  are  already  organising  non-GM  soybean  supply 
chains  for  animal  feed  (see  box  on  Soya  de  Pays).  Depending  on  the 
quantities needed, the origin is mainly domestic (French and Italian soybean 
production)  or  foreign,  in  particular  imports  from  Brazil.  However,  these 
initiatives  concern  a  limited  share  of  the  feed  market.  Most  initiatives  are 
taken  in  the  poultry  sector.  This  might  echo  the  attempts  to  restore  market 
confidence  after  the  dioxin  crisis.  In  addition  the  market  for  poultry  is  a 
segmented one, there are already price premia for identified quality (example 
red label chicken).
Soya de Pays, France
Feed  producer  Glon  Sanders  and  poultry  producer  Bourgoin  have 
established  a  production  chain  for  non-GM  eggs  and  poultry  meat 
production  based  on  French  non-GM  soya.  Participating  farmers  are  not 
allowed  to  plant  imported  US  soybean  seed,  have  to  enable  traceablity 
back  to  the  producer,  respect  distance  from  pollution  sources  and  other 
requirements.
The  costs  of  IP  are  entirely  bome  by  soymeals,  as  non-GM  soybean  oil 
cannot be easily valued because of substitution with rapeseed oil. French 
non-GM soybeans cost 30% more than imported ones. The first chickens 
fed  with  non-GM  soya  ("soja  de  pays")  have  been  on  shelves  in  April 
2000. The first eggs were already introduced in February and their price is 
15%  higher  than  standard  eggs.  Farmers  producing  chicken  said  that 
thanks to the "soja de pays" initiative, they could get a premium of 15 €/t. 
Based on increasing demand from processing industries, areas under "soja 
de  pays"  are  forecast  to  raise  from  20,000  ha  in  1999  to  60,000  ha  in 
2000, which represents 60% of the French soybean area.
While  poultry  is  mainly  fed  with  compound  feedstuffs,  cattle  and  pigs  are 
both  fed  with  compound  and  simple  feedstuffs.  In  the  EU  42%  of  the  key 
marketable  feedstuffs29  are  absorbed  by  the  pig  sector  and  20%  by  poultry. 
Soymeals also  enter  in  the  feed ration of cattle, which  accounts for  32%  of 
the  EU  feedstuffs  market.  However,  the  use  of  soybeans  in  cattle  rations  is 
more price elastic than for pig and poultry, mainly because of the number of 
available substitutes.
29  Marketable feedstuffs do not include green forages.
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Soymeals, com and its co-products account for key elements in animal feed. 
Three groups can be distinguished among key marketable feedstuffs:
-  cereals (54% of marketable feeding stuffs in the EU);
-  energy rich elements (27%),
-  protein rich elements (19%).
Figure 5.6 Protein and Energy rich feedstuffs on the EU market
PROTEIN-RICH FEEDSTUFFS
48%
□ Soya oil-cakes B Other oil-cakes □ Other proteins
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feed.  Com  Gluten  Feed  and  Com  Germ  Cakes,  which  are  mainly  imported 
from  the US, represent  20%  of energy rich feedstuffs.  Soymeals,  which are 
mainly  imported  from  Argentina  and  Brazil,  represent  nearly  half  of  the 
protein rich elements in the EU. This points the EU dependency on imports 
of com products and soybeans for energy and protein rich feedstuffs, and to 
its exposure on GM products.
In short term, segregation of the feed market into GMO and non-GMO stuff 
would increase feed production costs and thus animal production costs within 
■  the  EU.  Depending  on  the  market  development,  imports  in  soybean  meal, 
com gluten products and other ingredients might be reduced and demand for 
locally  produced  feedstuffs,  particularly  rapeseed  meal,  barley  and  wheat 
could increase. (Gill, 1999)
As long as there are significant origins for non-GM crops, the need to set up 
IP  systems  would  be  limited.  Trade  flows  would  just  adapt  to  this  new 
demand.  Secondly,  if  a  product  can  easily  be  substituted,  then  IP  is  also 
unlikely  to  occur,  because  it  will  be  far  easier  to  switch  to  the  substitute. 
Thirdly, if the commodity in question has many outlets around the world, the 
reaction on other markets will be relevant to the EU market. For instance, if 
Japan  is  paying  a  premium  for  non-GM  soya  then  any  IP  system  set  up  is 
going to supply this market first.
Non-food/feed  uses  of  GM  crop  are  expected  to  provide  market  oppor­
tunities  in  the  medium  or  long  term.  There  are  possibly  good  prospects  for 
renewable resources used in energy production and in the chemical industry. 
In general, the societal and ethical acceptance of these applications is higher 
than that of GM food products (Menrad, 1999 and Eurobarometer, 2000).
However,  according  to  Menrad  (1999),  non-food  applications  of 
biotechnology would need a concerted effort involving science, industry and 
politics, also taking into account the interests of other groups (eg farmers) to 
speed up.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 945.6. The trade issue/dimension
While  accounting  for  the  main  producer of  GM  com  and  soybeans,  the  US 
are  the  leading  exporter  for  these  commodities.  Argentina  is  the  second 
biggest producer of GM soybeans and the third exporter. The main importing 
countries  for  these  commodities,  the  EU  and  some  South-East  Asia 
countries, have taken a restrictive stance on GM food. In particular, labelling 
of the GM nature of food ingredients is compulsory in the EU. Japan intends 
to implement mandatory labelling by the second half of 2000.
Not  surprisingly,  this  situation  has  become  a  trade  issue.  However,  it  is 
difficult  to  isolate  the  possible  effect  of  biotechnology  on  developments  in 
trade,  as  many  other  factors  play  a  role,  like  changes  in  competitiveness, 
transportation costs and the transaction costs of giving up of long-established 
trade links.
The issues at stake are of a different order of magnitude for soybeans and for 
com.  Between  1995  and  1997,  EU  imports  from  the  US  were  worth,  on 
average, 2 billion € for soybeans and soymeals and 0.03 billion € for com. In 
addition, EU imports of Com Gluten Feed are estimated to be worth around 
500 Mio €.
US soybean exports declined from 26 to 20 Mio tonnes between 1997 and
1998,  while world soybean trade held fairly steady. EU soya imports from the 
US have been partially replaced by imports from Argentina. The USD A has 
concluded that "traditional competitive forces (primarily prices) appear to be 
the  main  driving  factors  behind  the  changes  in  observed  bilateral  trade 
patterns". As the share of GM soybeans is much higher in Argentina than in 
the  US,  this  shift  in  trading  pattern  cannot  be  attributed  to  reluctance  to 
import GM soybeans.
The  drop  is  even  sharper  for  com  than  for  soybeans.  US  com  exports  fell 
from 60 Mio tonnes in 1995 to 41 Mio in 1998. Most of the drop occurred 
on South-East Asia markets (with the exception of Japan) and is explained by 
the situation of China, which became again a net exporter of com. On the EU 
market for com, the share of US has steadily fallen while the share of other 
partners, in particular Argentina and Hungary, has significantly increased. The 
USD A considers that the loss of shares on the EU market results from issues 
related  to  biotechnology,  in  particular  the  differences  in  regulatory 
approaches.
While 11 types of GM com have been approved in the US, only 4 have been 
cleared  at  EU  level  (table  5.12),  and  some  Member  States  have  decided  to 
suspend  authorisations  for  growing.  Non-authorised  GM  crops  cannot  be 
placed on the EU market. In the absence of tolerance thresholds, if traces of 
such  crops  are  found  in  a  given  consignment,  it  cannot  be  cleared  for 
importing  into  the  EU.  According  to  the  USDA,  this  situation  has  created 
uncertainties.
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US EU
GM crops approved % sowings approved pending
Com 11 35% 4 5 among 
which
1 already approved for 
import s&process
2 are the same GM crop but with 
different uses
Soybeans 3 50% 1 none
Rapeseed 3 15% 4 3 only one is same as in US
Source: International Grain Council 1999, expect for % sowings (own estimation)
However,  the  type  of  GM  soybeans  which  is  mostly  grown  in  the  US 
(herbicide  tolerant)  is  authorised  in  the  EU  for  imports  and  processing  (but 
not for growing purposes). According to the USD A, only a small part of US 
areas  have  been  sown  to  non-EU  approved  com  varieties  and  the  EU  only 
accounts for 1% of US com exports.
Trade  issues  have  been  addressed  in  the  Biosafety  Protocol,  which  aims  at 
ensuring  an  adequate  level  of  protection  for  transfer,  handling  and  use  of 
GMOs which might have an adverse effect on biodiversity. Reference is made 
to  the  precautionary  principle  in  this  respect.  It  is  hoped  that  procedures 
foreseen  under  this  Protocol,  in  particular  information  sharing  and 
accompanying  documentation,  will  help  improving  the  predictability  of 
transboundary movements of GMOs.
Biosafety Protocol
The Biosafety Protocol provides a framework for addressing environmental impacts of 
bioengeneered products that cross international borders. It was concluded in Montreal in 
January 2000 by delegates from 138 countries.
"In accordance with the precautionary approach (...), the objective of this [Biosafety] 
Protocol is to contribute to ensuring an adequate level of protection in the field of safe 
transfer,  handling  and  use  of  Living  Modified  Organisms  resulting  from  modem 
biotechnology that may have an adverse effect on the conservation and sustainable use of 
biological  diversity,  taking  also  into  account  risks  to  human  health,  and  specifically 
focussing on transboundary movements" (Article 1).
The procedures foreseen under the Protocol are different for Living Modified (LM) seeds 
and commodities.
•  For LM seeds: Advance Informed Agreement procedures shall apply before the first 
transboundary  movement  of  seeds.  Notification  of  exporter  before  movement. 
Accompanying documentation with precise identification and requirements.
•  For LM commodities used as food, feed or for processing:
-  Information sharing on approved LMOs through Biosafety Clearing House. 
Possibility for developing countries without domestic regulation on LMOs to 
take  decisions  on  imports  under  the  Protocol,  to  benefit  from  assistance 
(financial, technical, capacity-building).
-  Documents  accompanying  transboundary  movements  of  LMO  commodities 
stating  that  they  "may  contain  LMOs".  Detailed  requirements  on  the 
identification of LMOs should be adopted within two years after the entry into
________force of the Protocol (entry into force itself might require 2 years).________
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revision. Changes are also considered in the US and in many other countries. 
Biotechnology is discussed in the context of the transatlantic dialogue.
Finally, it is worthwhile noting that Identity Preserved markets are expected 
to increase in number and market share, with or without GMOs entering the 
markets. Trade experts have estimated a 25% market share for IP com and IP 
soybeans by 2005 (Clarkson, 1999). Identity preservation systems in the US 
currently account for 8-10% of US agricultural production, and in ten years’ 
time would be accounting for 25-30% (Young, 1999).
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APPENDIX A
PROFILES OF THE LEADING AGRI-BIOTECH FIRMS 
AgrEvo (Headquarters in Germany)
AgrEvo (A company owned by Schering and Hoechst, the latter having merged with 
Rhone Poulenc to form Aventis) is the fourth largest global agricultural and chemical 
producer and marketer. A high proportion of sales revenue is spent on research and 
development  (13%)  of  which  80%  is  spent  on  chemicals  and  20%  is  spent  on 
biotechnology.  The  company  has  invested  heavily  on  seed  activities.  In  1999,  it 
acquired  three  Brazilian  seed  companies  (Mitla  Pesquisa,  Sementes  Ribeiral  and 
Sementes Fartura). All three companies specialise in hybrid corn seed. AgrEvo also 
completed  the  acquisition  of  Biogentic  Technologies  B.V.  (BGT).  BGT  is  a  100% 
owner  of  the  Proagro  Group,  which  has  its  headquarters  in  New  Delhi,  India.  In 
overall  terms,  Proagro  is  the  second  largest  Seed  Company  in  India  and  is  ranked 
number one in corn, millet and forage sorghum and number two in India in sunflower 
and grain sorghum.
AgrEvo’s investment in genomics has been quite substantial in the latter part of 1998 
and  continues  in  1999  with  its  95%  acquisition  of  PlantTec  Biotechnologie  in 
September of this year and its acquisition of GeneX (terms undisclosed) in October 
1999. The company has extensive agreements with numerous research institutes and 
Genomics  corporations  such  as  Cotton  Seed  International  Proprietary  Ltd,  Gene 
Logic, Center for Plant Breeding & Reproductive Research and Lynx Therapeutics.
Novartis (Headquarters in Switzerland)
Novartis  was  formed  in  1996  as  a  result  of  a  merger  between  Ciba-Geigy  (agro­
chemicals) and Sandoz (pharma) and has core businesses in healthcare, agribusiness 
and nutrition. It is a lifesciences company and has invested significantly in agricultural 
biotechnology and genomics. In October 1998 the company announced that it would 
invest  US$600  million  in  plant  genomics.  This  would  involve  the  formation  of  the 
Novartis  Agricultural  Discovery  Institute  (NADI)  which  would  be  located  in  San 
Diego,  California.  The  company  is  involved  in  numerous  collaborations  with 
agrigenomic partners.
In terms of acquisition of seed companies, Novartis acquired the majority of the seed 
activities of Eridania Beghin-Say, a company that specialises in breeding, producing 
and marketing field-crop seeds. The transfer of activities include the majority of the 
Italian subsidiary Agra, the French Agrosem companies the Spanish Koipesol Semilla 
company as well as Hungarian and Polish seed activities.
Although Novartis holds participations in the food industry, its strategy appears to be 
more  input-oriented,  at  least  for  the  time  being.  Among  the  partners  of  Novartis  in 
the  food  industry,  the  example  of  Gerber  illustrates  the  case  of  non-integration 
between biotech and food activities. Gerber announced earlier this year that it would 
not include GM ingredients in its baby food.
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Monsanto  spinned  off  its  chemical  activities  in  1997,  and  instead  acquired  biotech 
firms such as Calgene. It already entered the seed market in 1996 when it formed a 
strategic  alliance  with  DeKalb  Genetics.  Continuing  on  from  this,  Monsanto 
purchased a 40% stake of DeKalb in the first half of 1998 for US$2.5 billion. This 
gives Monsanto an important outlet for its Roundup Ready and YieldGard varieties. 
In  September  1996  Monsanto  acquired  Asgrow  Agronomics  for  US$240  million. 
Asgrow  Agronomics  has  45%  of  its  sales  in  Soybeans.  In  January  1997  Monsanto 
agreed  to  buy  Holden’s  Foundation  Seeds  for  US  $1.02  billion.  This  acquisition 
along with other key acquisitions has given Monsanto key channels of distribution for 
its  genetically  altered/modified  seeds.  Then  in  1998  Monsanto  announced  an 
acquisition  plan  for  Delta  and  Pineland  outright  for  US$1.9  billion.  Delta  and 
Pineland  specialises  in  GM  cotton  and  it  already  distributes  Monsanto’s  Bollgard, 
Ingard  insect-protected  cotton  and  Roundup  Ready  Cotton.  Monsanto  however 
dropped this plan in early 2000, following both concerns expressed under the Anti- 
Trust Law and terms agreed under the merger with Pharmacia. Finally in July 1998, 
Monsanto  acquired  Plant  Breeding  International  Cambridge  (PBI)  for  US  $525 
million.  PBI,  a  UK-based  company,  specialises  in  the  breeding  and  marketing  of 
winter  wheat,  barley,  rapeseed,  potatoes  and  other  crops.  Taken  together  all  the 
above acquisitions give Monsanto a considerable market share of the seed business 
both in the United States and in South America.
In  addition  to  the  above  acquisitions,  Monsanto  also  entered  into  a  number  of 
agreements  with  both  seed  companies  and  genomic  research  institutions.  In  April 
1998 Monsanto obtained licenses to all aspects of GeneTrace’s technologies for plant 
and animal agriculture.
While Monsanto has heavily invested in input-traits and seed activities, it also has a 
portfolio  of  second-generation  products,  which  are  more  oriented  towards  food 
processors/consumers.  In  the  early  part  of  this  year  Monsanto  entered  into  an 
agreement  with  Cargill  to  create  and  market  new  products  enhanced  through 
biotechnology for the crop processing and animal feed markets.
Dow Agroscience (Headquarters in the US)
Dow Agroscience is a wholly owned subsidiary of The Dow Chemical Company and 
was formed in 1998 after Dow purchased the remaining shares of its joint partner Elli 
Lilly.  The  joint  venture  between  Eli  Lilly  and  Dow  was  formerly  known  as 
DowElanco. Dow’s commitment to biotechnology was exemplified by the formation 
of a new company in September 1998 called Advanced AgriTraits LLC. The strategy 
of the new company involves developing the company’s own technology and forming 
alliances  with  other  companies  to  expand  its  biotechnology  base  in  a  cost-effective 
way.  Dow  Agroscience  formed  a  strategic  partnership  and  controlling  interest  in 
Mycogen in 1996. Mycogen is the sixth largest Seed Company in the United States. 
Mycogen  is  the  biotech  arm  of  Dow  Agrosciences  and  concentrates  on  agronomic 
traits for new plant varieties. Dow Agrosciences also has numerous agreements with 
many  different  companies.  The  agreements  are  for  the  most  part  concerned  with 
crops such as com and canola. At the end of 1997, Dow signed an agreement with 
Seed  Genetics  Inc.  to  develop,  market  and  license  high  oil  com  inbreds  using 
DowElanco’s technology (now Dow Agroscience), as well as biotech traits as they
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 99become  available.  In  1998  Dow  formed  an  alliance  with  three  major  companies, 
Performance  Plants  Incorporated,  BioSource  Technologies  Inc.  and  Illinois 
Foundation Seeds all of which are in genomics. In the second 1999 Dow formed a 
joint venture with Danisco to develop new varieties and hybrids that will increase the 
value of canola to customers.
Zeneca (Headquarters in the UK)
In 1994, Zeneca introduced the first GM-food crop on both the US market, namely 
an  increased  pectin  tomato.  Proceedings  for  authorising  its  introduction  on  the  EU 
market  are  on-going.  Therefore,  Zeneca  is  considered  to  have  an  output-oriented 
strategy.  Nevertheless,  it  also  has  invested  in  the  seed  market,  as  well  as  in  input- 
traits.  In  1996,  Zeneca  and  Van  der  Have  formed  Advanta,  which  now  accounts 
among  the  top  5  of  the  seed  industry.  It  then  acquired  several  biotech  companies 
active  in  disease  resistance  and  quality  traits.  In  1998,  Zeneca  seeds  formed  an 
alliance  with  American  Cyanamid,  to  combine  Zeneca's  expertise  in  biotechnology 
and  Cyanamid's  one  in  herbicide  tolerance.  Cyanamid  was  the  first  company  to 
introduce herbicide tolerant com in 1992, however it is not considered as transgenic. 
This  company  has  searched  for  ways  of  naturally  incorporating  herbicide  tolerance 
into the plant through traditional and hybrid methods of plant breeding.
Rhone-Poulenc (Headquarters in France)
Rhone-Poulenc  is  a  lifesciences  company  and  has  over  200  production  plants  in 
Austria,  Brazil,  France,  Germany,  Italy,  Spain,  Switzerland,  UK  and  the  United 
States.  In  December  1998  it  announced  a  merger  with  Hoechst  (owner  of  AgrEvo, 
together with Schering) to create Aventis. The merger was effective in December
1999,  with the first quotations for Aventis on stock exchanges places. Hoechst and 
Rhone-Poulenc have agreed to spin-off their chemical activities before merging. As a 
result,  Aventis  will  focus  on  life-sciences,  in  particular  on  pharma  (70%  of  the 
turnover).  Its  agri-biotechnology  sector  is  quite  small  but  is  a  growing  part  of  the 
overall  operations  of  the  company.  The  plant  and  animal  health  sector  contributed 
19%  of  total  sales  in  1998,  which  were  US  $15.5  billion  in  total.  Unlike  its 
counterparts  in  the  United  States,  the  strategy  of  Rhone-Poulenc  has  been  to  focus 
on joint ventures and research agreements without the cost that would be involved in 
acquiring seed companies. The company has a number of agreements in the area of 
genomics, including, Biogemma, The National Agricultural Centre Brazil (which will 
pursue  the  development  of  GM  soybeans)  and  Dow  Agroscience  where  the 
collaboration  will  focus  on  GM  traits  in  com,  canola,  soybeans,  sunflower  and 
cotton.
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DuPont formed a joint venture with Pioneer in 1997 in which DuPont purchased a 
20% stake in Pioneer for US$1.2 billion. In November of this year DuPont purchased 
the  remaining  80%  of  Pioneer  for  US$7.7  billion.  Although  DuPont  has  gained  an 
extended access to the seed market by acquiring Pioneer, it is considered to be more 
output-oriented. While other companies have focused on input traits i.e. those traits 
which are of particular benefit to farmers in improving the yield of the crop, DuPont 
has  remained  focused  on  output  or  value  added  traits  or  those  traits  which  are  of 
direct benefit to the processor and consumer. In addition, Du-Pont/Pioneer has also 
developed  quality  traits  by  conventional  breeding.  Pioneer  seeks  to  improve  the 
output  traits  of  crops  and  specialises  in  GM  com,  soybeans  and  other  oilseeds  in 
order  to  improve  their  oil,  protein  and  carbohydrate  composition.  In  January  1998, 
DuPont  acquired  Protein  Technologies  International  for  US$1.5  billion.  Protein 
Technologies  International  supplies  soy  proteins  for  the  food  and  paper  processing 
firms  and  has  a  75%  market  share  worldwide  for  soy  proteins.  DuPont  also  has  a 
number of agreements with research institutes such as the John Innes Centre and has 
an agreement with Lynx Therapeutics in which DuPont will have exclusive access to 
Lynx’s DNA sequence analysis technologies for the study of com, soybeans, wheat 
and rice.
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Table A.4.1: Commodity versus IP prices for US corn/maize and soybeans 
(November 1999).
Price to farmer
Corn/maize characteristic regular non-GMO organic
US#2 yellow Commodity grade, not IP 75 81 150
US#2 yellow high oil 81 NA 150
US#2 yellow high starch 79 79 150
US#2 yellow hard endosperm 83 83 150
US#1 white soft endosperm 94 94 169
US#1 white hard endosperm 94 94 169
US#1 white very high protein 113 113 188
US#2 blue color 311 311 311
Price to farmer (€/t)
Soybeans characteristic regular non-GMO organic
US#1 Commodity grade, not IP 169 177 414
US#1 medium high protein 190 190 483
US#1 very high protein 224 224 518
US#1 very high protein and 
excellent taste
241 241 621
US#1 sugar balanced 310 310 724
US#1 low lipoxygenase 241 241 621
Source: Clarkson, 1999.
ECONOMIC IMPACTS OF GM CROPS ON THE AGRI-FOOD SECTOR A FIRST REVIEW 102Table A.4.2: Comparison of additonal costs of firms incurred in handling 
specialty corn/maize and soybeans (in €/t).
Average
(n=55)
Corn/maize Soybeans
Storage (per month) 1.07 1.11 1.40
Handling/ segregation 3.56 2.22 5.26
Risk management 1.42 0.37 2.46
Transportation 2.49 1.48 4.21
Analysis/testing 0.36 0.37 0.35
Marketing 1.07 0.74 1.40
Other 1.42 0.00 2.10
Subtotal 11.39 6.29 16.84
Purchasing (incl. premium) 16.73 7.03 25.96
Total 28.12 13.32 42.79
Source: Bender et al. 1999.
Table  A.4.3:  Comparison  of  additonal  costs  of  firms  incurred  in  handling 
different specialty crops (in €/t).
Food corn
(n=7)
HO corn 
(n=21)
Food
soybeans
(n=26)
STS
Soybeans
(n=10)
Storage (per month) 1.48 0.37 1.40 0.70
Handling/segregation 7.03 0.74 7.02 2.10
Risk management 0.00 0.37 2.10 2.46
Transportation 2.22 0.00 5.26 0.00
Analysis/testing 0.37 0.37 0.70 0.35
Marketing 3.33 0.37 1.75 0.70
Other 0.00 0.00 3.16 0.00
Subtotal 14.43 2.22 21.40 6.31
Purchasing (incl. premium) 12.95 4.44 37.53 5.26
Total 27.37 6.66 58.93 11.58
Source: Bender et al. 1999.
HO corn: high oil corn
STS soybeans: Sulfonylurea Tolerant Soybeans
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